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Abstract 
Is it possible to find an easy, generic method for protein refolding?  The preparation of 
functionally  active  protein  molecules  from  the  unfolded  state  can  be  a  difficult  task.  
Although  there  are  many  well-established  techniques  for  protein  refolding,  such  as 
dilution, dialysis, chromatography and others, in many instances these methods can be time 
consuming and inefficient.  A rapid, inexpensive and simple method for protein folding is a 
much sought after technique. 
Proteins in the unfolded state (either inclusion bodies or unfolded by chemical or physical 
means) are generally solubilised in solutions containing urea or guanidine hydrochloride.  
The removal of these molecules from the protein environment is commonly utilised as a 
method for triggering refolding. 
A  new  method  for  the  refolding  of  biomolecular  species  has  been  developed  via  the 
formation  of  Protein  Coated  Micro-crystals  (PCMC).    The  formation  of  PCMC  is  a 
recently developed method for the immobilisation protein upon the surface of a water-
soluble  excipient  (salt, amino acid  or  sugar)  via  a  co-precipitation  reaction in a  water 
miscible organic solvent.  These proteins can then be used as immobilised biocatalysts in 
both the aqueous and organic phase.  
In the immobilisation of unfolded, solubilised protein, the solubilising agents (e.g. urea or 
guanidine hydrochloride) are removed from the protein environment as they are soluble in 
the organic phase.  The removal of these molecules initiates protein folding during the co-
precipitation process. 
In the course of this project, a number of proteins were studied in order to observe their 
behaviour in this immobilisation and simultaneous folding process.  Lysozyme was utilised 
as it is an enzyme which is relatively simple to refold from the chemically unfolded state 
by conventional methods such as dilution.  Upon immobilisation of lysozyme from the 
chemically unfolded state, up to 92% of the activity of the native protein was regained.  
The enzyme lipase, which is notoriously difficult to fold, was also used to determine the 
efficiency of this method under more challenging conditions.  Lipase immobilised from the 
chemically unfolded state was seen to regain up to 36 % of the activity of the native 
protein.    
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Definitions 
Protein Coated Micro-Crystals (PCMC) - Protein immobilised upon the surface of a 
water soluble carrier material (excipient) via a co-precipitation reaction in organic solvent. 
Excipient - An inactive water soluble material used as a carrier in the formation of PCMC 
Measured Solids Recovery (%) - A measure of the percentage of the solids (protein and 
carrier) precipitated into organic solvent which is retrieved at the end of the process. 
Theoretical Protein Loading (TPL) (%) - The ratio of protein to the total mass of solids 
used in the precipitation process (e.g. 6 mg of protein upon 54 mg carrier material would 
have a % TPL of (6/(54+6)) x 100 % = 10 %). 
Measure  Protein  Loading  (MPL)  (%)  -  The  actual  protein  loading  based  upon  the 
measured  protein  concentration  of  the  PCMC  upon  reconstitution  (e.g.  if  10  mg  of 
reconstituted PCMC (in 1 ml) have a protein concentration of 0.99 mg/ml, then the % MPL 
of the samples is (0.99/10) x 100 % = 9.9 %). 
Specific  Activity  of Enzyme  - A measure of the change in absorbance of a substrate 
solution with respect to time per milligram of enzyme present per millilitre of solution (i.e. 
dA min
-1 mg
-1 ml
-1) during an activity assay. 
% Activity of Native Protein - A comparison of the activity of the treated samples with 
the native protein.  Calculated by dividing the specific activity of the treated protein by that 
of the native form.    
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1.1  Proteins 
Proteins are the very fabric of life.  The number of different kinds of proteins in the human 
body  approaches  100,000  and  these  molecules are  involved  in  various  processes  upon 
which our lives depend.
1  In fact, every molecule in a living organism is essentially either a 
protein or formed as a result of the action of proteins.
2  Proteins are extremely versatile 
molecules  which  are  involved  in  a  number  of different  biochemical  processes.    These 
include  (but  are  not  limited  to)  the  control  of  gene  expression,  catalysis,  immune 
protection, mechanical support, transportation, growth initiation and nerve impulses.
3, 4 
Proteins  are  of  great  scientific  interest  because  they  carry  out  important  functions.  
However, they are also structurally interesting.  One of the great mysteries of modern 
biochemistry is the ability of these biomolecules to fold spontaneously to form a compact 
three-dimensional structure with all of the intricate detail required for functionality 
5 
1.1.1 Proteins: From Amino Acid Sequence to Three- Dimensional 
Structure 
The  wide  diversity  of  protein  molecules  would  suggest  the  presence  of  fundamental 
differences  in  their  synthesis.    However,  these  are  a  homogenous  class  of  molecules 
manufactured  using the same cellular machinery.  The  basic building blocks of  protein 
molecules are amino acids, of which there are twenty different types.  These monomeric 
units consist of 3 parts: a carboxylic acidl group, an amino group and a side chain.   
 
 
 
Figure 1: The Generic Structure of Amino Acids 
6 
Variations in the functionality of the amino acid side chains include thiols, carboxylic 
acids, alcohols and other groups. The side chain functionality and the sequence of the 
amino  acid  chain  are  responsible  for  the  structural  and  functional  diversity  of  protein 
molecules.
7   
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Amino acids can adopt one of two isomeric forms; either D or L.  However, it is only the L 
form of amino acids which are found as constituents of protein molecules.
8    
The side chains of the 20 amino acids are depicted in Figure 2.   
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Figure 2: The Molecular Structure of the Sidechains of the Twenty Amino Acids Including 
Three-Letter Abbreviations and Single Letter Codes 
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Amino acid residues are covalently linked by peptide bonds in order to form specific linear 
chains.  These resulting strands fold to form three dimensional, active biomolecules.  
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Figure 3: The Peptide Bond.  The bonds shown in bold are the planar peptide bonds 
6 
The peptide bonds shown are planar and usually adopt a trans conformation.
9  Rotation is 
possible around the bond between the nitrogen and α-carbon.  This angle is denoted φ 
(phi).  Similarly, the angle of the bond between the α-carbon and β-carbon is denoted ψ 
(psi).  Obviously this means that there are a large number of possible combinations of 
angles, of which only one subset is correct to form the native structure.    
The hierarchy of biomolecular structure describes the structural characteristics of protein 
molecules.  From a single chain of amino acid residues, secondary structural characteristics 
can be formed including alpha helices, beta sheets and random coils.   Katrina A. Davidson, 2008    Chapter One 
21 
 
Figure 4: The Hierarchy of Protein Structure 
10 
These secondary structural elements can themselves interact to form the tertiary structure 
of proteins.  Multimeric structures can be formed when two or more of these folded amino 
acid chains interact giving rise to protein quaternary structure.
11 
1.1.1.1  Interactions  Involved  in  the  Maintenance  of  Protein  Three-Dimensional 
Structure 
The three dimensional structure of protein molecules is maintained by both covalent and 
non-covalent  interactions.
12    Covalent  bonds  are  formed  by  the  sharing  of  a  pair  of 
electrons  by  two  atoms,  and  example  of  which  are  disulfide  bonds.    Non-covalent 
interactions  are  however,  the  overwhelming  forces  involved  in  the  stabilisation  of  the 
native, folded structure. 
Non-covalent  interactions  are  important  in  the  formation  of  the  organised  structure  of 
proteins.  These non-covalent interactions are involved in the secondary and higher order Katrina A. Davidson, 2008    Chapter One 
22 
structures  within  protein  molecules.    These  include  electrostatic  interactions,  van  der 
Waals forces, hydrogen bonding and hydrophobic interactions.
13 
Electrostatic  interactions  occur  between  oppositely  charged  groups  within  protein 
molecules.  Examples of electrostatic interactions found in proteins include salt bridges, 
ionic bonds and ion pairs.
13   
Van der Waals interactions occur due to the fact that at any one time, the distribution of 
charge  surrounding  an  atom  is  asymmetrical.    This  fluctuating  dipole  subsequently 
influences  the  electronic  distribution  of  the  neighbouring  atoms  via  induced  dipole 
interactions.  These interactions are relatively short range (3-4 Ǻ apart) and low energy 
(approximately 1 kcal mol
-1).
13 
Hydrogen bonding is at the boundary of covalent and non-covalent interactions.  These 
interactions involve the sharing of a proton between two atoms of which one is hydrogen 
donor and the other a hydrogen acceptor.
14  Within protein molecules, the hydrogen donor 
is an oxygen or nitrogen atom which has a proton attached; the acceptor is either oxygen or 
nitrogen.  Hydrogen bonding is vital for the maintenance of protein secondary structural 
characteristics such as helices and sheets. 
 
 
 
 
 
                                            (a)                                                   (b) 
Figure  5:  Hydrogen  Bonding  in  the  Maintenance  of  Protein  Secondary  Structural 
Characteristics 
15 
The hydrogen bonds (>C=O
….H−N−) are shown with dashed lines. The hydrogen atoms are not 
shown 
(a) a-helical segment from Helicobacter pylori (b) fragment of a b-sheet from antithrombin. The first 
and second polypeptide chains are parallel in orientation; the second and the third are antiparallel.  Katrina A. Davidson, 2008    Chapter One 
23 
The  addition  of  hydrogen  bonds  to  protein  molecules confer  increased  stability  to  the 
structure, with the average hydrogen bond having energy of between 3 and 7 kcal mol
-1.
13    
Hydrophobic interactions are the repulsive forces which occur between non-polar groups 
and water.
16  Non-polar groups of protein molecules will tend to form clusters due to their 
repulsion  of  water  and  are  therefore  commonly  found  buried  within  protein  structure, 
separated  from  the  polar  solvent.
16    Hydrophobic  interactions  are  some  of  the  most 
important in driving protein folding. 
1.1.2 Proteins: Structural and Functional Variety 
In general, protein molecules can be divided into four different types: globular proteins, 
fibrous proteins, membrane proteins and natively unfolded proteins.   
Globular proteins are the most abundant protein structure and are generally found to be 
soluble.  Many enzyme molecules are found to have globular structures.  Fibrous proteins 
are  often  found  in  connective  tissue  and  are  generally  mechanically  strong  structures.  
Many fibrous proteins are found to be extremely regular in conformation, large in size and 
insoluble under aqueous conditions.
17  Membrane proteins are found either connected to or 
transecting cell membranes and can act as receptors or transporters, although insolubility in 
conventional  media  has  proven  to  be  an  obstacle  for  widespread  characterisation.
18  
Natively unfolded proteins are found to be important in transcriptional and translational 
regulation in eukaryotic organisms.
19  These protein molecules are found to have a lack of 
specific  tertiary  structure  which  confers  an  ability  to  bind  to  a  range  of  ligands  for 
functionality.  Binding of a ligand generally results in increased order or folding of the 
disordered structure.
19   
1.1.3 Enzymes 
1.1.3.1  Introduction to Enzymes 
Enzyme molecules are proteins which display catalytic activity, usually upon a specific 
substrate or group of substrates.
20  Enzymatic action has been utilised for thousands of 
years, although the molecules responsible were unknown.  Many different processes used 
in  the  preparation  of  alcohol,  cheese  and  other  everyday  products  were  catalysed  by 
enzymes.  Early in the 19
th century, studies were carried out upon the activity of yeast in 
sugar fermentation and the digestion of meat by stomach secretions.  In the latter stages of 
that century, Eduard Buchnar discovered that it was possible to ferment sugar using yeast Katrina A. Davidson, 2008    Chapter One 
24 
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extract, where no living cells were present.
21  He named the enzyme responsible for this 
zymase and for this discovery; he was awarded the Nobel Prize in Chemistry in 1907.
22  
This  was  the  birth  of  enzymatic  research,  leading  to  biochemical  studies,    structural 
biology and genomics. 
1.1.3.2  Enzyme Structure 
Understanding  the  complex  function  of  enzyme  molecules  can  be  extremely  difficult.  
Enzymes act as catalysts for chemical reactions and as such there is much interest in how 
these three-dimensional structures function with a view to industrial implementation.   
Generally,  within  the  three  dimensional structure  of  an  enzyme,  there  is  a  region  that 
includes residues working together to produce this catalytic activity.  This is commonly 
referred to as the active site of the enzyme.
23  Here, the enzymatic substrate will bind via 
highly specific non-covalent interactions so that the catalytic function of the enzyme can 
be carried out.  Examples of such interactions include; hydrogen bonding, van der Waals, 
electrostatic and hydrophobic interactions. 
24 
1.1.3.3  Catalysis 
A  catalytic  species  is  one  which  accelerates  the  rate  of  a  chemical  reaction  whilst 
remaining  unchanged  upon  reaction  completion.    Catalysts  are  retrievable  from  the 
reaction  media  so  that  they  might  be  used  in  subsequent  chemical  transformations.
25  
Catalytic species and their effect upon a chemical transformation can be visualised using a 
reaction profile. 
 
 
 
 
 
 
 
 
Figure 6: The Effect of Catalysts upon the Reaction Profile 
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Catalysts, such as enzymes, lower the activation energy of chemical reactions, such that the 
reaction pathway from reactants to products has changed.  The energy required to reach the 
transition state is reduced.  Although the enthalpy change for the overall reaction process 
remains the same, the energy barrier to complete this process has been reduced resulting in 
an increased rate of reaction.  However, although the activation energy of the reaction is 
changed, the free energy of both the reactants and products remains the same.
27    
1.1.3.4  Industrial use of Enzymes  
Enzymes play a major role in many industrial processes due to their specificity and the 
large scope of reactions in which they can be involved.  The biocatalytic fermentation of 
sugar to form ethanol is a reaction carried out by enzymes present in yeast.  This, as a 
process, has been recognised for thousands of years in the production of alcohols such as 
wine and beer.  Enzyme action is also noted in the oxidation of ethanol to form acetic acid. 
This reaction has been used in the manufacture of vinegar for thousands of years.  In fact, 
there is a plethora of everyday products, from detergents to cheese, where manufacture 
relies upon the action of enzymes.
28 
Enzymes are able to carry out a broad range of highly specific reactions and also those 
which appear impossible by any other route.  However, inherent problems which limit the 
use of enzymes as industrial catalysts are biomolecular instability in the desired reaction 
media and difficulties encountered in recycling.
29  Ambient temperatures (15-50 °C), pH 
(5-9) and use in aqueous media are generally required for enzymes to function efficiently if 
at all, hampering the use of these catalysts in an industrial setting.
30, 31       Katrina A. Davidson, 2008    Chapter One 
26 
1.2  Protein Folding, Misfolding and Aggregation 
The human body contains approximately 100,000 different types of protein, all of which 
are involved in day to day running of many processes upon which we are reliant.
5  Upon 
synthesis  of  linear  chains  of  amino  acids  in  vivo  upon  the  ribosome,  these  then  are 
converted into three-dimensionally packed structures with biological activity.
5 
There is extensive interest in the process of protein folding with regards to the level of 
intricacy  and  efficiency  with  which  this  can  be  carried  out  in  living  cells.    A  greater 
knowledge of the processes by which protein molecules fold has implications in medicine, 
structural biology and materials science.
32 
1.2.1 Introduction to Protein Folding 
As  described  previously,  protein  molecules  are  extremely  complex  three-dimensional 
structures. But how exactly do they obtain a native conformation from the unfolded state?  
This is one of the greatest mysteries in protein biochemistry, but at present there is no 
definitive answer.  
Protein folding is understandably a phenomenally popular area of research.  Researchers 
are attempting to gain an insight into the methods by which protein molecules fold with a 
view  to  utilising  this  knowledge  in  a  number  of  different  areas  of  science  including 
molecular biology, biophysical chemistry and health and disease among others. 
1.2.2 The History of Protein Folding Research 
Over the last hundred or so years, there has been extensive research carried out in an effort 
to determine the physical and structural properties of protein molecules.  It was noted by 
Ramsden in 1910 that “A dead frog placed in a saturated urea solution becomes translucent 
and falls to pieces in a few hours”.
33  Ramsden noted that urea was responsible for the 
decomposition of the frog and this serendipitous finding illustrates some of the earliest 
studies of protein unfolding.  These early studies have lead to an entire branch of science 
devoted to understanding, both physically and mechanistically, just how protein molecules 
achieve their native three-dimensional structure.   
There have been many theories conveyed in an attempt to explain how protein molecules 
fold.  One such influential theory was that of Cyrus Levinthal in the 1960s who speculated Katrina A. Davidson, 2008    Chapter One 
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that there must be specific pathways (both energetic and kinetic) by which protein folding 
occurs.
34  In the unfolded state, a polypeptide chain has a large number of degrees of 
freedom due to the rotation around the φ and ψ angles of the peptide backbone.  As such 
there  is  an  astronomical  number  of  structural  possibilities  for  the  native  state.
35    An 
example of this would be a polypeptide of approximately 100 residues.  If there were only 
3 possible torsion angles for each bond, there would be 9
100 possible conformations.  If all 
of these conformations were explored sequentially, even at picosecond speed, it could still 
take  longer  than  the  age  of the known universe to find the correct conformation.   He 
concluded therefore that there must be specific pathways through which proteins fold to 
find the correct native structure.
34  
Throughout the 1960s and 1970s, Christian Anfinsen was carrying out research on protein 
folding.  At the time Anfinsen was carrying out this work, it was only possible to detect 
gross  changes  in  protein  structure,  due  to  a  lack  of  spectroscopic  and  hydrodynamic 
methods.
32    As  such,  many  biomolecular  folding  experiments  were  carried  out  using 
enzymes for which there were known activity assays readily available.  Protein folding was 
observed by the regained activity of the treated species compared with a native sample.  
Anfinsen  carried  out  a  number  of  studies  with  the  enzyme  ribonuclease.    This  work 
showed that upon oxidative refolding, of the 105 possible disulfide combinations of the 8 
half-cystines, only one is formed; the correct one.
36  This led Anfinsen to speculate that, at 
least in the case of small globular proteins, under a given set of environmental conditions 
(pH, solvent, temperature etc.), the spontaneous folding of protein molecules into a native 
state was governed by the amino acid sequence.
36  This native state would also occur at a 
minimum of free energy.  Anfinsen also speculated that other proteins such as “shuffling 
enzymes” may be  responsible  for the overcoming  of the rate limiting  steps in cellular 
protein folding by acting as catalysts.
37  It was for his work with ribonuclease that, in 1972, 
Anfinsen received the Nobel Prize in Chemistry.
38  
1.2.3 The Nature of the Unfolded State 
To understand the nature of the unfolded state, it is first necessary to consider the native 
structure.  The native state is usually the biologically active form of the protein which 
consists  of  a  number  of  regions  of  secondary  structure  held  together  by  non-covalent 
interactions  such as hydrogen bonds.   However, in the case of the unfolded state, the 
parameters are less well defined.
16 Katrina A. Davidson, 2008    Chapter One 
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Under the generic heading of ‘unfolded protein’, there are a number of subsets which can 
be considered.  Protein molecules can be misfolded, aggregated, in a molten globule or in a 
random coil conformation.  
Misfolded structures are generally incorrectly or partially folded, but not entirely unlike the 
native structure.  These structures can form as a result of a number of different chemical 
modifications including disulfide rearrangement or isomerization of proline residues.
16 
Aggregated  protein  can  form  as  a  result  of  thermal  unfolding  and  generally  contains 
regions of unfolded polypeptide.  There are possibly regions of native structure present, but 
these combine with the unfolded regions to form dense aggregated species. 
The molten globule state is a compact intermediate in the pathway of protein folding.
39  
Within the molten globule, there is often found to be regions which correlate well with the 
peptide  backbone  of  the  native  state  (in  terms  of  secondary  structural  characteristics).  
However, there is found to be a high level of disorder within the amino acid side chains.
16    
Randomly coiled structures can be considered to be the most irregular structure.  Here, 
there is no correlation of structure from one amino acid to the next in the sequence.  Every 
possible conformation is just as likely, therefore the amino acid chain is considered to have 
an entirely random conformation.
16 
In  the  context  of  this  study,  we  are  mostly  concerned  with  the  native,  misfolded  and 
aggregated state. 
1.2.4 Current View of Protein Folding 
Many analytical techniques have been used in order to determine the path embarked upon 
by an amino acid sequence to gain three-dimensional structure.  The use of stopped flow 
techniques has described the formation of intermediates in a staged folding process.
32  It is 
also  known  that  the  hydrophobic  effect  is  one  of  the  major  driving  forces  in  protein 
folding.
39  The hydrophobic effect occurs due to the fact that water molecules have a high 
affinity  for  other  water  molecules  via  the  formation  of  hydrogen  bonds.    Non-polar 
molecules do not have the ability to form such H-bonds, and therefore they are excluded 
from the network of water molecules.  In the case of protein molecules in solution, the 
result of this is the burial of amino acids containing hydrophobic side chains in the interior 
of the structure, thus excluding water. 
40 Katrina A. Davidson, 2008    Chapter One 
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The  processes  by  which  proteins  fold  to  form  native  structure  can  be  imagined  by 
considering an energy landscape or folding funnel.
32, 39  
 
 
 
 
 
 
 
 
Figure 7: Schematic Diagram of a Folding Energy Landscape 
32, 39 
Unfolded protein is found at the top of the folding funnel.  This is energetically high and as 
the protein molecules decrease in energy, a decrease in entropy is also seen (i.e. an increase 
in order).  As the energy of the protein molecules decrease, partially folded protein is seen 
to  populate  local  energy  minima.    This  results  in  the  formation  of  stabilised  molten 
globules of protein.  The energy barrier of these minima is not sufficiently high to trap the 
partially  folded  protein;  instead  these  serve  as  energy  stops  on  the  route  to  native 
structure.
32 
Although research has given an insight as to how protein molecules might actually fold in 
vivo,  an  efficient  method  for  the  folding  of  synthetic  polymers  and  protein  from  the 
unfolded state is still proving an elusive target. 
1.2.5 Protein Synthesis and Folding in the Cell 
The wonder of protein biosynthesis cannot be underestimated.  The manufacture of such 
large molecules with precise sequence and structural characteristics is no mean feat.  The 
synthesis and folding of protein molecules in the cell is a highly complicated and intricate 
process for which the instruction is all detailed in the genetic material of the cell. 
DNA molecules contain all of the information required to biosynthesise every protein in 
the body.  The particular area of a DNA molecule which codes for a specific protein is Katrina A. Davidson, 2008    Chapter One 
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called a gene.  The genes are accessed via unwinding of the DNA double helix close to the 
site  of  the  required  gene.    A  complementary  strand  of  messenger  RNA  (mRNA)  is 
transcribed from the gene where three nucleic acids code for each amino acid.  This group 
of  three nucleic acids which  determine the amino acids used to synthesise  the  protein 
molecule are called codons.  As each of the codons is transcribed, the DNA helix begins to 
recoil, forming the well known double helical structure.    The mRNA molecule vacates the 
cellular nucleus and enters the cytoplasm to undergo translation upon the ribosome.  In 
order for translation to occur, transfer RNA (tRNA) molecules (which are specific for 
types of amino acids) read for the encoded amino acid and subsequently present this to the 
ribosome so that it may become part of the growing polypeptide chain.
41  The truncated 
amino acid chain folds into the lowest energy conformation. However, this often leads to 
obtaining a non-native three-dimensional structure.  Similarly, the high concentration of 
macromolecules  in  the  cellular  environment  can  lead  to  crowding  and  therefore 
aggregation.  Protein molecules, such as molecular chaperones, resident in the cytoplasm 
have the ability to prevent or reverse this misfolding.
5   
Molecular chaperones are proteins whose functions include allowing incorrectly folded 
protein a second chance to find the correct fold.  These chaperones act co-translationally to 
find misfolded protein and subsequently allow it to fold into a native conformation.
32         
1.2.6 The Importance of Understanding Protein Folding 
The  understanding  of  protein  folding  has  wide  implications  for  a  number  of  different 
scientific genres.  This is evident upon considering the number of scientific papers which 
have been published annually over the last forty or so years. 
 
Figure 8: Annual Publication Numbers of Manuscripts (1960-1999) with the Words ‘Protein’ 
and ‘Folding’ in the Title or Abstract 
32 Katrina A. Davidson, 2008    Chapter One 
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These publications included interests from molecular biology, biophysical characterisation, 
protein therapeutics, health and disease and method development and analysis.  
1.2.6.1  Protein Folding in Health and Disease 
Erroneous protein folding is a fundamental problem associated with the onset of many 
diseases.  There are a number of procedures that protein molecules go through in the cell to 
ensure that they have the correct fold and to detect misfolding.  However, despite these 
checks, errors occasionally occur giving rise to the manufacture of misfolded or aggregated 
species.
42  
The diverse functionality of protein molecules in an organism cannot be underestimated.  
These  biomolecules  are  involved  in  everything  from  immune  response  to  signalling 
pathways and therefore if a protein molecule is unable to carry out its desired function, 
these essential processes cease to occur.
5   
There are around twenty diseases which can be attributed to protein misfolding and/or the 
impairment of cellular machinery involved in the synthesis of correctly folded protein.
43 
A number of these diseases are documented in Table 1. 
Disease  Protein Involved  Molecular Phenotype 
      Cystic Fibrosis  CFTR  Misfolding 
      Marfan Syndrome  Fibrillin  Misfolding 
      Scurvy  Collagen  Misfolding 
      Cancer  p53  Misfolding 
      Creutzfeldt-Jakob Disease  Prion  Aggregation 
      Alzheimer’s Disease  β-Amyloid  Aggregation 
      Cataracts  Crystallins  Aggregation 
      Familial Amyloidosis  Transthyretin/Lysozyme  Aggregation 
  
Table 1: Diseases Attributed to Protein Misfolding or Aggregation 
43  Katrina A. Davidson, 2008    Chapter One 
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Seemingly insignificant errors in protein synthesis can therefore lead to serious medical 
conditions or impairments.  The understanding of the methods by which protein molecules 
fold  is  important  in  medical  research  for  drug  discovery,  disease  prevention  and 
intervention.   
1.2.6.2  Inclusion Bodies 
The advent of molecular biology has led to the ability to express recombinant genes in 
bacterial species such as E.coli.  One of the problems commonly encountered upon using 
this technique is the formation of insoluble aggregated species called inclusion bodies.
44  
Inclusion bodies are formed when bacteria are encouraged to produce large quantities of 
protein.  Before these unfolded species can fold into a native conformation, some form of 
nucleation occurs to form aggregates.
45  The exact mechanism of inclusion body formation 
is unknown, but is thought to arise from the relative insolubility of unfolded polypeptides 
which aggregate before forming their native, soluble form.
46   
A kinetic competition exists between protein folding and aggregation.  Protein folding is a 
zero order process and is therefore independent of protein concentration.  Aggregation 
however is an intermolecular higher order process and as such has a rate which is raised to 
the power of the concentration of the protein present.
47  Therefore, if the concentration of 
protein is high, then the likelihood of aggregation occurring is high also. 
Although there is no generic relationship between the types of proteins expressed and the 
ability to form inclusion bodies; net charge, solubility and rate of folding of intermediates 
appear to play a role.
48  However, for functional protein to be isolated from these insoluble 
species, they must first be solubilised in some way and then subjected to a laboratory 
protein folding technique. 
1.2.7 Practical Methods for Laboratory Protein Folding 
There are a number of methods which are currently employed for the folding of protein 
from aggregated species; dialysis, dilution, and chromatographic methods are the most 
common.  All of these methods rely upon the solubilisation and (partial) unfolding of the 
protein  before  any  folding  can  occur  and  subsequently,  the  gradual  removal  of  these 
solubilisation agents from the protein environment to trigger folding.   Katrina A. Davidson, 2008    Chapter One 
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1.2.7.1  Solubilisation Agents 
Solubilising agents are molecules which are used commonly to increase the solubility of 
protein molecules in solution.
49  Generally solutions of urea and guanidine hydrochloride 
are used to this end.   
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Figure 9: The Chemical Structure of Solubilising Molecules 
50 
The ability of these molecules to solubilise protein is dependent upon interactions with the 
surface of  the  biomolecule and  the  surrounding solvent.   Urea has  the  ability  to form 
hydrogen bonds with water, therefore reducing the hydrophobic effect.  This leads to an 
increase in the solubility of the protein in the unfolded state.  Other solubilising agents 
include  molecules  such  as  polyethylene  glycol  which  inhibits  aggregation  and 
cyclydextrins which form host-guest complexes with the hydrophobic exposed side chains 
and therefore reduce aggregation.       
Dithiothreitol (DTT) and mercaptoethanol are reducing agents commonly used to break 
incorrectly  (and  correctly)  matched  disulfides  which  have  formed  in  the  aggregation 
process, ensuring that the protein is entirely solubilised.
49     
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Figure 10: The Solubilisation of Aggregated Protein en Route to Native Structure 
The  solubilising  molecules  essentially  prevent  the  individual  protein  molecules  being 
drawn together in the formation of aggregated species.
50  The unfolded biomolecules are 
therefore held apart in solution, ready to undergo the folding process. Katrina A. Davidson, 2008    Chapter One 
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1.2.7.2  Dilution and Dialysis 
Dilution is one of the most commonly utilised methods for refolding protein due to its 
simplicity.
51    This  method  triggers  the  folding  of  solubilised  protein  by  gradually 
separating the solubilising agents from the environment of the unfolded biomolecule.  This 
is generally carried out by adding a refolding buffer to the denatured protein in order to 
dilute  the  salt  concentration  of  the  agent  (unfortunately,  the  protein  concentration  is 
reduced also).
48  Dialysis is an alternative to the dilution method in that there is still a 
gradual  removal  of  the  small  molecules  from  the  protein  environment,  without  the 
inconvenience of a more dilute protein sample.
52 
A refolding buffer is an aqueous solution containing low concentrations of solubilising 
agents (such as urea at 1-2 M or GdnHCl at 0.5-1.5 M).
53  Also a redox couple such as 
cysteine/cystine  or  glutathione/reduced  glutathione  (usually  at  a  10:1  molar  ratio)  is 
commonly  added  to  simultaneously  reduce  and  re-oxidise  mismatched  (and  correctly 
matched) disulfide bonds until the correct, energetically favourable combination is found.
54  
In  some  cases,  it  has  also  been found  that the presence  of  arginine  or  detergents  can 
promote protein refolding.
55 
The unfolded protein can be diluted directly into or dialysed against the refolding buffer, 
which  results  in  the  concentration  of  the  solubilising  molecules  being  reduced  and 
refolding  initiated.    Refolding  yields  of  65  %  can  be  achieved  by  85-fold  dilution  of 
denatured/reduced  lysozyme,  but  due  to  the  nature  of  this  dilution  very  low  protein 
concentrations are typically obtained (as an illustration; 15 mg/ml subjected to 85 fold 
dilution is equivalent to a final protein concentration of 0.18 mg/ml).
56  This method is 
therefore  mainly  used  in  small-scale  research  studies  requiring  low  protein 
concentrations.
53 
1.2.7.3  Chromatography 
Protein refolding can also be achieved using a number of chromatographic techniques.  
Chromatographic refolding is an attractive prospect as it can be easily automated and again 
results in the gradual removal of solubilising agents from the environment of the protein.
53 
1.2.7.3.1 Ion Exchange Chromatography 
For the refolding of protein using ion exchange chromatography (IEC), initially the column 
is equilibrated with high concentrations of urea (8 M) and the unfolded protein in buffer is 
reversibly  adsorbed  to  the  ion  exchanger  helping  to  minimise  aggregation.
57    The 
concentration of urea is  gradually decreased by passing a refolding  buffer through the Katrina A. Davidson, 2008    Chapter One 
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column.  This triggers the refolding of the protein molecules, which are prevented from 
aggregating  by  the  spatial  constraints  placed  by  the  ion  exchange  matrix.    Once  the 
solubilising  agents  are  removed  and  the  protein  is  potentially  refolded,  it  is  left  to 
equilibrate on the column for up to 40 hours for refolding to be completed.  The refolded 
protein is subsequently eluted upon the implementation of a NaCl gradient.
57 
Although large volumes of refolding buffer are passed through the column, this is not used 
to dilute the protein to the same extent as dilution methods and therefore higher protein 
concentrations can be obtained using IEC.   
In a particular example, bovine serum albumin (BSA) unfolded in urea was refolded on an 
IE column.  Recovery yields of 55% refolded protein were obtained with a dilution of 
approximately 10-fold.
57   
1.2.7.3.2 Size Exclusion Chromatography 
Size  exclusion  chromatography  (SEC)  is  a  technique  commonly  employed  for  the 
separation of molecules on the basis of their size.
58  In the case of unfolded, solubilised 
protein, SEC can be used to gradually separate small molecules such as urea and DTT from 
the protein environment.
59  The solubilising molecules are of the size to enter the pores of 
the  beaded  matrix  and  are  therefore  separated  from  the  larger  biomolecules.
51    This 
separation of unfolded and partially folded structures serves to reduce aggregation of the 
protein.
59  The newly folded protein essentially runs straight through the size exclusion 
column for collection, while the solubilisation molecules are subsequently washed from the 
matrix.   
Utilising  this  method,  refolding  of  hen  egg  white  lysozyme  has  led  to  yields  of  60% 
refolded protein after approximately 100-fold dilution of the protein with the refolding 
buffer.
51 
1.2.7.4  Three-Phase Partitioning  
Three-Phase Partitioning (TPP) is a recent advancement in methodology design for the 
refolding of protein.  Unfolded, solubilised protein is saturated with a common salting out 
reagent such as ammonium sulfate.  Tertiary butanol is added to this mixture and is left to 
incubate at 40°C for 4 hours.  At this stage, both aqueous and organic phases can be seen 
separated by an interfacial precipitate.
60, 61 The solubilising agents are found in the organic 
layer (as here, they have high solubility) and are therefore separated from the aqueous 
protein. Katrina A. Davidson, 2008    Chapter One 
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A practical example of this methodology is the refolding of the enzyme xylanase from 
urea.
60  Here the refolded protein was purified 21-fold and the recovered protein had 93% 
of the activity of the native protein.  Unfortunately, only 5% of the total protein put into 
this refolding process  was  actually found to  be present in the aqueous  layer, with the 
remaining 95% in the interfacial precipitate.  This protein was found to be irretrievable, 
presumably denatured and aggregated as a result of exposure to a denaturing interface.
60 Katrina A. Davidson, 2008    Chapter One 
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1.3  Protein Immobilisation 
Enzymes  are  highly  specific  catalytic  species  and  for  this  reason  they  are  commonly 
utilised  in  chemical  transformations.
62    Enzyme  use  under  process  conditions  can  be 
hampered by the lack of stability of protein under such conditions.  Protein immobilisation 
is a method which is used in order to circumvent the problems associated with enzymatic 
stability and ease of handling.
63 
Over the past 30 years, great effort has been devoted to developing protein immobilisation 
techniques with a view to improving enzyme operational performance, ease of handling 
and recovery of the biocatalytic species.
31   
1.3.1 Advantages of Protein Immobilisation 
There are a number of reasons why the immobilisation of protein molecules is carried out.  
Generally, immobilisation confers increased stability of the biomolecule and removes the 
need  for  delicate  handling.
31    In  biocatalysis,  the  immobilised  enzyme  has  increased 
stability, is more easily retrieved from reaction media and therefore offers a prospect where 
the  cost  of  product  manufacture  is  decreased.
29,  64    For  biomedical  applications,  it  is 
advantageous to remove the need for refrigeration from protein based drugs.  This can be 
achieved via immobilisation.  Similarly, the immobilisation matrix may be used as a drug 
delivery vehicle when therapeutic proteins are immobilised.  Immobilisation is also an 
attractive method for the controlled release of protein therapeutics.  It is also possible to 
immobilise more than one protein together therefore allowing “cascade processes” or a 
series of chemical reactions to occur in one pot.
31 
1.3.2  Protein Immobilisation Methods 
Generally,  protein  immobilisation  occurs  via  one  of  three  main  processes;  entrapment 
within an organic or inorganic polymer, chemical cross linking of protein molecules and 
immobilisation upon a carrier material.
31 
These immobilisation methods all have their advantages and disadvantages, some of which 
will be discussed. Katrina A. Davidson, 2008    Chapter One 
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1.3.2.1  Protein Immobilisation via Polymer Entrapment 
It is possible to immobilise proteins within sol-gel matrices.
31  Sol-gel encapsulation is a 
facile  and  efficient  method  for  the  immobilisation  of  protein  molecules,  particularly 
enzymes for use in industrial applications such as synthetic organic chemistry.
65 
This method requires the acid or base catalysed hydrolysis of tetraalkoxysilanes in the 
presence of the protein of interest giving rise to a SiO2 matrix for the encapsulation of the 
biomolecule.
65 
There  are  a  number  of  examples  of  the  use  of  this  methodology  in  the  literature
65-67 
producing stable, highly active preparations for enzymatic catalysis. 
1.3.2.2  Protein Immobilisation via Chemical Cross Linking 
1.3.2.2.1 Cross-Linked Enzyme Crystals (CLECs) 
Chemical  cross-linking  of  crystallised  proteins  using  glutaraldehyde  was  initially 
developed in 1964 by Quiocho and co-workers as a method for increasing the stability of 
delicate protein crystals for x-ray diffraction studies.
68  The researchers noted that these 
newly created cross-linked enzyme crystals (CLECs) retained (and in some cases improved 
upon) catalytic activity.  
Glutaraldehyde  is  a  bifunctional  cross-linking  agent  which  reacts  with  the  amine 
functionality of lysine residues available upon the surface of protein molecules.
69  The 
homobifunctionality of glutaraldehyde means that it can form crosslinks between lysine 
residues either inter or intra molecularly.   
Enzymes which have undergone chemical cross-linking to form CLECs have been shown 
to  have  increased  activity,  stability  and  enantioselectivity  in  organic  solvents  and 
water/solvent mixtures.
70  These immobilised enzymes can be stored at room temperature 
due to this increased stability which is generated as a result of the stabilisation of the 
protein crystal matrix.
69  These crystals also show greater ease of recycling when compared 
with their untreated counterparts due to their increased mechanical resistance.
69  CLECs 
have become commercially available as immobilised enzyme preparations and this has 
lead to their increased use.  CLECs are commonly utilised in biotransformations, in x-ray 
studies and as microporus materials.
71 
A particular example of the stability conferred upon protein via CLEC immobilisation is 
illustrated.  CLECs of chloroperoxidase cross-liked using glutaraldehyde retain most of Katrina A. Davidson, 2008    Chapter One 
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their catalytic activity up to 70 °C compared to their non-immobilised counterparts which 
only retain activity to 50 °C. 
One of the main advantages of the use of CLECs over other immobilised enzymes, is the 
fact that there is no immobilisation matrix as such and therefore the entire mass of the 
CLECs are active species.  Generally, some kind of matrix is required for immobilisation 
to take place and therefore gram per gram, CLECs have higher specific activity than other 
biocatalysts.
72   However,  in order to  manufacture CLECs, crystals of protein  are  used 
(which require high purity to form) and this can be a major stumbling block limiting the 
proteins available.
31 
1.3.2.2.2 Cross-Linked Enzyme Aggregates (CLEAs) 
Chemical  crosslinking  of  proteins  using  glutaraldehyde  can  also  be  used  in  the 
manufacture of CLEAs.  This technique involves the precipitation of an aqueous solution 
of  protein  before  subsequent  cross-linking  of  the  enzyme  aggregates  via  reaction  with 
glutaraldehyde or dextran polyaldehyde.
73  Precipitation gives rise to protein aggregates, 
but also acts as a purification method and therefore, small molecules are removed from the 
immediate environment of the protein.   
CLEAs of penicillin G acylase were found to retain up to 90 % activity when immobilised 
in this way using dextran polyaldehyde as the cross-linking agent.
74   
1.3.2.3  Protein Immobilisation via the use of a Carrier Material 
1.3.2.3.1 Protein Coated Micro-Crystals (PCMC) 
The formation of Protein Coated Micro-Crystals is a recently developed method for the 
temporary  immobilisation  of  protein.   These crystals  are  formed from  a  water  soluble 
excipient material, an aqueous solution of protein and organic solvent.  This is therefore an 
inexpensive method of protein immobilisation.
75 
The core of these crystals can be made from a number of different materials including salts 
(e.g. K2SO4, KCl), amino acids (D,L-valine, L-glutamine) sugars (mannitol) and solid state 
buffers. (Na-AMPSO).
76 
PCMC can be stored as dry powders on the bench or as a suspension in organic solvent.  
The immobilised protein shows increased stability with no need for refrigeration.  These 
crystals also display high activity and morphology which can be predicted, indicating that 
this method for protein immobilisation could therefore have widespread applications.
75   Katrina A. Davidson, 2008    Chapter One 
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1.4  Protein Coated Micro-Crystals (PCMC) 
PCMC production is a novel method for the manufacture of immobilised proteins.  The 
protein  and crystal-forming component are mixed in  an aqueous solution before being 
subsequently added drop-wise to a stirring water-miscible organic solvent.  The protein 
molecules are rapidly dehydrated and are immobilised upon the crystal surface.  Once 
immobilised, the protein is functional in either organic or aqueous media.
75 
 
Figure 11: Schematic of PCMC Preparation Process 
This  rapid,  one-step  dehydration  permits  the  majority  of  immobilised  biomolecules  to 
retain activity and minimise denaturation.
31 
The resultant particles are composed of a crystalline core of excipient material coated in 
the desired biomolecule.   Katrina A. Davidson, 2008    Chapter One 
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Figure 12: Schematic Representation of PCMC Structure (Image used with the permission of 
Dr. Marie Claire Parker, XstalBio Ltd.) 
A schematic representation of PCMC structure is shown.  The blue core is the crystal of 
salt,  amino  acid  or  sugar  and  the  green  molecules  on  the  surface  are  dehydrated 
immobilised protein.  The biomolecules which coat the crystal act to arrest crystal growth 
and therefore define particle size and morphology.  These immobilised protein preparations 
have  shown  increased  activity  in  organic  solvent  and  are  also  water  soluble  and  can 
therefore can be used for aqueous applications also.
77   
In the initial PCMC studies, the salt K2SO4 (which is insoluble in polar organic solvents 
and non hygroscopic) was mixed with protein.  This mixture was subsequently dehydrated 
in a water miscible organic solvent.  The carrier material is therefore prepared in situ via 
this dehydration process and the protein molecules associate with the support.  Enzyme 
immobilisation and rapid dehydration have previously been demonstrated as a method for 
the production of enzyme preparations with enhanced activity in organic media.
78    
Further investigation indicated that this material was crystalline and the size of which 
could  be  tuned  by  varying  the  excipient  material  and  protein  loading.    Transmission 
Electron Microscopy (TEM) of the immobilised protein preparation indicated that these 
crystals were 5 - 7 µm in size. Katrina A. Davidson, 2008    Chapter One 
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Figure  13:  Transmission  Electron  Microscopy  (TEM)  Image  of  Subtilisin  Coated  K2SO4 
Crystals 
75 
In the absence of protein, the crystal size is greater indicating that the protein acts to limit 
the growth of the crystals during the precipitation process.
75 
The products of co-precipitation could be either immobilised protein contained within or 
upon the surface of the crystals.  Atomic force microscopy was carried out in order to 
determine the surface morphology of the immobilised species. 
 
The z-height is 15 nm and the image is 500 nm x 500 nm on the crystal surface. 
Figure  14:  Atomic  Force  Microscopy  (AFM)  Image  of  Subtilisin  Coated  K2SO4  Crystals 
(Image used with the permission of Dr. Marie Claire Parker, XstalBio Ltd.) 
Atomic  force  microscopy  (AFM)  of  the  surface  of  subtilisin  Carlsberg  coated  K2SO4 
indicated that rather than a smooth surface (evidence of K2SO4 on its own) an uneven 
500 nm Katrina A. Davidson, 2008    Chapter One 
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surface  was  present  which  had  presumably  been  coated  with  protein.    The  protein 
molecules upon the surface of the PCMC were resident as small clusters of around 15 nm 
(subtilisin Carlsberg is approximately 5 nm in size).  
1.4.1.1  Preparation of PCMC - Selection of Excipient 
The choice of excipient for protein immobilisation to form PCMC is very important and 
entirely depends upon the protein and its uses.  In the case of therapeutic proteins for 
patient use, it is important to select a crystal-forming material which has no known hazards 
to  human  health.    Examples  of  excipients  which  can  be  used  for  therapeutic  protein 
immobilisation are glutamine, valine and a number of sugars.
79 
If the purpose of immobilisation is for biocatalyst preparation, it is important to ensure that 
the immobilisation medium does not interfere with any future chemical transformations 
which the enzyme will carry out.  Salts such as potassium sulfate (K2SO4) and potassium 
chloride (KCl) are good for this purpose.
75, 77  Solid state buffers can also be used as the 
immobilisation  matrix  in  the  preparation  of  biocatalysts.    This  can  lead  to  increased 
activity in the organic phase.  Compounds such as Na-AMPSO, Na2CO3 and NaHCO3 can 
be used.
76 
For research studies, it is not only important to select an inert material for immobilisation, 
but also one which will not interfere with further analysis of the sample (e.g. circular 
dichroism  (CD),  fluorescence,  UV/vis  spectroscopy).    To  carry  out  CD  studies  on 
immobilised samples, it is important that the immobilisation medium is either achiral or a 
racemate, and as such does not interfere with the spectroscopic method.  Excipients such as 
K2SO4 and D,L-valine have these pre-requisites.  
1.4.1.2  Preparation of PCMC - Selection of Solvent 
Another important consideration when preparing PCMC is the choice of solvent.  Although 
generally removed from the environment of the PCMC, traces of the solvent may remain 
within the crystals.  When immobilising proteins which have therapeutic properties, it is 
important to select the solvent carefully to ensure that it is not detrimental to health to have 
traces of the solvent within an administrable drug. 
In  general,  solvents  such  as  propan-1-ol,  propan-2-ol  and  ethanol  are  used  in  PCMC 
preparation.  These solvents are used for a number of different reasons including their 
water miscibility properties and their ease of obtainment.    Katrina A. Davidson, 2008    Chapter One 
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1.4.1.3  PCMC Isolation 
PCMC can either be stored as a suspension in organic solvent or collected as a dry powder.  
For storage as a suspension, the crystals can be kept in their precipitating solvent or this 
solvent decanted and replaced with another. To obtain a dry powder sample, it is necessary 
to separate these crystals from the solvent medium.  This can be achieved by vacuum 
filtration through the use of filter membranes.  The dry powders which are obtained can be 
subsequently stored upon the bench.  In the course of this research project, all PCMC 
samples were isolated as dry powders. 
1.4.2 Process of PCMC Formation 
The mechanism of PCMC formation is not entirely understood.  As the aqueous mixture is 
added  to  stirring  organic  solvent,  both  precipitation  of  protein  and  crystallisation  of 
excipient material are occurring.  There are a number of possibilities with regards the 
possible structures which can form from the aqueous mixture of protein and excipient.   
The excipient material, although soluble in water, has limited (or no) solubility in polar 
organic  solvent.    This  causes  rapid  super-saturation  of  the  solvent,  beyond  which, the 
material crystallises. 
1.4.2.1  Crystal Lattice Mediated Self Assembly (CLAMS) 
Co-precipitation can occur conventionally by one of two methods; both the protein and 
crystal forming component remain separate or the protein and excipient form a crystalline 
material with protein held within the crystal randomly.   
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Figure 15: The Conventional Co-Precipitation Process (Image used with the permission of Dr. 
Barry D. Moore, WestChem Department of Pure and Applied Chemistry, University of Strathclyde) 
However, in the case of PCMC formation, the co-precipitation process is thought to be 
driven by the crystal lattice energies, forcing the protein molecules to form a layer upon the 
surface of the crystals.   
solvent 
non-solvent 
non-solvent 
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Figure 16: CLAMS Crystal Lattice Mediated Self-assembly (Image used with the permission of 
Dr.  Barry  D.  Moore,  WestChem  Department  of  Pure  and  Applied  Chemistry,  University  of 
Strathclyde) 
It  is  generally  accepted  that  under  conditions  of  high  organic  solvent  content  (50:50 
aqueous/organic), that protein is denatured.
78  However, in the formation of PCMC, rapid 
crystallisation results in the protein molecules passing through the denaturing conditions 
extremely quickly and as such become fortuitously trapped in the native state. 
75, 80 
In PCMC formation, protein molecules act as a ‘poison’
75 to the crystallisation of excipient 
and are therefore driven out to the surface of the crystal which is still growing.  Due to the 
insoluble nature of protein molecules in organic solvent, they remain at the crystal surface.  
This process has been termed Crystal Lattice Mediated Self-assembly (CLAMS).
80  
1.4.3 Applications of PCMC Technology 
The immobilisation of biomolecules to form PCMC  has proven  to be a very  versatile 
method for the production of bioactive species.  PCMC technology can be used for the 
immobilisation  of  enzymatic  species,  vaccines,  therapeutic  proteins,  DNA  and 
nanoparticles. 
co-precipitation 
solvent  non-solvent 
assembly 
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1.4.3.1  Immobilisation of Enzymes  
One of the major applications of PCMC technology is in the manufacture of biocatalysts.  
The potential use of enzymes in organic synthesis is huge, but one of the major problems is 
the need to be able to carry out these reactions in organic solvent.
77  There is therefore an 
ever  expanding  need  to  find  a  generally  applicable  method  for  the  immobilisation  of 
enzymes for use in biotransformations.
29   
The immobilisation of enzymes  as PCMC  produces a  protein coated powder which  is 
soluble under aqueous conditions.  In the organic phase, PCMC are insoluble and can 
therefore be employed in chemical transformations.
75  The enzyme remains active (and in a 
number of cases, proves to be more active than their non-immobilised counterpart)
77, 81 and 
can be easily retrieved from this medium for reuse.
76    
1.4.3.2  Immobilisation of Vaccines and Therapeutic Proteins 
A major stumbling block in the supply of vaccine and therapeutic protein products is lack 
of thermal stability and maintenance of the cold chain.
82  Immobilisation of vaccines upon 
the surface of PCMC results in the formation of a dry powder formulation with increased 
stability  and  no  need  for  refrigeration.
79,  83    Examples  of  vaccines  which  have  been 
immobilised  in  this  way  include  diphtheria  toxoid,  anthrax  vaccine  and  the  adenylate 
cyclase toxin of Bordetella pertussis.
79, 83  Therapeutic proteins such as insulin have also 
been immobilised.  The particles are approximately 5 µm in size (depending upon the 
excipient material) and therefore are of suitable size for inhalation therapies.
84 
1.4.3.3  Immobilisation of DNA 
There is an example in the literature of the use of PCMC technology to immobilise DNA 
molecules.
85  In exactly the same way as proteins, nucleic acids can be immobilised on to 
the surface of crystals prior to use as a primer in the polymerase chain reaction (PCR).  The 
bioactivity of an immobilised oligonucleotide was retained, resulting in the correct gene 
product being amplified and no bases were altered or truncated.
85  It is possible therefore to 
immobilise DNA using this method with little or no detrimental effect to the activity of the 
nucleic acid which can be used in subsequent transfections.
85 
1.4.3.4  Immobilisation of Nanoparticles  
The self assembly of nanoparticles upon the surface of crystalline materials can result in 
the manufacture  of products  with interesting optical,  magnetic, electronic and catalytic 
properties.
86-88   Rapid co-precipitation of an excipient  material with gold  nanoparticles Katrina A. Davidson, 2008    Chapter One 
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results in the formation of immobilised species which can be easily stored in the solid state 
without  aggregation.    The  resultant  particles  are  also  amenable  to  further  chemical 
modification and polymer inclusion.
89 Katrina A. Davidson, 2008    Chapter One 
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1.5  Protein  Folding  via  Immobilisation  on  Crystal 
Surfaces - Aims and Outline of Work 
The  formation  of  Protein  Coated  Micro-Crystals  (PCMC)  is  a  novel  method  for  the 
immobilisation of aqueous protein solutions upon the surface of a water-soluble excipient 
(salt,  amino  acid  or  sugar)  via  a  co-precipitation  reaction  in  a  water  miscible  organic 
solvent.
75  
It is the aim of this project to establish if it is possible to reversibly adsorb functionally 
active proteins from the unfolded state via immobilisation onto the surface of water-soluble 
crystals  of  an  amino  acid,  sugar  or  salt  with  the  simultaneous  removal  of  denaturant 
molecules.  This method of protein immobilisation from the native state has been used 
successfully with a number of different proteins.
75, 76, 81  Can this method of immobilisation 
provide  an  alternative,  faster,  more  convenient,  more  economic  way  to  refold  stable, 
readily-refoldable  proteins  such  as  lysozyme?    Also  can  this  method  provide  a  more 
successful method for the refolding of more intractable proteins such as lipase? 
Unfolded or solubilised protein molecules are generally present in a solution containing 
additives such as urea, guanidine hydrochloride or dithiothreitol (DTT).   
 
Figure 17: Preparation of PCMC of Potentially Refolded Protein 
Upon  mixing  with  a  crystal  forming  component  and  subsequent  precipitation,  these 
solubilising molecules are removed from the protein environment due to the fact that they 
Add a crystal forming co-precipitant at 
high concentration 
Precipitate into stirring 
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(chemically or thermally) Katrina A. Davidson, 2008    Chapter One 
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are soluble in polar organic solvent.  The protein and excipient remain insoluble in the 
organic phase and therefore are free to associate to form PCMC with the immobilisation of 
protein from the unfolded state.   
An important consideration in the adoption of this approach for protein folding is at which 
stage of the manufacture of PCMC does the possible refolding of protein molecules occur?  
There are three possibilities: in the mixing of the excipient material with the denatured 
protein; the coprecipitation step; and upon the reconstitution of these dry powders into 
aqueous solution.  Each of these steps will be considered. 
In order to assess the feasibility of this approach, a number of physical methods including 
fluorescence, circular dichroism and UV/Vis spectroscopy, will be employed.  The success 
and limitations of this approach will be described utilising lysozyme and lipase. 
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2   Materials and Methods 
2.1  Materials 
Lysozyme (EC 3.2.1.17) from hen egg white (≥90 % purity), Lipase (EC 3.1.1.3, type I) 
from wheat germ ( ≥80 % purity), micrococcus lysodeikticus (ATCC No. 4698), urea (MW 
= 60.06; ≥ 99.5 % purity), guanidine hydrochloride (MW = 95.53; 98 % purity), potassium 
sulfate (MW = 174.26; ≥ 99 % purity), D,L-valine (MW = 117.15; ≥ 99.5 % purity), L-
glutamine (MW = 146.14; ≥ 99.5 % purity), L-cystine (MW = 240.30; 99.5 % purity), L-
cysteine (MW = 121.16; ≥ 99.5 % purity), para-nitrophenyl acetate (MW = 181.15; 99.5 % 
purity), sodium phosphate (MW =119.98; ≥ 99.0 % purity), trizma hydrochloride (MW = 
157.60;  ≥  99.5  %  purity),  D,L-dithiothreitol  (MW  =  154.25;  ≥  99.5  %  purity)  were 
purchased from the Sigma-Aldrich company (Dorset, UK). Potassium chloride (MW = 
74.55; ≥ 99.5 % purity) was sourced from BDH though VWR International, Lutterworth, 
UK.  Propan-2-ol (≥ 99.5 % purity, HPLC grade) was purchased form Reidel-de-Haën.  
Ethanol (absolute purity) and Millipore filtration equipment (flask, filter and funnel) and 
filter  membranes  (47  mm  diameter,  0.45  µm  pore  size)  were  purchased  from  Fisher 
Scientific.  Dialysis cassettes of 3 ml volume and molecular weight cut off (MWCO) of 
10000  Da were  purchased  from Pierce.  All materials were used as received, with  no 
further purification or modification. 
2.1.1 Lysozyme 
Lysozyme  is  an  enzyme  for  which  the  function  has  been  known  for  many  years.  
Discovered in 1921 by Sir Alexander Fleming,
90-92 it has adopted a role as one of the most 
researched proteins in  terms  of its structural and functional  characteristics and is  used 
extensively for protein unfolding and folding studies.
93  Lysozyme was the first enzyme to 
successfully undergo x-ray diffraction in order to obtain a three-dimensional structure.
94, 95   
This research has lead to some understanding of the actual protein folding process and how 
errors in this process can lead to problems of misfolding, aggregation and disease.
96 
Lysozyme is a small, single chain globular protein which is present in many mammalian 
secretions and tissues.
97, 98  The function of the enzyme in vivo is to selectively hydrolyse 
the β-(1,4) glycosidic linkage which is present in the cell walls of many micro-organisms 
and as a consequence of this, lysozyme is known to have antimicrobial properties.
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most researched source of lysozyme is that from hen egg white, the structure of which is 
shown (Figure 1):  
 
Figure 18:  A Ribbon Structural Representation of Lysozyme (Image used with permission of 
Dr. A. McEwan, Department of Chemistry, University of Glasgow) 
The protein is made up of 129 amino acid residues and physical properties including a 
molecular mass of 14.2 kDa.  It is also known to have an isoelectric point at pH 11 and an 
optimum pH of 9.2.
98  There are four disulfide bonds present in lysozyme.
100 
2.1.2 Lipase 
Lipase is an esterase belonging to the family of serine proteases.
101   It is used routinely in 
organic synthesis as a catalyst for the hydrolysis of ester bonds including triglycerides and 
carboxylic acid esters.
102  The enzyme also has a number of uses in food industries and can 
be used for the manufacture of baked goods, cheeses and even biofuels.
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Figure 19: A Ribbon Structural Representation of Lipase (Image used with permission of Dr. A. 
McEwan, Department of Chemistry, University of Glasgow) 
Lipase from wheat germ (Triticum aestivim) contains 350 amino acid residues and has a 
molecular weight of approximately 42 kDa and a pH optimum of 8.0.
101, 104  The enzyme is 
comprised of 20 % α-helix, 40 % β-sheet and the rest is of aperiodic structure.
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2.2  Methods  
2.2.1 Determination of Protein Concentration 
2.2.1.1  UV/Visible Absorption Spectroscopy 
Ultra-violet  absorption  spectroscopy  has  been  shown  to  be  an  invaluable  tool  for  the 
determination of protein concentration
105, 106  UV absorption in the region of 250 - 300 nm 
gives information regarding the aromatic amino acid residues, whilst down towards 200 
nm,  the  amide  group  of  the  peptide  backbone  is  found.    These  are  the  chromophores 
present in protein which each have a characteristic transition or signals in these regions.
107 
UV-visible spectrophotometers are used for this purpose, measuring the intensity of a light 
beam  passing  through  a  sample  as  a  function  of  wavelength.
108    Absorption 
spectrophotometers can be either single beam or double beam instruments.  The optical 
path of a single (split) beam instrument such as the one used for this study is shown. 
 
Figure 20: The Optical Path of a Single (Split) Beam Spectrophotometer 
108 
In order to measure the absorbance of a sample at different wavelengths, tungsten and 
deuterium lamps are used to provide light in the visible (340-800 nm) and UV(200-350 
nm) ranges, respectively.  The light is reflected to a rotating concave holographic grating, 
which splits the light into its constituent wavelengths so that the absorbance at each of 
these wavelengths can be measured simultaneously by the detectors.  The beam splitter 
allows the absorbance of a sample and a reference to be measured at the same time.
108 
 
Beam splitter 
Reference  Sample 
Detector  Detector 
Tungsten lamp 
Deuterium lamp 
Rotating concave 
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2.2.1.1.1 Molar Extinction Coefficient and the Beer-Lambert Law 
In  order  to  determine  protein  concentration,  it  is  first  necessary  to  obtain  the  molar 
extinction coefficient.  The molar extinction coefficient is a measure of the ability of a 
protein sample to absorb light at a particular wavelength.
109  In the case of proteins, the 
wavelength  of  interest  is  280  nm.    This  is  where  the  aromatic  amino  acids  such  as 
phenylalanine,  tyrosine  and  in  particular  tryptophan  absorb  light  and  give  rise  to 
measurable absorbance.  This absorbance can be related to the concentration of protein 
present by the Beer-Lambert law;
110 
A(λ) = log (I0/I) = ε(λ)cl 
Equation 1: The Beer-Lambert Law for the Determination of Protein Concentration 
111 
Where  A  is  the  absorbance at a  specific  wavelength,  I  and  I0 are the transmitted and 
incident light respectively, ε is the molar extinction coefficient at a specific wavelength, c 
is the protein concentration and l is the path length of the cuvette.
111 
A UV spectrum of the protein at different concentrations (by weight) is obtained and a 
calibration graph prepared.  The gradient of this calibration plot is equal to the extinction 
coefficient of the desired protein.  This experimentally determined coefficient can then be 
used  to  determine  the concentration  of  protein  in  future  samples.    The  experimentally 
derived extinction coefficient can be different from published values.  This difference can 
be attributed to impurities present in the preparation received from the supplier or simply 
experimental error. 
The extinction coefficient can also be estimated for proteins of known sequence based 
upon the number of tryptophan and tyrosine residues present.  These aromatic amino acids 
are the primary chromophore when measuring the absorbance of a protein sample at 280 
nm.     
To determine the extinction coefficient of the desired proteins and further determine the 
protein  concentration  of  samples,  Shimadzu  UV-160A  and  Thermo  Biomate  5 
spectrophotometers were used. 
2.2.1.2  Determination of Lysozyme Concentration 
In order to determine the concentration of lysozyme present in samples, a calibration graph 
was  prepared  of  the  absorbance  at  λ  =  280  nm  with  respect  to  the  concentration  (by 
weight).  The data was obtained in triplicate and the graph shown is an average of the data. Katrina A. Davidson, 2008                                                                                               Chapter Two 
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Figure 21: Calibration Graph of Lysozyme Concentration 
The extinction coefficient of lysozyme determined from this calibration graph is 2.28 mL 
mg
-1 cm
-1 which was used to calculate the concentration of lysozyme present in samples 
prepared.  The published extinction coefficient for lysozyme from hen egg white is 2.64 
mL mg
-1 cm
-1. 
2.2.1.3  Determination of Lipase Concentration 
To  determine  the  concentration  of  lipase  present  in  samples,  a  calibration  graph  was 
prepared of the absorbance at λ = 280 nm with respect to the concentration (by weight).  
The data was obtained in triplicate and the graph shown is an average of the data. 
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Figure 22: Calibration Graph of Lipase Concentration Katrina A. Davidson, 2008                                                                                               Chapter Two 
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The  extinction  coefficient  of  lipase  determined  from  this  calibration  graph  is  0.95           
mL mg
-1 cm
-1 and this was used to calculate the concentration of lipase present in samples 
prepared.  The published extinction coefficient of lipase from wheat germ is 1.75 mL mg
-1 
cm
-1.   
2.2.2 Determination of Enzymatic Activity 
The  activity  of  an  enzymatic  sample  can  be  routinely  determined  by  carrying  out  an 
activity  assay.    This  involves  measuring  spectrophotometrically  the  changes  in  the 
absorption  characteristics  of  enzymatic  substrates  during  chemical  transformations.
112  
Monitoring this observed change in absorbance with respect to time allows a calibration 
graph to be produced, from which the activity of enzyme samples can be determined. 
The specific activity of an enzyme is a measure of the change in absorbance of the reaction 
mixture per unit time, per milligram of protein present.  Activity assays used for lysozyme 
and lipase are described. 
To  determine  the  activity  of  the  enzymes  lysozyme  and  lipase,  activity  assays  were 
employed using either a Shimadzu UV-160A or Thermo Biomate 5 spectrophotometers. 
2.2.2.1  Determination of Activity of Lysozyme 
Native lysozyme has antimicrobial properties and therefore has the ability to break down 
the cell walls of certain bacteria.  This attribute is used in order to determine the activity of 
the enzyme.  Micrococcus lysodeikticus cells are the most commonly utilised substrates in 
measuring the activity of lysozyme.   
The enzyme breaks down the bacterial cell wall, giving rise to a change in the turbidity of 
the suspension as the cell contents spill into the supernatant.  This change in turbidity can 
be seen spectrophotometrically by monitoring the absorbance at 450 nm at 25 °C.  The rate 
of change of the absorbance of the suspension is indicative of the activity of the enzyme. 
To carry out the assay, a suspension of Micrococcus lysodeikticus (9 mg in 30 ml 0.1 M 
potassium phosphate buffer, pH 7.0) and solutions of lysozyme of known concentration are 
required.
113 
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Reference Cuvette:  
1.45 ml Micrococcus lysodeikticus cells 
0.05 ml H2O 
Sample Cuvette:      
1.45 ml Micrococcus lysodeikticus cells 
0.05 ml lysozyme of various concentrations in H2O 
The activity of each concentration of lysozyme is measured over a 5 minute time frame 
and  is  obtained  in  triplicate  in  order  to  prepare  a  calibration  graph.    The  change  in 
absorbance is negative as the turbidity of the suspension decreases in the cuvette. 
In  the  course  of  this  project,  2  different  bottles  of  lysozyme  were  used  to  prepare 
immobilised samples.  Calibration graphs were prepared for each lot of enzyme. 
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Figure 23: Calibration Graph of Lysozyme Activity 
The specific activity of  both lots of enzyme  was  determined by the method  described 
above and was found to be 0.876 and 0.650 A min
-1mg
-1ml
-1 respectively.  The specific 
activity of the lysozyme utilised will be quoted with each set of samples prepared.  Katrina A. Davidson, 2008                                                                                               Chapter Two 
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2.2.2.2  Determination of Activity of Lipase 
A simple method for the determination of the activity of lipase is the spectrophotometric 
monitoring of the hydrolysis of para-nitrophenyl acetate.
114   
Lipase is known to catalyse the hydrolysis of the aromatic ester para-nitrophenyl acetate 
(p-NPA) to the para-nitrophenoxide anion (p-NPO
-) in the presence of water.  
 
 
 
 
 
 
Figure 24: Hydrolysis of p-NPA catalysed by Lipase 
The  substrate  p-NPA  is  insoluble  in  water  and  it  is  therefore  initially  dissolved  in 
acetonitrile to carry out this assay.  The p-NPA is a colourless solution, but the phenoxide 
anion is coloured yellow.  This means that not only is the formation of product visible to 
the eye, but also by measuring the change in absorbance of the reaction mixture at 400 nm.  
If this change in absorbance is measured at 400 nm as the reaction proceeds, the rate of 
change of the absorbance is indicative of the rate of the hydrolysis reaction and can be 
measured in A min
-1mg
-1of protein (the specific activity).
114 
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Reference Cuvette:  
0.55 ml of 0.05 M sodium phosphate, pH 7.8 
0.2 ml of 3 mM p-NPA in AcCN 
Sample Cuvette:      
0.5 ml of 0.05 M sodium phosphate, pH 7.8 
0.2 ml of 3 mM p-NPA in AcCN 
0.05 ml of lipase of various concentrations in 0.05 M sodium phosphate, pH 7.8 
The activity of each concentration of lipase is measured over a three minute time frame 
and is obtained in triplicate to prepare a calibration graph. 
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Figure 25: Calibration Graph of Lipase Activity 
The specific activity of native lipase calculated from the calibration is 0.188 Amin
-1mg
-1. Katrina A. Davidson, 2008                                                                                               Chapter Two 
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2.2.3 Protein Unfolding 
Protein molecules can be unfolded by employing both chemical and physical methods.  
Urea, GdnHCl and pH change are the most commonly used chemical methods for this 
purpose and physical methods include heating and pressure perturbation. 
2.2.3.1  The Urea Unfolding of Proteins 
The chemical unfolding of proteins by urea was carried out by dissolving the protein in a 
solution of 8 M urea in water or addition of the solubilising agent to an aqueous solution of 
protein.  The unfolding of the protein was monitored by fluorescence and CD spectroscopy 
and activity assay where possible. 
2.2.3.2  The Guanidine Hydrochloride Unfolding of Proteins 
The chemical unfolding of proteins by GdnHCl was carried out by dissolving the protein in 
a solution of 6 M GdnHCl in water or addition of the salt to an aqueous solution of protein.  
The unfolding of the protein was monitored by fluorescence and CD spectroscopy and 
activity assay where possible 
2.2.3.3  The Thermal Unfolding of Proteins 
The thermal unfolding of proteins was carried out by heating the protein to 100 °C and 
then allowing the protein to cool to room temperature.  Upon cooling, the aggregates which 
form are solubilised upon the addition of 6 M GdnHCl or 8 M Urea.  This process was 
monitored by DSC, fluorescence and CD spectroscopy and activity assay where possible. 
2.2.4 Preparation and Isolation of PCMC 
2.2.4.1   Preparation of PCMC Samples - Standard Method 
PCMC  are  prepared  using  a  standard  protocol.    This  involves  the  mixing  of  protein 
molecules (in either the native or unfolded state) and the excipient material (salt or amino 
acid), before adding this mixture drop-wise to stirring organic solvent. 
The theoretical protein loading (TPL) of the PCMC describes the percentage by mass of 
protein present to excipient material.  In order to investigate the effect of loading of the 
biomolecule on to the crystal surface, different ratios of protein to excipient were used.  
This allowed for the preparation of PCMC samples of different protein loadings. Katrina A. Davidson, 2008                                                                                               Chapter Two 
63 
During the precipitation of the protein/excipient mixture in the stirring organic solvent, the 
water content of this solvent was kept constant (between four and five percent by volume). 
2.2.4.2  Preparation of PCMC - Continuous Method 
A further method was employed for the preparation of PCMC.  A continuous method was 
developed which allowed the mixing of excipient and protein (either unfolded or native) to 
occur over a period of time before subsequent addition to the solvent.  This was achieved 
using syringe pumps and generally a flow rate of 0.01 ml/min of excipient into protein was 
used before precipitation in organic solvent. The hypothesis that led to the design of this 
method was that the mixing of protein and excipient solutions over time would lead to the 
gradual dilution of the solubilising agents, therefore triggering refolding.   
2.2.5 Circular Dichroism Spectroscopy 
Circular dichroism (CD) spectroscopy is  a technique which is commonly  employed in 
determining the structural characteristics of proteins.
115  CD occurs when the left and right 
handed components of circularly polarized light are absorbed to differing extents by a 
chiral chromophore.
116, 117  The chirality of the chromophore can be intrinsic or via the 
linkage  of  a  chiral  centre  or  placing  in  an  asymmetric  environment.
115    When  CD  is 
measured  over  a  range  of  wavelengths,  this  gives  rise  to  a  CD  spectrum.    The  unit 
commonly utilised in CD measurement is the mean residue ellipticity denoted [θ]mrw,λ at a 
given wavelength is deg.cm
2.dmol
-1.
118   
There are 2 main classes of chromophore in protein molecules; the peptide backbone and 
the amino acid side chains.  The peptide backbone can be analysed in the far UV region 
(240-180 nm) to determine the helical or sheet content of the protein.
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Figure 26: Far UV CD Spectrum  Associated with Protein Secondary Structural Elements.  
Solid line, α-helix; long dashed line, antiparallel β-sheet; dotted line, type I β-turn; cross dashed 
line, extended 310-helix or poly (Pro) II helix; short dashed line, irregular structure.
118  
The CD of the aromatic amino acid side chains can be observed in the near UV region 
(320-260 nm) giving information about the environment of the side chains and the tertiary 
structure.
115, 118  This means that CD spectroscopy is therefore a useful tool in monitoring 
protein folding events and structural changes.
32   
2.2.5.1  CD Spectroscopy in the Aqueous Phase 
CD spectroscopy is most commonly used upon aqueous samples of protein, free of any 
dust  or  other  suspended  particles.    This  is  due  to  the fact  that  if  there  are  suspended 
particles present in the CD sample, then this can cause scattering of the light and lead to a 
red-shifted CD spectrum.
119  It is therefore important to ensure that samples are free of 
such artefacts.   
2.2.5.1.1 CD Spectroscopy in the Aqueous Phase - Protocol 
All CD measurements were made with the guidance of Dr. Sharon M. Kelly of the Protein 
Characterisation Facility at the University of Glasgow and were made on a Jasco J-810 
spectropolarimeter with model number J-810-150S. Katrina A. Davidson, 2008                                                                                               Chapter Two 
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Near UV measurements were made between 320 nm and 250 nm.  A data pitch of 0.2 nm 
(distance between data points) was used with the instrument was in continuous scanning 
mode.  A scanning speed of 10 nm/min, response time of 2 seconds and a bandwidth of 1 
nm  were  also  employed.    Accumulations  of  3  scans  were  recorded  of  the  protein  at 
approximately 1 mg/ml.  The cell path length used for carrying out these measurements 
was 0.5 cm. 
Far UV data was collected between 260 and 180 nm.  A data pitch of 0.2 nm was used with 
the instrument in continuous scanning mode.  A scan speed of 50 nm/min, response time of 
0.5 seconds and a bandwidth of 1 nm were also employed.  The CD spectrum of each 
sample was collected 4 times and subsequently accumulated to give a smooth spectrum 
using  a  cylindrical  cell  of  path  length  0.02  cm  and  a  protein  concentration  of 
approximately 0.5 mg/ml. 
2.2.5.2  CD Spectroscopy in the Solid Phase 
There is great interest in the development of a spectroscopic method which allows the 
structure  of  immobilised  protein  and  other  particulate  suspensions  to  be  probed.  
Spectroscopic  investigations  of  immobilised  proteins  usually  involve  the  protein  being 
desorbed before the measurements take place in an effort to avoid light scattering.
120 
CD spectroscopy can now be carried out on proteins immobilised upon hydrophobic and 
hydrophilic  surfaces,  although  light  absorption  and  scattering  by  the  immobilisation 
matrices can lead to errors.
121  
A  recent  development  in  this  field  allows  the  collection  of  CD  spectra  of  protein 
immobilised  on  the  surface  of  PCMC,  alhydrogel  or  silica.
122    This  method  involves 
incorporating a motorised rotating cell holder into the spectropolarimeter, which allows the 
immobilised sample to remain suspended during the time of measurement.   Katrina A. Davidson, 2008                                                                                               Chapter Two 
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Figure 27: The Rotating Cell Holder (Image used with permission of Dr. A. Ganesan, XstalBio 
Ltd.) 
The  use  of  a  rotating  cell  holder  avoids  the  sedimentation  process  which  is  a  major 
problem associated with CD measurement of particulate suspensions.   
                
Figure 28: Far and Near UV CD Spectra of Immobilised BSA.  Soluble BSA - solid line; BSA on 
alhydrogel (uncorrected), dot-dash; BSA on alhydrogel (5% w/w corrected) dotted 
122 
In  the  figure  above,  it  can  be  seen  that  the  CD  spectra  obtained  from  the  corrected 
alhydrogel immobilised protein is similar to that obtained from the soluble protein.  This 
indicates that the structure of BSA immobilised upon the surface of the particles is very 
similar to the native form. 
The rotation speed (usually 40-100 rpm) and cell path length must be optimised in order to 
maintain the uniformity of the suspension and as such avoid the uneven distribution of the 
immobilised protein particles in the light beam.
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The use of a rotating cell holder circumvents the errors associated with sedimentation and 
light scattering and therefore can be used to obtain CD spectra of particulate suspensions in 
UV transparent solvents such as water and ethanol.
122 
2.2.5.2.1 CD Spectroscopy in the Solid Phase - Protocol 
All CD measurements were made on a Jasco J-810 Spectropolarimeter with model number 
J-810-150S.  
Near UV measurements were made between 320 and 250 nm.  The rotating cell holder was 
employed using a regulator setting of 4.5 V (this determines the speed of rotation).  A data 
pitch  of  0.2  nm  was  used  and  the  instrument  was  in  continuous  scanning  mode.    A 
scanning speed of 10 nm/min, response time of 2 seconds and a bandwidth of 1 nm were 
also employed.  Accumulations of 6 scans were obtained using a cell of path-length 0.05 
cm with approximate protein concentration of 1 mg/ml. 
Far  UV  data  was  collected  between  260  and  180  nm.  The  rotating  cell  holder  was 
employed  using  a  regulator  setting  of  3.0  V.   A  data  pitch  of  0.2  was  used  with  the 
instrument in scanning mode.  A scan speed of 50 nm/min, response time of 0.5 seconds 
and a bandwidth of 1 nm were also employed.  The CD spectrum of each sample was 
collected  6  times  and  subsequently  accumulated  to  give  a  smooth  spectrum  using  a 
cylindrical cell of path length 0.02 cm with a protein concentration of approximately 0.5 
mg/ml. 
2.2.6 Fluorescence Spectroscopy 
Fluorescence spectroscopy is one of the most widely utilised  tools in monitoring structural 
perturbations  and  environmental  changes  in  protein  molecules.
123    Fluorescence  is  a 
phenomenon which occurs when excited molecules return to the electronic ground state.  
Generally, when molecules de-excite, they return to the ground state non-radiatively.   In 
fluorescence,  the  molecules  undergo  the  process  of  vibrational  relaxation  (due  to 
intermolecular  collisions)  which  reduces  the  energy  of  the  excited  species.
124    The 
molecule  therefore  returns  to  the  ground  state  from  a  lower  energy  excited  state  and 
therefore emits light of a lower energy (higher wavelength) than that used to excite the 
molecule. 
The wavelength at which the maximum fluorescence intensity occurs (λmax) is determined 
by the difference in energy between the ground state and the excited state.  The polarity of Katrina A. Davidson, 2008                                                                                               Chapter Two 
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the molecular environment (solvent) can affect this.  Upon excitation, an electron (which is 
negatively charged) is separated from the positive nucleus.  This leads to a change in the 
dipole moment of the molecule.  The energy required to induce this dipole depends upon 
the polarity (or dielectric constant) of the environment.  If a molecule is present in a polar 
solvent, the energy required for excitation is lower than that for a non-polar medium. This 
means that as the polarity of the surroundings increases, the energy required for excitation 
decreases and therefore λmax increases. 
40 
Fluorescence of protein molecules occurs due the intrinsic properties of the aromatic amino 
acid building blocks.
123   The technique of fluorescence spectroscopy makes use of this 
natural phenomenon, although in some instances, fluorescent probes can be used in order 
to introduce fluorescent properties into molecules.
123  
A spectrofluorimeter is comprised of a source of light and an excitation monochomator.  
This allows different excitation wavelengths to be selected.  Once the light has passed 
through the sample, the emitted fluorescence is measured at right angles to the incident 
light by a detector.  A schematic representation of this is shown. 
                        
Figure 29: A Schematic Representation of the Path of Light Through a Fluorimeter 
125 
Tryptophan  fluorescence  is  commonly  used  in  protein  folding  studies.    Tryptophan 
residues give rise to the largest fluorescence intensity with relatively few of these residues 
being present in the protein.
126   
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Irradiating  protein  samples  with  light  of  290  nm  excites  the  electrons  of  tryptophan 
residues  and  they  therefore  emit  fluorescence.    The  value  of  λmax  is  indicative  of  the 
microenvironment  of  the  tryptophan  residues.
127    Low  wavelengths  suggest  that  the 
tryptophan residues are buried within the hydrophobic, non-polar structure of the protein 
molecules.    However, a  shift  towards  higher  wavelengths  suggests  that  the  tryptophan 
residues are no longer buried and are therefore able to interact with the surrounding polar  
solvent, changing the nature of their environment from the hydrophobic core of the protein, 
to the exterior solvent.
128 
2.2.6.1  Fluorescence Spectroscopy - Protocol 
To  carry  out  fluorescence  measurements,  a  Spex  FluoroMax  spectrofluorimeter  was 
employed.  Samples were excited at 290 nm and fluorescence emission was measured 
between  280  nm  and  460  nm.    In  the  case  of  each  sample,  relevant  baselines  were 
subtracted from the sample spectrum (e.g. buffers, salts etc.).  All spectra were collected at 
25 °C. 
2.2.7 Differential Scanning Calorimetry (DSC) 
Differential Scanning Calorimetry (DSC) is a technique used to study the energetics of 
transitional changes in protein molecules.  This is a direct method to measure the heat 
energy uptake in a sample of known concentration as the temperature is being increased or 
decreased in a controlled fashion.
129  The energy required in order to keep both the sample 
and  the  reference  cells  at  the  same  temperature  is  measured  and  hence  DSC  data  is 
obtained.
130  A schematic representation of a differential scanning calorimeter is shown. Katrina A. Davidson, 2008                                                                                               Chapter Two 
70 
                   
Figure 30:  A Schematic Representation of a DSC Instrument.  S, sample; R, reference; P, 
small pressure applied to the system.
129  
In a DSC instrument, the main heaters increase the temperature of both the sample and 
reference cells. The temperature of both cells is increased and monitored carefully until 
there is a difference between the sample and reference (due to energy being used to carry 
out a thermal transition).
131  The instrument recognises this difference and supplies more 
heat energy, via the feedback heaters, to the cell at the lower temperature.  This allows the 
system to maintain the zero temperature difference between the sample and reference.
132   
The temperature at which the most heat energy is required for the sample and reference to 
maintain that temperature, gives rise to a transition in the DSC thermogram.  This is the 
Tm, the mid-point temperature of the transition from the folded to the unfolded state.
129 
2.2.7.1  DSC Measurement - Protocol 
In the context of this project, the information required from the DSC experiments was 
simply the temperature at which the thermal unfolding of the proteins of interest takes 
place and the reversibility of this process. 
DSC measurements were carried out on a MicroCal VP-DSC microcalorimeter and all 
buffers were centrifuged and degassed.  Sample protein concentrations were determined 
using  the  previously  described  molar  extinction  coefficients  and  the  scan  rate  if  the 
instrument was set to 1 °Cmin
-1.  For each sample, a thermogram of the buffer in which the 
protein was present was carried out to check for any artefacts and to use as a baseline.  A 
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DSC thermogram of the sample was then obtained followed by a rescan to assess the 
reversibility of the unfolding process.  
2.2.8 Dialysis 
Dialysis  is  a  purification  method  which  allows  proteins  to  be  separated  from  small 
molecules by use of a semi permeable membrane, usually made from cellulose.
133  This 
membrane contains pores of a defined size so that there is a Molecular Weight Cut-Off 
(MWCO).  This ensures that small molecules will be free to pass through the membrane 
into the surrounding medium, whilst keeping larger macromolecules within.
133 
Dialysis as a method can be used in order to exchange buffers or remove salts or other 
small molecules from the environment of proteins.  The dialysis membrane containing 
protein and small molecules is immersed in an aqueous solution into which the latter can 
diffuse via the pores.  Once equilibrium is reached, the dialysate is replaced until most of 
the  small  molecules  have  been  removed  from  the  environment  of  the  protein  and  the 
concentration is at an acceptable level.  
 
Figure 31: Dialysis - Gradual Removal of Small Molecules from Protein Environment 
Dialysis  is  also  a  method  commonly  employed  in  protein  folding  methodology.    The 
gradual removal of agents such as GdnHCl or urea from the protein is known to trigger the 
folding process and therefore dialysis is a simple method that may be used for protein 
folding experiments. 
Replace 
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2.2.8.1  Dialysis - Protocol 
Dialysis was carried out using dialysis cassettes with a 3 ml volume and molecular weight 
cut-off dependent upon the enzyme being used.   
The solubilising agents were removed from the protein environment by dialysing against 
buffer in the absence of these additives.  Unfolded lysozyme was dialysed against 50 mM 
Tris/HCl, pH 8.1.  Lipase was dialysed against 50 mM Tris/HCl, pH 7.8.  
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3  Unfolding,  Immobilisation  and  Potential 
Refolding of Lysozyme 
Techniques employed for the unfolding of protein molecules are generally found to take 
advantage  of  intrinsic  properties  of  the  biomolecules.    Solutions  of  urea  or  guanidine 
hydrochloride are commonly utilised as they have the ability to increase protein solubility 
and  interact at  the  protein  surface  to  exclude solvent  water  (therefore  dehydrating  the 
protein).
134  These additives also have the capacity to interact with the hydrophobic core of 
protein molecules, therefore essentially pulling them apart from the inside out.
134  The 
physical nature of the interactions which hold protein molecules together can be easily 
exploited by these chaotropic agents. 
A number of different methods can be used to unfold proteins such as lysozyme.  Chemical 
and thermal unfolding are the most routinely practised due to their ease of implementation 
and success. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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3.1  Chemical Unfolding of Lysozyme 
3.1.1 Urea Unfolding of Lysozyme 
In carrying out the urea unfolding of proteins, a number of things must be taken into 
consideration.    It  is  necessary  to  prepare  fresh  urea  solutions  for  each  unfolding 
experiment.  This is due to  the  fact that urea can form amidates  with the amino  acid 
residues  The chemical unfolding of lysozyme can be monitored utilising using a number 
of  different  analytical  techniques  including  activity  assays,  fluorescence  and  CD 
spectroscopy.
32   
3.1.1.1  Urea Unfolding of Lysozyme - Activity With Respect to Time. 
In  order  to  determine  the  optimal  conditions  for  unfolding  of  lysozyme  using  urea, 
unfolding curves were prepared by determining the enzymatic activity with respect to time 
while varying the concentration of urea and reducing agent.   
Lysozyme was dissolved in 50 mM Tris/HCl, pH 8.1 containing either 6 M or 8 M urea 
with 32 mM DTT.  The activity of each of these samples was determined at set time 
intervals and an unfolding curve prepared. 
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Figure 32: Urea Unfolding of Lysozyme with Respect to Time - Effect of Urea Concentration Katrina A. Davidson, 2008                                                                                             Chapter Three 
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As is expected, as the concentration of the chaotropic agent increases, the time which the 
protein takes to unfold is decreased.  Unfolding in 8 M urea with 32 mM DTT allows the 
lysozyme to be unfolded after approximately four hours.  
The activity of lysozyme incubated in 8 M urea containing different concentrations of DTT 
was also measured with respect to time.  This was completed in order to see what effect (if 
any) the concentration of DTT had upon the time taken for the irreversible inactivation of 
lysozyme to occur. 
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Figure 33: Urea Unfolding of Lysozyme with Respect to Time - Effect of DTT Concentration 
DTT concentration plays an important role in the rate of lysozyme unfolding.  The higher 
the  concentration  of  DTT  present,  the  faster  the  enzyme  appears  to  unfold.    As  the 
concentration of DTT is increased, the ratio of the reducing agent with respect to protein 
increases.  This results in rapid reduction of the disulfide bridges present in the protein.  
From the studies carried out here, optimal conditions for unfolding of lysozyme are 8 M 
urea and 32 mM DTT. 
Incubation of lysozyme in 8 M urea in the absence of DTT does not have any significant 
effect upon the activity of the protein.  Further studies were required in order to determine 
if this was due to the dilution of the denaturant from the environment of the protein upon Katrina A. Davidson, 2008                                                                                             Chapter Three 
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carrying out the activity assay (and hence refolding taking place to some extent) or if the 
protein was simply not being unfolded under these conditions. 
3.1.1.2  Urea Unfolding of Lysozyme - Fluorescence Spectroscopy 
The intrinsic fluorescent properties of lysozyme can be used in order to probe the enzyme 
structure both in the native and urea-incubated conformations. 
Fluorescence spectra of lysozyme (0.1 mg/ml) incubated in 8 M urea (in the absence of 
DTT) were obtained with respect to time with a view to determining what was happening 
to the enzyme under these conditions.   
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Figure 34: Urea Unfolding of Lysozyme with Respect to Time - Fluorescence Spectroscopy  
In the case of native lysozyme, the wavelength at which the maximum fluorescence occurs 
is at 345 nm.  This is typical for a globular protein in which the tryptophan residues are 
buried within the structure.
40   
Upon  incubation  of  the  protein  in  urea,  the  once  buried  tryptophan  residues  begin  to 
interact with the external environment leading to a change in the fluorescent properties of 
the molecule.  A red shift in the wavelength at which the maximum fluorescence intensity 
occurs  is  seen;  therefore  the  maximum  fluorescence  intensity  occurs  at  a  longer 
wavelength.  Incubation of lysozyme in urea alters the wavelength at which maximum Katrina A. Davidson, 2008                                                                                             Chapter Three 
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fluorescence occurred to 357 nm.  This indicates that the tryptophan residues are no longer 
buried and are therefore free to interact with the surrounding solvent. 
3.1.1.3  Urea Unfolding of Lysozyme - CD Spectroscopy 
For protein folding and unfolding studies, CD spectroscopy is used routinely as it can 
provide  a  clear  insight  into  structural  changes  with  greater  effectiveness  than  other 
spectroscopic methods.
116 
Circular  dichroism  spectroscopy  of  both  the  native  and  urea-incubated  enzyme  in  the 
presence and absence of DTT were obtained.  This was to ascertain the effect of the urea 
and DTT upon the structure of the protein and gain an insight into the effect upon the 
protein at a molecular level. 
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Figure 35: Far UV CD Spectrum of Lysozyme in the Native and Urea-Unfolded, Reduced 
State 
The far UV CD spectrum of native lysozyme indicates that the protein is mainly composed 
of alpha helices.  Incubation of lysozyme in 8 M urea in the absence of DTT appears to 
have some effect upon the secondary structure of the protein.  Upon incubation of the 
enzyme in 8 M urea containing 32 mM DTT, the structure has changed.  The secondary 
structure of the protein is no longer native, but appears to be unfolded.  The presence of Katrina A. Davidson, 2008                                                                                             Chapter Three 
79 
DTT in  the  incubation buffer results  in noise in  the  CD  spectrum below 205  nm and 
therefore  when  measuring  the  spectrum  of  the  urea-unfolded,  reduced  lysozyme,  the 
spectrum is not recorded below that wavelength. 
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Figure 36: Near UV CD Spectrum of Lysozyme in the Native and Urea-Unfolded, Reduced 
State 
The near UV CD spectrum of native lysozyme indicates that there are contributions from 
the aromatic amino acid residues present in the native structure.  Incubation of the protein 
in 8 M urea results in the absence of near UV CD signal.  This is due to the fact that urea 
has  entered  the  charged,  hydrophobic  protein  interior  and  has  therefore  affected  the 
chirality of the amino acid environment which is required to give rise to CD.
50  In the urea-
unfolded, reduced protein the urea molecules are not only able to permeate the protein 
interior, but the DTT present reduces the disulfide bonds present.  This therefore results in 
a lack of CD signal in the near UV region.   
3.1.1.4  Urea Unfolding of Lysozyme - Discussion 
Lysozyme is routinely used for protein folding and unfolding studies due to the ease with 
which  the  enzyme  will  refold  upon  removal  of  the  denaturing  molecules  from  its 
environment.
135, 136  Activity measurements of urea-incubated and urea-incubated, reduced 
lysozyme  indicate that in the  absence of DTT, it is  not possible to completely unfold Katrina A. Davidson, 2008                                                                                             Chapter Three 
80 
lysozyme.  However, the observed activity could simply be an effect of the dilution of the 
urea from the lysozyme environment upon carrying out the aqueous activity assay.  The 
observation that lysozyme activity decreases with respect to incubation time (rather than 
instantaneously) could equally be due to the effect of chemical modification of the amino 
acid residues by urea (amidate formation) or isomerization of proline. 
Fluorescence  measurements  of  lysozyme  incubated  in  8  M  urea  indicate  that  there  is 
evidence of some kind of unfolding. A red-shift in the wavelength at which the maximum 
absorbance occurs is generally indicative of aromatic amino acids being exposed to the 
polar solvent, water (i.e. unfolding).
127  The shift in fluorescence maximum occurs almost 
immediately  upon  incubation  of  the  protein  in  8  M  urea  and  can  be  attributed  to  the 
interaction of newly exposed aromatic amino acid residues, residing close to the surface of 
the  protein,  with  solvent  rather  than  those  buried  deep  within  the  non-polar  protein 
interior.
137     
Lysozyme incubated in 8 M urea containing 32 mM DTT for 4 hours showed no activity 
and the CD spectrum indicated that the protein was unfolded.  This was due to the presence 
of DTT which reduced the disulfide bonds of the protein resulting in enhanced unfolding.  
The removal of disulfide bonds acts to decrease the overall stability of protein molecules.  
Specific examples of the removal of one of the disulfide bridges present in lysozyme (Cys6 
-  Cys127)  results  in  various  thermodynamic  and  kinetic  consequences.    Although  the 
enzyme retains the same secondary and tertiary structure, its Tm is 25 °C lower than the 
untreated protein and the unfolded state becomes significantly more favourable (70 J K
-1 
mol
-1)
100, 138   
High concentrations of urea are not in themselves sufficient to induce complete lysozyme 
unfolding, but may lead to chemical modification of the amino acid residues (hence we see 
a decrease  in activity  with respect  to incubation time) or areas of localised unfolding.  
Spectroscopic evidence suggests that a reducing agent such as DTT is required to cause the 
complete collapse of lysozyme structure via the reduction of disulfide bonds. 
3.1.2 Guanidine Hydrochloride Unfolding of Lysozyme 
The chemical unfolding of lysozyme by salts such as 6 M guanidine hydrochloride was 
monitored  using  a  number  of  spectroscopic  methods  including  fluorescence  and  CD 
spectroscopy.
32     Katrina A. Davidson, 2008                                                                                             Chapter Three 
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3.1.2.1  Guanidine  Hydrochloride  Unfolding  of  Lysozyme  -  Fluorescence 
Spectroscopy 
The  GdnHCl  unfolding  of  lysozyme  was  observed  utilising  fluorescence  spectroscopy.  
Lysozyme (0.1 mg/ml) was dissolved in 50 mM Tris/HCl, pH 8.1 either in the presence or 
absence  of  GdnHCl.    The  GdnHCl  sample  was  incubated  for  two  hours  at  room 
temperature prior to carrying out any measurements.     
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Figure 37: Guanidine Hydrochloride Unfolding of Lysozyme - Fluorescence Spectroscopy 
Upon incubation for two hours in 6 M GdnHCl, lysozyme appears to be unfolded.  The 
maximum fluorescence in the native sample is at 345 nm and in the case of the GdnHCl 
incubated sample; the maximum is at 352 nm.  As the molecule begins to unfold, the 
buried aromatic residues begin to interact with the surrounding solvent.  This subsequently 
changes the wavelength at which the maximum fluorescence occurs.  This shift towards 
higher wavelength indicates that structural changes have occurred within the molecule and 
therefore the lysozyme is no longer in a native conformation 
3.1.2.2  Guanidine Hydrochloride Unfolding of Lysozyme - CD Spectroscopy 
Circular dichroism spectroscopy of both the native and guanidine hydrochloride incubated 
enzyme was obtained.  This was to ascertain the effect of the salt upon the structure of the 
protein and gain an insight into the effect upon the protein at a molecular level. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure 38: Far UV CD Spectra of Native and Guanidine Hydrochloride Incubated Lysozyme 
The far UV CD spectrum of native lysozyme (as described previously), indicates that the 
protein contains a large alpha helical content.  Upon incubation of native lysozyme in 
GdnHCl for two hours, the protein begins to loose that helical content as the tertiary and 
secondary structural characteristics associated with the protein are removed.  The presence 
of GdnHCl results in a lot of noise appearing in the CD signal below 210 nm or so.  This is 
due to the presence of the chloride ions at such high concentrations (6 M GdnHCl).   
Near UV CD spectroscopy is routinely used to probe the secondary structure of protein 
molecules and gain an insight into the chirality of the environment of individual aromatic 
amino acids.  The near UV CD spectra of native and GdnHCl incubated lysozyme are 
shown. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure 39: Near UV CD Spectra of Native and Guanidine Hydrochloride Incubated Lysozyme 
Upon incubation of lysozyme in the salt GdnHCl, there is a complete loss of CD signal.  
This is a result of the GdnHCl unfolding the protein, therefore disrupting the structure 
leading to a change in the chirality of the amino acid environment. 
3.1.2.3  Guanidine Hydrochloride Unfolding of Lysozyme - Discussion 
From the studies carried out, it is evident that incubation of lysozyme in the chaotropic 
agent GdnHCl results in the disruption of the protein molecule so that it is no longer in a 
folded/native  conformation.    Fluorescence  and  CD  spectroscopy  indicated  that  upon 
incubation in the salt, the buried aromatic amino acids were no longer so.  GdnHCl can 
therefore be considered a suitable denaturing salt for the enzyme lysozyme. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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3.2  Thermal Unfolding of Lysozyme 
For the preparation of thermally-unfolded lysozyme, it is first necessary to assess how the 
protein responds to heat and at which temperature unfolding takes place.  
3.2.1 Differential Scanning Calorimetry of Lysozyme 
Differential Scanning Calorimetry (DSC) was carried out on lysozyme to assess protein 
response to increasing temperature.  This involves the controlled heating of the protein to 
determine at which temperature the protein is unfolded and if there is any refolding of the 
protein upon cooling.  The DSC thermogram and rescan of lysozyme at 1 mg/ml is shown:  
 
 
 
 
 
 
 
 
Figure 40: DSC Thermogram of Lysozyme 
The DSC thermogram indicates that in order to unfold lysozyme thermally, the protein 
must be heated to a minimum of 72.8 °C (the measured Tm).  The rescan shows that upon 
cooling, thermally-unfolded lysozyme either regains some structure or some of the protein 
is able to refold into a native conformation and therefore a thermal transition is seen on the 
DSC rescan.  However, the majority of protein remains apparently unfolded after heating 
to 100 ºC and subsequently cooled under these conditions.    
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3.2.2 Thermal  Unfolding  of  Lysozyme  -  Fluorescence 
Spectroscopy 
Lysozyme (0.1 mg/ml) was thermally unfolded by heating to 90 °C and then allowed to 
cool  to  room  temperature.    Once  cooled,  aggregates  were  seen  to  form  (hence  large 
intensity of scatter peak in the fluorescence spectrum).  The thermally-unfolded lysozyme 
was solubilised upon addition of 6 M GdnHCl and the aggregates were seen to dissolve 
(hence reduction in the intensity of the scattering peak in spectrum).   The fluorescence 
spectra of both the thermally-unfolded and solubilised proteins were obtained. 
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Figure 41: Thermal Unfolding and Guanidine Hydrochloride Solubilisation of Lysozyme 
As can be seen from the data shown, upon thermal unfolding, the fluorescence spectrum of 
lysozyme changes (as expected).  The presence of a high intensity scattering peak at 290 
nm indicates that there are aggregates present in the protein solution.  Upon addition of the 
salt GdnHCl, the scattering peak is removed.   
3.2.3 Thermal Unfolding of Lysozyme - CD Spectroscopy 
A CD spectrum of thermally-unfolded lysozyme was obtained upon solubilisation of the 
aggregates in GdnHCl.   Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure 42: Far UV CD Spectra of Lysozyme in the Native, Thermally-Unfolded and Guanidine 
Hydrochloride Incubated State 
Thermal  unfolding  and  GdnHCl  solubilisation  of  lysozyme,  removes  the  secondary 
structural elements associated with the enzyme.   Near UV CD spectroscopy was carried 
out to determine the effect of thermal unfolding and subsequent solubilisation upon the 
amino acid residues of lysozyme. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure 43: Near UV CD Spectra of Native, Thermally-Unfolded and Guanidine Hydrochloride 
Incubated Lysozyme 
Near  UV  CD  spectroscopy  indicates  unsurprisingly  that  upon  thermal  unfolding  and 
subsequent solubilisation of lysozyme with GdnHCl, there is loss of CD signal due to 
complete unfolding.   
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3.3 Immobilisation  of  Lysozyme  from  the  Native  and 
Unfolded State 
PCMC of native and unfolded lysozyme were prepared to determine the efficiency of this 
method for both the immobilisation and potential folding of the enzyme.   
To find the optimum conditions for the immobilisation and potential folding steps, various 
excipients, solvents, protein loadings and concentrations were employed.  Additives such 
as a redox couple (for example cystine and cysteine) were also used to assess what effect, 
if any, they had upon the potential refolding of lysozyme.  Different methods were also 
employed in the manufacture of PCMC.   
3.3.1 Immobilisation of Lysozyme from the Native and Guanidine 
Hydrochloride Unfolded State 
3.3.1.1  Immobilisation of Lysozyme from the Native and Guanidine Hydrochloride 
Unfolded State 
Lysozyme  was  unfolded  upon  incubation  of  the  protein  in  50  mM  Tris/HCl,  pH  8.1 
containing 6 M GdnHCl.  The unfolded protein was subsequently immobilised via the 
formation of PCMC. 
3.3.1.1.1 Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine 
Hydrochloride Unfolded State - Results 
PCMC of both native and GdnHCl unfolded lysozyme were analysed via reconstitution of 
the immobilised protein sample in 50 mM Tris/HCl, pH 8.1 and subsequent determination 
of the % MPL (Measured Protein Loading) and specific activity (0.876 Amin
-1mg
-1ml
-1 for 
untreated protein preparation) 
Details of PCMC sample preparation can be found in Appendix 1.  
 
 Katrina A. Davidson, 2008                                                                                             Chapter Three 
89 
Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC158_01 
Lysozyme on 
D,L-valine, 15 % 
load in 2-PrOH 
98.3  16.3  0.832 (± 0.017)  94.9 (± 1.9) 
KC158_02 
Lysozyme on 
D,L-valine, 20 % 
load in 2-PrOH 
87.5  20.4  0.843  96.2 
KC158_03 
Lysozyme on 
D,L-valine, 25 % 
load in 2-PrOH 
97.9  25.9  0.812  92.7 
KC162_01 
Lysozyme in 
GdnHCl on D,L-
valine, 12.5 % 
load in 2-PrOH 
84.3  11.3  0.673 (± 0.021)  77.0 (± 2.4) 
KC162_02 
Lysozyme in 
GdnHCl on D,L-
valine, 15 % load  
in 2-PrOH 
76.1  15.9  0.642  73.4 
KC162_03 
Lysozyme in 
GdnHCl on D,L-
valine, 17.5 % 
load in 2-PrOH 
83.7  18.6  0.713  81.5 
KC162_04 
Lysozyme in 
GdnHCl on D,L-
valine, 20 % load  
in 2-PrOH 
79.4  21.8  0.673 (± 0.026)  76.8 (± 3.0)  
KC162_05 
Lysozyme in 
GdnHCl on D,L-
valine, 22.5 % 
load in 2-PrOH 
67.4  24.1  0.703  80.3 
KC162_06 
Lysozyme in 
GdnHCl on D,L-
valine, 25 % load 
in 2-PrOH 
67.8  28.6  0.694  79.3 
 
Table 2: Immobilisation of Lysozyme from the Native and Guanidine Hydrochloride Unfolded 
State - Results 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
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3.3.1.1.1.1  Immobilisation of Lysozyme from the Guanidine Hydrochloride Unfolded State - 
CD Spectroscopy 
 
CD spectroscopy was carried out of the immobilised protein samples upon reconstitution.  
The sample shown is KC162_03, GdnHCl unfolded lysozyme subjected to immobilisation 
on D,L-valine in propan-2-ol. 
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Figure 44: Immobilisation of Lysozyme from the Guanidine Hydrochloride Unfolded State - 
CD Spectroscopy 
3.3.1.1.2 Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine 
Hydrochloride Unfolded State - Discussion 
The measured solids recovery of the PCMC suspensions suggest that immobilised native 
lysozyme samples can be prepared using D,L-valine as an excipient with very little of the 
solid or protein being lost to the solvent.   
In order to ascertain the effect of the immobilisation on the activity of both the native and 
the GdnHCl unfolded protein, it is necessary to compare the observed activity measured 
for these samples. 
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Figure  45:  Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine  Hydrochloride 
Unfolded State - Comparison of Retained Activity  
Immobilisation of the native protein on D,L-valine at theoretical protein loadings ranging 
from 15 - 25 % can retain up to 96.2 % of activity when compared with the untreated 
lysozyme.    When  lysozyme  is  unfolded  in  GdnHCl  and  subsequently  subjected  to 
immobilisation, the protein regains up to 81.5 % of the activity of the untreated lysozyme.  
This suggests that the protein, although experimentally shown to be unfolded by GdnHCl 
(using fluorescence and CD spectroscopy), can regain activity upon removal of the salt 
from the protein environment.  
CD spectroscopy of the GdnHCl unfolded immobilised PCMC preparation indicates that 
upon  immobilisation  and  exclusion  of  the  solubilising  agent,  lysozyme  can  regain 
secondary structure and activity akin to the native state. 
3.3.1.2  Immobilisation of Lysozyme from the Native and Guanidine Hydrochloride 
Unfolded State at Lower Protein Loadings 
In order to determine if lysozyme could be immobilised and refolded successfully at lower 
protein  loadings,  samples  were  prepared  of  native  and  GdnHCl  unfolded  lysozyme  (6 
mg/ml) at protein loadings ranging from 0.6 - 20 %.   
3.3.1.2.1 Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine 
Hydrochloride Unfolded State at Lower Protein Loadings - Results 
PCMC of both native and GdnHCl unfolded lysozyme were analysed via reconstitution of 
the immobilised protein sample in 50 mM Tris/HCl, pH 8.1 and subsequent determination Katrina A. Davidson, 2008                                                                                             Chapter Three 
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of the % MPL (Measured Protein Loading) and specific activity (0.6502 Amin
-1mg
-1ml
-1 
for untreated protein preparation). 
Details of PCMC sample preparation can be found in Appendix 2. 
Sample 
Identifier  Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC198_01 
Lysozyme on D,L-
valine, 0.6 % load in 
2-PrOH 
90.7  0.9  0.592  91.0 
KC198_02 
Lysozyme on D,L-
valine, 5 % load in 2-
PrOH 
99.7  4.9  0.605  93.0 
KC198_03 
Lysozyme on D,L-
valine, 10 % load in 
2-PrOH 
86.8  10.6  0.604  92.9 
KC198_04 
Lysozyme on D,L-
valine, 15 % load in 
2-PrOH 
85.8  14.2  0.613  94.3 
KC198_05 
Lysozyme on D,L-
valine, 20 % load in 
2-PrOH 
88.4  20.7  0.544 (± 0.035)  83.7 (± 5.4) 
KC187_05 
Lysozyme in 
GdnHCl on D,L-
valine, 0.6 % load in 
2-PrOH 
87.7  0.8  0.435  66.9 
KC187_06 
Lysozyme in 
GdnHCl on D,L-
valine, 5 % load in 2-
PrOH 
89.5  5.3  0.398  61.2 
KC187_07 
Lysozyme in 
GdnHCl on D,L-
valine, 10 % load in 
2-PrOH 
77.5  9.8  0.489  75.2 
KC187_08 
Lysozyme in 
GdnHCl on D,L-
valine, 15 % load in 
2-PrOH 
75.8  16.2  0.546  84.0 
KC187_09 
Lysozyme in 
GdnHCl on D,L-
valine, 20 % load in 
2-PrOH 
95.8  21.2  0.521 (± 0.022)  80.1 (± 3.4) 
 
Table 3: Immobilisation of Lysozyme from the Native and Guanidine Hydrochloride Unfolded 
State at Lower Protein Loadings - Results    
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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3.3.1.2.1.1  Immobilisation of Lysozyme from the Native and Guanidine Hydrochloride 
Unfolded State - CD Spectroscopy 
 
Samples KC198_04 and KC187_08 were subjected to CD spectroscopy both as powders in 
suspension and upon reconstitution. 
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Figure  46:  Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine  Hydrochloride 
Unfolded State - CD Spectroscopy (The difference in intensities of bands is due to variations in 
sample protein concentration) 
3.3.1.2.2 Immobilisation  of  Native  and  Guanidine  Hydrochloride  Unfolded 
Lysozyme at Lower Protein Loadings - Discussion 
The  PCMC  prepared  from  native  and  GdnHCl  unfolded  lysozyme  at  lower  loadings 
indicate  that  lysozyme  can  be  immobilised  on  D,L-valine  with  high  measured  solid 
recovery. 
To  determine  the  effect  of  immobilisation  on  the  lysozyme,  the  observed  activity  is 
compared  for  PCMC  of  both  native  and  GdnHCl  unfolded  protein  of  identical 
formulations.  Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure  47:  Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine  Hydrochloride 
Unfolded State at Lower Protein Loadings - Comparison of Retained Activity 
Immobilisation of the native protein on D,L-valine at theoretical protein loadings ranging 
from 0.6 - 20 % can retain up to 94.3 % of activity when compared with the untreated 
protein.   
When lysozyme is unfolded in GdnHCl and subsequently subjected to immobilisation at 
these loadings, the enzyme regains up to 84.0 % of the activity of the untreated protein.  
This  suggests  that,  although  experimentally  shown  to  be  unfolded  by  GdnHCl  (by 
fluorescence and CD spectroscopy), the protein can regain activity upon removal of the salt 
from the protein environment, by employing loadings of 0.6 - 20 %.  
CD spectroscopy of the immobilised native lysozyme indicates that the protein is held in 
its native state upon the surface of the excipient material.  Upon reconstitution, the protein 
molecule  is released  from the surface and is present in the aqueous  phase as a native 
structure.  CD spectroscopy of lysozyme immobilised from the GdnHCl unfolded state 
results  in  protein  which  appears  to  be  in  a  conformation  similar  to  that  of  the  native 
enzyme.  
3.3.1.3  Immobilisation of Lysozyme from the Native and Guanidine Hydrochloride 
Unfolded State Using a Syringe Pump 
In order to determine if increased enzymatic activity could be regained by the gradual 
mixing of the protein solution and excipient as opposed to the abrupt change in immediate Katrina A. Davidson, 2008                                                                                             Chapter Three 
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mixing; a syringe pump was employed.  This allowed the excipient to be added to the 
protein containing solution at a slow rate (0.01 ml/min) to allow gradual dilution of the 
denaturant before the immobilisation step occurs. 
3.3.1.3.1 Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine 
Hydrochloride Unfolded State Using a Syringe Pump - Results 
PCMC of native and GdnHCl unfolded lysozyme manufactured using a syringe pump, 
were analysed via the reconstitution of the immobilised protein sample in 50 mM Tris/HCl, 
pH 8.1 and subsequent determination of the % MPL (Measured Protein Loading) and the 
specific activity (0.876A min
-1mg
-1ml
-1 for untreated protein). 
Details of PCMC sample preparation can be found in Appendix 3. 
Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity     
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC258_16 
Lysozyme, on D,L- 
valine, 5 % loading 
in 2-PrOH 
 
81.2 
 
5.6  0.544  62.1 
KC258_19 
Lysozyme in 
GdnHCl on D,L-
valine 5 % loading 
in 2-PrOH 
 
95.7 
 
6.1  0.128  14.6 
 
Table 4: Immobilisation of Lysozyme from the Native and Guanidine Hydrochloride Unfolded 
State Using a Syringe Pump - Results 
3.3.1.3.2 Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine 
Hydrochloride Unfolded State Using a Syringe Pump - Discussion 
Native  lysozyme,  when  mixed  gradually  with  excipient  using  a  syringe  pump  before 
precipitation,  shows  a  reduction  in  retained  activity  when  compared  with  identical 
formulations conventionally prepared.   
The PCMC prepared via the use of a syringe pump can be compared with two samples 
with  identical  formulations;  KC198_02  (native  lysozyme)  and  KC187_07  (GdnHCl 
unfolded lysozyme). Katrina A. Davidson, 2008                                                                                             Chapter Three 
96 
9
3
.
0
6
2
.
1
6
1
.
2
1
4
.
6
0
10
20
30
40
50
60
70
80
90
100
Conventional Mixing Syringe Pump
PCMC Preperation Method
A
c
t
i
v
i
t
y
 
W
h
e
n
 
C
o
m
p
a
r
e
d
 
w
i
t
h
 
t
h
e
 
U
n
t
r
e
a
t
e
d
 
L
y
s
o
z
y
m
e
 
(
%
)
Native Lysozyme
GdnHCl Unfolded Lysozyme
 
Figure  48:  Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine  Hydrochloride 
Unfolded State at 5 % Loading - Effect of Using a Syringe Pump 
When compared with identical PCMC formulations, those prepared using syringe pumps 
for gradual protein-excipient mixing tend to have lower activity than their conventionally 
mixed counterparts.   
Native lysozyme can be immobilised at 5 % loading with the retention of up to 93 % 
enzymatic activity.  However, when a syringe pump is employed to mix the protein and 
excipient before precipitation, this activity is reduced to 62 %.  This could be due to the 
time the aqueous solution of protein is kept at room temperature to carry out the slow 
mixing, when compared with the immediate mixing and precipitation of the conventional 
PCMC preparation method. 
PCMC  of  GdnHCl  unfolded  lysozyme  when  prepared  by  immediate  mixing  and 
precipitation can regain up to 61 % of the activity of the untreated protein.  However, when 
gradual mixing is employed, this regained activity is reduced to 14.6 %. 
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3.3.1.4  Dialysis Refolding of Lysozyme from the Guanidine Hydrochloride Unfolded 
State - Comparison with Immobilisation 
Dialysis  is  a  common  method  used  for  protein  folding  which  involves  the  gradual 
controlled removal of denaturing molecules from the environment of the protein.   
Dialysis,  as  a  method  for  refolding  was  compared  with  immobilisation  for  GdnHCl 
unfolded lysozyme.  Lysozyme (6 mg/ml in 50 mM Tris/HCl, pH 8.1) which had been 
chemically unfolded via addition of 6 M GdnHCl was subjected to dialysis against buffer 
containing no GdnHCl salt.  The protein was incubated for 2 hours in the salt before being 
subjected to dialysis (2 x 3 hours plus overnight).   
Upon dialysis,  protein aggregation was seen to occur to some extent, although not  all 
protein  had  aggregated.    Upon  removal  of  the  protein  from  the  dialysis  cassette,  the 
enzyme was subjected to fluorescence spectroscopy and the activity assay described for the 
protein.   
Fluorescence spectra of the GdnHCl unfolded and dialysed proteins were obtained.  The 
wavelength at which the maximum fluorescence intensity occurred for the native protein 
was the same as had been previously described (345 nm).  
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Figure 49: Dialysis Refolding of Lysozyme from the Guanidine Hydrochloride Unfolded State 
– Fluorescence Spectroscopy 
When the lysozyme had been subjected to GdnHCl unfolding, this wavelength increased 
(353 nm) as expected.  Upon subjecting the unfolded protein to dialysis, the wavelength at 
which the maximum fluorescence intensity occurs decreased slightly to 349 nm.  This 
indicated that the protein was no longer in an unfolded, solubilised state, but perhaps was 
partially refolded or aggregated. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure 50: Dialysis Refolding of Lysozyme from the Guanidine Hydrochloride Unfolded State 
– CD Spectroscopy 
CD spectroscopy of the guanidine hydrochloride unfolded and dialysed protein shows that 
upon implementation of dialysis as a refolding method, some regain of secondary structure 
is seen 
The enzymatic activity assay indicated that GdnHCl unfolded lysozyme at a concentration 
of 6 mg/ml could regain 19.8 % of the activity of the native, untreated protein.  This 
compares unfavourably with the immobilisation method which can regain 61.2 % activity 
from lysozyme under the same conditions.   
3.3.2 Immobilisation  of  Lysozyme  from  the  Native  and  Urea-
Unfolded State 
3.3.2.1  Immobilisation of Lysozyme from the Urea-Incubated and Urea-Unfolded, 
Reduced State 
Urea cannot induce complete unfolding of lysozyme from the native state on its own.  It 
requires  the  assistance  of  a  reducing  agent  such  as  DTT  (dithiothreitol)  to  break  the 
disulfide bonds involved in holding the protein molecule in a native conformation.   Katrina A. Davidson, 2008                                                                                             Chapter Three 
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PCMC  of  urea-incubated  and  urea-unfolded,  reduced  lysozyme  (12  mg/ml)  was 
manufactured in order to ascertain the effect of the addition of the reducing agent had upon 
the prepared immobilised samples.  These PCMC were prepared at the same theoretical 
protein loading in different precipitating solvent systems. 
3.3.2.1.1 Immobilisation  of  Lysozyme  from  the  Urea-Incubated  and  Urea-
Unfolded, Reduced State - Results 
PCMC  of  urea-incubated  and  urea-unfolded,  reduced  lysozyme  were  analysed  via 
reconstitution  of  the  immobilised  protein  sample  in  50  mM  Tris/HCl,  pH  8.1  and 
subsequent determination of the % MPL (Measured Protein Loading) and specific activity 
(0.876 Amin
-1mg
-1ml
-1 for untreated protein preparation).   
Details of PCMC sample preparation can be found in Appendix 4. 
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Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC111_01 
Lysozyme in urea 
+ DTT on D,L-
valine, 16.5 % 
load in EtOH 
57.2  **  **  ** 
KC111_02 
Lysozyme in urea 
+ DTT on D,L-
valine, 16.5 % 
load in 2-PrOH 
76.3  15.1  0.083 (± 0.019)  9.0 (± 2.2) 
KC111_03 
Lysozyme in urea 
+ DTT on D,L-
valine, 16.5 % 
load in 1-PrOH 
40.1  18.7  0.019  1.1 
KC111_04 
Lysozyme in urea  
on D,L-valine,   
16.5 % load in 
EtOH 
63.6  18.3  0.715  81.6 
KC111_05 
Lysozyme in urea 
on D,L-valine,   
16.5 % load in         
2-PrOH 
84.5  17.9  0.804  91.7 
KC111_06 
Lysozyme in urea 
on D,L-valine,   
16.5 % load in         
1-PrOH 
56.2  19.8  0.730 (± 0.041)  83.3 (± 4.7) 
 
Table 5: Immobilisation of Lysozyme from the Urea-Incubated and Urea-Unfolded, Reduced 
State  Using  Various  Solvents  -  Results  (**  The  sample  was  insoluble  upon  attempted 
reconstitution) 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
3.3.2.1.1.1  Immobilisation of Lysozyme from the Urea-Incubated State - CD Spectroscopy 
CD spectroscopy was carried out of the immobilised protein samples upon reconstitution.  
The sample shown is KC111_05, lysozyme incubated in urea subjected to immobilisation 
on D,L-valine in propan-2-ol. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure 51: Immobilisation of Lysozyme from the Urea-Incubated State - CD Spectroscopy 
3.3.2.1.2  Immobilisation  of  Lysozyme  from  the  Urea-Incubated  and  Urea-
Unfolded Reduced State - Discussion 
From  this set of experiments,  it  is evident that propan-2-ol  is the best  solvent  for the 
precipitation of lysozyme at this particular loading with D,L-valine as an excipient with 
regards to the measured solid recovery and the observed activity.   
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Figure  52:  Immobilisation  of  Lysozyme  from  the  Urea-Incubated  and  Urea-Unfolded, 
Reduced State - Observed Activity  
It is possible to prepare PCMC of urea-incubated lysozyme at 16.5 % loading in various 
solvents with  little overall loss of  activity.   Previous studies  indicate that lysozyme  is 
reversibly unfolded in 8 M urea, so little loss of activity would be expected, although it is 
interesting to note that urea can be removed from the environment of this protein without 
significant loss of enzymatic activity. 
The PCMC prepared from urea-unfolded, reduced lysozyme via precipitation in ethanol 
yielded insoluble protein and as such the measured protein loading and activity could not 
be determined.  However, the PCMC prepared in propan-2-ol and propan-1-ol were soluble 
and show some regain of enzymatic activity.  There are a number of reasons this could be 
possible.   
At the immobilisation stage, the amino acid carrier material takes longer to precipitate in 
ethanol than in propanol.  This could result in the enzyme being held in the unfolded state 
in the organic solvent for longer.  The presence of alcohols has been known to stabilise the 
unfolded state in many studies with lysozyme.
139, 140  It is therefore possible to suggest that 
in the case of immobilisation in ethanol, rather than the enzyme regaining native structure 
via immobilisation, the protein is held in a non-native conformational state (possibly as an 
aggregate)  which  is  then  immobilised.    This  could  explain  the  low  solubility  of  the 
immobilised protein upon reconstitution under aqueous conditions. 
The CD spectra indicate that it is possible to reversibly adsorb protein on to the surface of 
an amino acid (such as D,L-valine) with the exclusion of additives such as urea.  Upon Katrina A. Davidson, 2008                                                                                             Chapter Three 
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reconstitution,  the  biomolecule  appears  to  retain  most  (if  not  all)  of  the  secondary 
structural elements associated with the native state. 
3.3.2.2  Immobilisation of Lysozyme from the Urea-Incubated and Urea-Unfolded, 
Reduced State Using L-Glutamine as an Excipient 
PCMC of urea-incubated lysozyme and urea-unfolded, reduced lysozyme (12 mg/ml) were 
manufactured in order to see the effect of the addition of reducing agent upon the prepared 
immobilised samples.  These PCMC were prepared at the same theoretical protein loading 
in different precipitating solvents. 
3.3.2.2.1 Immobilisation  of  Lysozyme  from  the  Urea-Incubated  and  Urea-
Unfolded, Reduced State Using L-Glutamine as an Excipient - Results 
PCMC  of  urea-incubated  and  urea-unfolded,  reduced  lysozyme  were  analysed  via 
reconstitution  of  the  immobilised  protein  sample  in  50  mM  Tris/HCl,  pH  8.1  and 
subsequent determination of the % MPL (Measured Protein Loading) and specific activity 
(0.876 Amin
-1mg
-1ml
-1 for untreated protein preparation). 
Details of PCMC sample preparation can be found in Appendix 5. 
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Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC111_07 
Lysozyme in urea  
+ DTT on L-
glutamine, 37.5 
% load in EtOH 
60.3  **  **  ** 
KC111_08 
Lysozyme in urea  
+ DTT on L-
glutamine, 37.5 
% load in 2-
PrOH 
84.1  **  **  ** 
KC111_09 
Lysozyme in urea   
+ DTT on L-
glutamine, 37.5 
% load in 1-
PrOH 
84.8  **  **  ** 
KC111_10 
Lysozyme in urea  
on L-glutamine,  
37.5 % load in 
EtOH 
70.5  15.4  0.569  64.9 
KC111_11 
Lysozyme in urea 
on L-glutamine,   
37.5 % load in         
2-PrOH 
86.3  11.1  0.382  43.6 
KC111_12 
Lysozyme in urea 
on L-glutamine,  
37.5 % load in         
1-PrOH 
76.3  11.4  0.374 (± 0.023)  42.6 (± 2.6) 
 
Table 6: Immobilisation of Lysozyme from the Urea-Incubated and Urea-Unfolded, Reduced 
State  Using  L-Glutamine  as  an  Excipient  -  Results  (**  The  sample  was  insoluble  upon 
attempted reconstitution) 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
3.3.2.2.2 Immobilisation  of  Lysozyme  from  the  Urea-Incubated  and  Urea-
Unfolded,  Reduced  State  Using  L-Glutamine  as  an  Excipient  - 
Discussion 
The  use  of  the  excipient  L-glutamine  renders  all  of  the  samples  prepared  from  urea-
unfolded, reduced lysozyme as insoluble and as such the protein loading and activity of 
these samples have not been determined.   
In the case of PCMC prepared from urea-incubated lysozyme, the observed activity for 
these preparations is less than that seen for D,L-valine.  Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure  53:  Comparison  of  D,L-Valine  and  L-Glutamine  as  Excipients  for  Urea-Incubated 
Lysozyme Immobilisation 
From the data provided it is evident that D,L-valine is a better excipient for lysozyme under 
these conditions than  L-glutamine.  The PCMC prepared from  L-glutamine have lower 
measured solid recovery and observed activity than their D,L-valine counterparts.  
3.3.2.3  Immobilisation  of  Lysozyme  from  Urea-Incubated  and  Urea-Unfolded, 
Reduced state at Lower Protein Loadings 
To determine if reducing the loading of the protein could have any positive effect upon the 
solubility  (and  observed  activity)  of  the  PCMC,  immobilised  protein  samples  were 
prepared with these objectives in mind.  
Lysozyme  12  mg/ml  in  50  mM  Tris/HCl,  pH  8.1  containing  8  M  Urea  either  in  the 
presence or absence of 32 mM DTT was used as a stock from which to prepare PCMC 
immobilised upon D,L-valine. 
3.3.2.3.1 Immobilisation  of  Lysozyme  from  the  Urea-Incubated  and  Urea-
Unfolded, Reduced state at Lower Protein Loadings - Results 
PCMC  of  urea-incubated  and  urea-unfolded,  reduced  lysozyme  were  analysed  via 
reconstitution  of  the  immobilised  protein  sample  in  50  mM  Tris/HCl,  pH  8.1  and 
subsequent determination of the % MPL (Measured Protein Loading) and specific activity 
(0.876 Amin
-1mg
-1ml
-1 for untreated protein preparation) Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Details of PCMC sample preparation can be found in Appendix 6. 
Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC119_01 
Lysozyme in urea 
+ DTT on D,L-
valine, 9 % load 
in EtOH 
64.3  **  **  ** 
KC119_02 
Lysozyme in urea 
+ DTT on D,L-
valine, 9 % load 
in 1-PrOH 
35.2  **  **  ** 
KC119_03 
Lysozyme in urea 
+ DTT on D,L-
valine, 9 % load 
in 2-PrOH 
86.8  7.6  0.124 (± 0.036)  14.1 (±4.1) 
KC119_07 
Lysozyme in urea 
on D,L-valine, 9 
% load in EtOH 
70.5  8.9  0.664  75.8 
KC119_08 
Lysozyme in urea 
on D,L-valine, 9 
% load in 1-
PrOH 
86.3  7.9  0.712  81.3 
KC119_09 
Lysozyme in urea 
on D,L-valine, 9 
% load in 2-
PrOH 
89.3  9.3  0.772  88.1 
 
Table 7: Immobilisation of Lysozyme from the Urea-Incubated and Urea-Unfolded, Reduced 
state  at  Lower  Protein  Loadings  -  Results  (**  The  sample  was  insoluble  upon  attempted 
reconstitution) 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
3.3.2.3.2 Immobilisation  of  Lysozyme  from  the  Urea-Incubated  and  Urea-
Unfolded, Reduced state at Lower Protein Loadings - Discussion 
Reducing the protein loading has a significant effect upon the observed activity of the 
sample  precipitated  in  2-PrOH  when  compared  to  PCMC  prepared  at  16.5  %  loading 
(KC111_02).   
However, the PCMC of urea-unfolded, reduced protein precipitated in ethanol remains 
insoluble and therefore the measured protein loading and activity cannot be determined. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure  54:  Immobilisation  of  Urea-Unfolded,  Reduced  Lysozyme  on  D,L-Valine  -  Effect  of 
Protein Loading 
The activity of this sample increases by over 50 % (with respect to KC111_02 which has a 
protein loading of 16.5 %).  This is obviously a favourable effect upon the sample and 
further investigation was carried out in an attempt to improve upon this. 
3.3.2.4  Immobilisation of Lysozyme from the Urea-Unfolded, Reduced State from 
Lower Stock Concentrations  
The  previously  described  PCMC  were  manufactured  from  various  protein  stocks  at  a 
concentration of 12 mg/ml lysozyme in 50 mM Tris/HCl, pH 8.1 containing 8 M Urea and 
32 mM DTT.  To determine if reducing the protein concentration of the stock from which 
samples were prepared would have any positive effect upon the solubility (and observed 
activity) of the PCMC, immobilised protein samples were prepared from lysozyme at a 
concentration of 6 mg/ml.   
3.3.2.4.1 Immobilisation  of  Lysozyme  from  the  Urea-Unfolded,  Reduced  State 
from Lower Stock Concentrations - Results 
PCMC  of  urea-unfolded,  reduced  lysozyme  were  analysed  via  reconstitution  of  the 
immobilised protein sample in 50 mM Tris/HCl, pH 8.1 and subsequent determination of 
the % MPL (Measured Protein Loading) and specific activity (0.876 Amin
-1mg
-1ml
-1 for 
untreated protein). 
Details of PCMC sample preparation can be found in Appendix 7. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC77_01 
Lysozyme in urea 
+ DTT on D,L-
valine, 9 % load 
in EtOH 
62.0  **  **  ** 
KC77_02 
Lysozyme in urea 
+ DTT on D,L-
valine, 9 % load 
in 2-PrOH 
84.7  9.3  0.376 (± 0.021)  42.9 (± 2.4) 
KC77_03 
Lysozyme on 
D,L-valine, 9 % 
load in EtOH 
77.9  9.8  0.717  81.8 
KC77_04 
Lysozyme on 
D,L-valine, 9 % 
load in 2-PrOH 
89.6  8.6  0.825  94.2 
 
Table 8: Immobilisation of Lysozyme from the Urea-Unfolded, Reduced State from Lower 
Stock Concentrations - Results (** The sample was insoluble upon attempted reconstitution) 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
3.3.2.4.1.1  Immobilisation of Lysozyme from the Urea-Unfolded, Reduced State - CD 
Spectroscopy 
CD spectroscopy was carried out upon immobilised lysozyme which had undergone urea 
unfolding in the presence of DTT (KC77_02).  The protein immobilised in this sample was 
subjected to 8 M urea and 32 mM DTT before subsequent precipitation with D,L-valine in 
propan-2-ol.   Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure 55: Far UV CD Spectrum of Native Lysozyme and Urea-Unfolded, Reduced Lysozyme 
Immobilised on D,L-valine in Propan-2-ol 
 CD spectroscopy was carried out upon the reconstituted sample in 50 mM Tris/HCl, pH 
8.1.  Upon coprecipitation, the urea and DTT were dissolved in the precipitating solvent; 
propan-2-ol. 
To determine if the addition of a redox couple would have an effect upon the observed 
activity of the immobilised urea-unfolded, reduced lysozyme, further analysis was carried 
out on sample KC77_02.   
After  ascertaining  that  the  redox  couple  of  cystine/cysteine  had  no  effect  upon  the 
spectrophotometric activity assay, the PCMC were reconstituted in a buffer containing the 
redox pair (50 mM Tris/HCl, pH 8.1 containing 0.8 mM L-cystine and 8 mM L-cysteine) 
and incubated for two hours with gentle stirring.  The activity of KC77_02 was seen to 
increase to around 45 % when compared with the untreated lysozyme (an increase of 5 % 
when compared to KC77_02 in the absence of a redox couple.  
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3.3.2.4.2 Immobilisation  of  Lysozyme  from  the  Urea-Unfolded,  Reduced  State 
from Lower Stock Concentrations - Discussion 
Reducing the concentration of protein from which the PCMC preparation were made, has 
the effect of increasing the observed activity for samples prepared in propan-2-ol.   
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Figure  56:  Immobilisation  of  Urea-Unfolded,  Reduced  Lysozyme  on  D,L-Valine  -  Effect  of 
Protein Stock Concentration 
A decrease in the concentration of the protein stock from which the PCMC were prepared 
(from 12 mg/ml to 6 mg/ml) resulted in a 300 % increase in the observed activity of the 
PCMC sample prepared in 2-PrOH. 
As previously noted, the measured  solid recovery is highest in  propan-2-ol  due to the 
slightly higher solubility of D,L-valine in ethanol than in 2-PrOH.  There is also a delay in 
the  addition  of  the  lysozyme/  D,L-valine  mixture  and  the  appearance  of  precipitated 
material (PCMC).   
The  obtained  CD  spectrum  of  sample  KC77_02  indicates  that  upon  immobilisation  of 
lysozyme upon the surface of D,L-valine, significant  secondary structure can be regained.  
This could be a result of either a mixture of folded and unfolded populations or a partially 
folded population.  Nonetheless, it is possible to say that the immobilisation of lysozyme 
from the unfolded, reduced state can give rise to either a partially folded or mixed product.  
It would have been interesting to carry out solid state CD spectroscopy on this formulation, 
but this could not be done due to inadequate quantities of the material. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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The addition of a redox couple during reconstitution had little effect upon the observed 
activity.  After two hours incubation of the PCMC in reconstitution buffer containing the 
redox couple, the activity of the protein increased by 5 % when compared with the non-
incubated sample. 
3.3.2.5  Immobilisation of Lysozyme from the Native and Urea-Unfolded, Reduced 
State Using a Syringe Pump 
In order to determine if increased enzymatic activity could be regained by the gradual 
mixing of the protein solution and excipient; a syringe pump was employed.  This allowed 
the excipient to be added to the protein containing solution at a slow rate (0.01 ml/min) to 
allow dilution of the denaturant before the immobilisation step occurs. 
3.3.2.5.1 Immobilisation  of  Lysozyme  from  the  Native  and  Urea-Unfolded, 
Reduced State Using a Syringe Pump - Results 
PCMC of native and urea-unfolded, reduced lysozyme manufactured through the use of a  
syringe pump, were analysed via the reconstitution of the immobilised protein sample in 50 
mM Tris/HCl, pH 8.1 and subsequent determination of the % MPL (Measured Protein 
Loading) and the specific activity (0.876A min
-1mg
-1ml
-1 for untreated protein). 
Details of PCMC sample preparation can be found in Appendix 8. 
Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity     
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC258_16 
Lysozyme, on D,L- 
valine, 5 % load in 
2-PrOH 
 
81.2 
 
5.6  0.544  62.1 
KC258_20 
Lysozyme in Urea 
+ DTT on D,L-
valine 5 % load in 
2-PrOH 
77.2  **  **  ** 
 
Table  9:  Immobilisation of Lysozyme  from the Native  and  Urea-Unfolded, Reduced  State 
Using a Syringe Pump - Results (** The sample was insoluble upon attempted reconstitution) 
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3.3.2.5.2 Immobilisation  of  Lysozyme  from  the  Native  and  Urea-Unfolded, 
Reduced State Using a Syringe Pump - Discussion 
As  previously  noted,  native  lysozyme,  when  mixed  gradually  with  excipient  before 
precipitation using a syringe pump, shows a reduction in retained activity when compared 
with identical samples prepared in the conventional manner. 
PCMC  of  urea-unfolded,  reduced  lysozyme  when  prepared  by  immediate  mixing  and 
precipitation can regain up to 43 % of the activity of the untreated protein.  However, when 
gradual mixing is employed, the resultant PCMC are insoluble in the reconstitution buffer 
and as such, the protein loading and observed activity cannot be determined. 
3.3.2.6  Dialysis  Refolding  of  Lysozyme  from  the  Urea-Unfolded,  Reduced  State  - 
Comparison with Immobilisation 
Dialysis, as a method for refolding was compared with immobilisation for urea-unfolded, 
reduced lysozyme.  Lysozyme (6 mg/ml in 50 mM Tris/HCl, pH 8.1) which had been 
chemically unfolded via the addition 8 M Urea with 32 mM DTT was subjected to dialysis 
against buffer containing no additives.  The protein was incubated for two hours before 
being subjected to dialysis (2 x three hours plus overnight).   
Upon dialysis,  protein aggregation was seen to occur to some extent, although not  all 
protein  had  aggregated.    Upon  removal  of  the  protein  from  the  dialysis  cassette,  the 
enzyme was subjected to fluorescence spectroscopy and the activity assay described for the 
protein.   
Fluorescence spectra of the urea-unfolded, reduced and dialysed proteins were obtained.  
The  wavelength  at  which  the  maximum  fluorescence  intensity  occurred  for  the  native 
protein was the same as had been previously described (345 nm).  
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Figure 57: Dialysis of Urea-Unfolded, Reduced Lysozyme - Fluorescence Spectroscopy 
When the lysozyme had been subjected to urea unfolding and reduction, this wavelength 
increased (356 nm) as expected.  Upon subjecting the unfolded protein to dialysis, the 
wavelength at which the maximum fluorescence intensity occurs decreased slightly to 353 
nm.   
The  enzymatic  activity  assay  indicated  that  urea-unfolded,  reduced  lysozyme  at  a 
concentration of 6 mg/ml could regain 9.2 % of the activity of the native, untreated protein.  
This compares unfavourably with PCMC formation.  Immobilisation of lysozyme from the 
urea-unfolded, reduced state can lead to the regain of up to 43 % activity compared with 
the untreated enzyme.   
3.3.3 Immobilisation of Lysozyme from the Native and Thermally-
Unfolded State 
Thermal  unfolding  of  proteins  is  a  commonly  used  technique  in  protein  denaturation 
studies.  Upon heating, the protein molecules begin to unfold and interact with each other, 
resulting in the formation of aggregates.  This aggregated/misfolded state may be a better 
model for inclusion bodies than lysozyme in the urea or guanidine hydrochloride unfolded 
state.  In order to carry out any kind of refolding methodology on this aggregated protein, Katrina A. Davidson, 2008                                                                                             Chapter Three 
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these insoluble species must first be solubilised in the presence of an agent such as urea or 
GdnHCl. 
PCMC of both native and thermally-unfolded GdnHCl (6 M) or urea (8 M) solubilised 
lysozyme were prepared.   
3.3.3.1  Immobilisation  of  Lysozyme  from  the  Native  and  Thermally-Unfolded, 
Guanidine Hydrochloride-Solubilised State 
To  determine  if  it  is  possible  to  immobilise  thermally-unfolded,  GdnHCl-solubilised 
lysozyme on to the surface of D,L-valine with the regain of enzymatic activity, immobilised 
protein samples were prepared.  Lysozyme was thermally-unfolded and solubilised upon 
incubation of the aggregated protein in 6 M GdnHCl. 
3.3.3.1.1 Immobilisation of Lysozyme from the Native and Thermally-Unfolded, 
Guanidine Hydrochloride-Solubilised State - Results 
PCMC  of  thermally-unfolded,  GdnHCl-solubilised  lysozyme  were  analysed  via 
reconstitution  of  the  immobilised  protein  sample  in  50  mM  Tris/HCl,  pH  8.1  and 
subsequent determination of the % MPL (Measured Protein Loading) and specific activity 
(0.876 Amin
-1mg
-1ml
-1 for untreated protein). 
Details of PCMC sample preparation can be found in Appendix 9. 
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Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1 ml
-1) 
% Activity 
of Native 
Protein 
KC258_01 
Lysozyme on 
D,L-valine, 1 % 
load in 2-PrOH 
92.2  0.7  0.785  89.6 
KC258_02 
Lysozyme on 
D,L-valine, 5 % 
load in 2-PrOH 
88.2  6.1  0.825  94.2 
KC258_03 
Lysozyme, heat 
unfolded on D,L-
valine, 1 % load 
in 2-PrOH 
88.0  **  **  ** 
KC258_04 
Lysozyme, heat 
unfolded on D,L-
valine, 5 % load 
in 2-PrOH 
94.0  **  **  ** 
 
Table 10: Immobilisation of Lysozyme from the Native and Thermally-Unfolded Guanidine 
Hydrochloride-Solubilised  State  -  Results  (**  The  sample  was  insoluble  upon  attempted 
reconstitution) 
3.3.3.1.2 Immobilisation of Lysozyme from the Native and Thermally-Unfolded, 
Guanidine Hydrochloride-Solubilised State - Discussion 
Upon  reconstitution,  the  thermally-unfolded  GdnHCl-solubilised  protein  samples  were 
insoluble in the aqueous phase.  As such, the measured protein loading and specific activity 
of these samples could not be determined.   
3.3.3.2  Immobilisation of Lysozyme from the Native and Thermally-Unfolded, Urea-
Solubilised State 
In order to determine if it is possible to immobilise thermally-unfolded, urea-solubilised 
lysozyme on to the surface of D,L-valine with the regain of enzymatic activity, immobilised 
protein samples were prepared.  Lysozyme was thermally unfolded and solubilised upon 
incubation of the aggregated protein in 8 M urea. 
3.3.3.2.1 Immobilisation of Lysozyme from the Native and Thermally-Unfolded, 
Urea-Solubilised State - Results 
PCMC  of  thermally-unfolded  lysozyme  solubilised  in  urea  were  analysed  via 
reconstitution  of  the  immobilised  protein  sample  in  50  mM  Tris/HCl,  pH  8.1  and 
subsequent determination of the % MPL (Measured Protein Loading) and specific activity 
(0.876 Amin
-1mg
-1ml
-1 for the untreated protein). Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Details of PCMC sample preparation can be found in Appendix 10. 
Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC258_01 
Lysozyme on 
D,L-valine, 1 % 
load in 2-PrOH 
92.2  0.7  0.785  89.6 
KC258_02 
Lysozyme on 
D,L-valine, 5 % 
load in 2-PrOH 
88.2  6.1  0.825  94.2 
KC258_05 
Lysozyme, heat 
unfolded on D,L-
valine, 1 % load 
in 2-PrOH 
82.8  **  **  ** 
KC258_06 
Lysozyme, heat 
unfolded on D,L-
valine, 5 % load 
in 2-PrOH 
94.3  **  **  ** 
 
Table  11:  Immobilisation  of  Lysozyme  from  the  Native  and  Thermally-Unfolded,  Urea-
Solubilised State - Results (** The sample was insoluble upon attempted reconstitution) 
3.3.3.2.2 Immobilisation of Lysozyme from the Native and Thermally-Unfolded, 
Urea-Solubilised State - Discussion 
Upon  reconstitution,  the  thermally-unfolded,  urea-solubilised  protein  samples  were 
insoluble in the aqueous phase.  As such, the measured protein loading and specific activity 
of these samples could not be determined.   
3.3.3.3  Immobilisation of Lysozyme from the Native and Thermally-Unfolded State 
Using a Syringe Pump  
To  determine  if  the  gradual  dilution  of  urea  from  the  environment  of  the  thermally-
unfolded,  solubilised  protein  would  help  to  regain  activity  from  the  unfolded  protein, 
PCMC samples were prepared using a syringe pump.  This equipment allows the gradual 
dilution of GdnHCl or urea from the environment of the protein before precipitation begins 
(therefore triggering the refolding process via dilution). 
3.3.3.3.1 Immobilisation of Lysozyme from the Native and Thermally-Unfolded 
State Using a Syringe Pump - Results 
PCMC  were  prepared  of  lysozyme  (from  both  the  native  and  thermally-unfolded, 
solubilised state) using a syringe pump to mix the excipient and protein together gradually Katrina A. Davidson, 2008                                                                                             Chapter Three 
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(0.01 ml/min excipient into protein) before immediate precipitation of the mixture into 2-
PrOH.   
PCMC  prepared  from  GdnHCl  or  urea-solubilised,  thermally-unfolded  lysozyme,  were 
analysed via the reconstitution of the immobilised protein preparation in 50 mM Tris/HCl, 
pH 8.1 and subsequent determination of the % MPL (Measured Protein Loading) and the 
specific activity (0.876 Amin
-1mg
-1ml
-1 for the untreated protein). 
Details of the PCMC sample preparation can be found in Appendix 11. 
Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1ml
-1) 
% Activity 
of Native 
Protein 
KC258_16 
Lysozyme on 
D,L-valine, 5 % 
load in 2-PrOH 
 
81.2 
 
5.6  0.544  62.1 
KC258_17 
Lysozyme, heat 
unfolded, in 
GdnHCl on D,L-
valine, 5 % load 
in 2-PrOH 
88.7  **  **  ** 
KC258_18 
Lysozyme, heat 
unfolded, in urea 
on D,L-valine, 5 
% load in 2-
PrOH 
93.2  **  **  ** 
 
Table 12: Immobilisation of Lysozyme from the Native and Thermally-Unfolded State Using a 
Syringe Pump - Results (** The sample was insoluble upon attempted reconstitution) 
3.3.3.3.2 Immobilisation of Lysozyme from the Native and Thermally-Unfolded 
State Using a Syringe Pump - Discussion 
As  previously  noted,  native  lysozyme,  when  mixed  gradually  with  excipient  before 
precipitation using a syringe pump, shows a reduction in retained activity when compared 
with identical samples prepared without the use of a syringe pump. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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Figure  58:  Immobilisation of Lysozyme  from the Native  State at  5  %  Loading  -  Effect of 
Using a Syringe Pump 
Identically  prepared  PCMC  samples  of  native  lysozyme  immobilised  on  D,L-valine  in 
propan-2-ol retain activity within 2 % of each other.  However, when the excipient material 
and protein are gradually mixed as in the case of KC258_16, the activity retained decreases 
to approximately 62 %.  This could be due to the time the aqueous solution of protein is 
kept at room temperature to carry out the slow mixing when compared with the immediate 
mixing and precipitation of the conventional PCMC preparation method. 
When  PCMC  of  thermally-unfolded  lysozyme  are  prepared,  the  resulting  immobilised 
protein is insoluble.  Similarly when gradual mixing is employed to thermally-unfolded, 
urea  or  GdnHCl-solubilised  lysozyme  before  precipitation,  the  resultant  PCMC  are 
insoluble in the reconstitution buffer and as such, the protein loading and activity cannot be 
determined. Katrina A. Davidson, 2008                                                                                             Chapter Three 
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3.4  Discussion and Conclusions  
In the immobilisation and refolding of lysozyme, there are three different stages during 
which  the  refolding  of  the  enzyme  can  occur:  upon  the  addition  of  excipient  to  the 
unfolded protein (and subsequent dilution of the denaturant materials); during the actual 
PCMC  coprecipitation  process;  or  upon  reconstitution  of  the  powder  under  aqueous 
conditions.   
Activity  measurements  show  that  lysozyme  does  not  display  catalytic  activity  upon 
dilution of the denaturing molecules from the protein environment.  There is no evidence 
also that the presence of the excipient material D,L-valine has any triggering effect upon 
the refolding of lysozyme.  Although amino acids such as arginine can be used in order to 
trigger protein folding, valine has no such effect.
141 
Solid State CD spectroscopy was carried out upon chemically unfolded lysozyme which 
had been subjected to PCMC formation.  This indicated that the enzyme was present upon 
the surface of the microcrystal in a structure resembling the native state (section 3.3.1.2).  
CD spectroscopy of the reconstituted material showed very little change in the secondary 
structure  of  the  protein  when  compared  with  the  solid-state  structure.    The  evidence 
obtained in the course of this study using lysozyme therefore indicates that the refolding of 
this particular enzyme occurs during the process of PCMC formation. 
During  PCMC  formation,  the  ability  of  the  surrounding  solvent  in  maintaining  native 
structure  can  be  considered.    Solvent  conditions  are  important  for  protein  folding  and 
structure.
142  Under aqueous conditions, the interior of protein molecules are hydrophobic 
in character with the exterior being generally of a polar nature.  In the presence of organic 
solvent, ionic and hydrogen bonding interactions are disrupted.
142  However, it has been 
shown from this study that lysozyme can be coprecipitated in organic solvent from both the 
native  and  the  chemically-unfolded  state  with  the  retention  (regain)  of  structure  and 
function. 
In the precipitation of lysozyme from the native state, the protein is seen to retain its 
structural characteristics.  There is a body of evidence suggesting that in the presence of 
high concentrations of hydrophobic solvent, protein molecules such as lysozyme retain 
native structure due to “kinetic trapping which results  in a more rigid structure in the 
absence of water”.
142  This is a result of the restrictions placed upon the conformational 
flexibility  of  the  protein  in  organic  solvent  when  compared  with  aqueous-organic Katrina A. Davidson, 2008                                                                                             Chapter Three 
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mixtures.
143  During  precipitation  of  chemically-unfolded  lysozyme,  the  denaturing 
molecules  (urea  or  GdnHCl)  are  rapidly  removed  from  the  environment  of  the 
biomolecule, triggering folding.      
From  the  data  obtained,  lysozyme  can  be  chemically  unfolded  utilising  urea  (in  the 
presence or absence of DTT) or the salt guanidine hydrochloride and subsequently refolded 
via the formation of PCMC  from a range of conditions and solvents.   Urea-incubated 
lysozyme can be immobilised upon the surface of DL-valine in 2-PrOH with the retention 
of up to 94.2 % of the activity compared to untreated lysozyme (KC77_04).   
Upon addition of DTT to the unfolding conditions, the reduction of disulfide bonds leads 
to  suppression  of  the  regained  activity.    Immobilisation  of  urea-unfolded,  reduced 
lysozyme can result in the regain of 42.9 % of the activity of the native, untreated protein.  
When  compared  with  a  commonly  employed  method  for  refolding  (dialysis),  the 
immobilisation  method  compares  favourably.    Dialysis  of  lysozyme  from  the  urea-
unfolded, reduced state regains 9.2 % of the activity of the native, untreated enzyme with 
formation of some aggregated species.   
Lysozyme immobilised from the GdnHCl unfolded state can regain up to 84 % of the 
activity of the untreated enzyme depending upon the immobilisation excipient material and 
the precipitating solvent.  Again, when compared with dialysis as a method for refolding, 
the PCMC immobilisation method excels.  Dialysis of GdnHCl unfolded lysozyme regains 
19.8 % of the activity of the untreated enzyme. 
The immobilisation of lysozyme from the thermally-unfolded, solubilised state proved to 
be  a  greater  challenge  for  this  method  than  chemically  unfolded  species.    Upon 
immobilisation, thermally-unfolded, solubilised lysozyme from various conditions yielded 
an insoluble enzyme preparation with little or no native structure.  However, dialysis of the 
thermally unfolded, solubilised material also yielded an insoluble, aggregated product.   
The  refolding  of  lysozyme  from  the  chemically  or  thermally-unfolded  state  via  the 
formation  of  PCMC  therefore  outperforms  or  compares  well  with  a  generally  applied 
method for protein refolding. 
 
  
 
 
 
 
 
 
Chapter Four - Unfolding, Immobilisation and 
Potential Refolding of Lipase Katrina A. Davidson, 2008                                                                                               Chapter Four 
4  Unfolding,  Immobilisation  and  Potential 
Refolding of Lipase 
Lipases  have  enormous  potential  as  biocatalysts  for  biotransformations.
144,  145    These 
enzymes  are  utilised  in  a  number  of  different hydrolysis  reactions  including  ester  and 
triglyceride hydrolysis.
104 
Lipase was subjected to chemical and thermal unfolding experiments and fluorescence and 
CD spectroscopy used to determine the conformational state of the protein.  The enzyme 
was subsequently immobilised in both the native and unfolded state upon the surface of 
water soluble materials such as salts and amino acids for the formation of Protein Coated 
Micro-Crystals (PCMC).
77, 81  
75 
The unfolding of lipase is typically irreversible; this presents a much greater challenge to 
the PCMC refolding technique than lysozyme.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.1 Preparation  of  Chemically  and  Thermally-Unfolded 
Lipase 
4.1.1 Preparation of Chemically-Unfolded Lipase 
Chemically-unfolded lipase was prepared via the incubation of the protein in an aqueous 
solution of salts such as GdnHCl (6 M). 
4.1.1.1  Guanidine Hydrochloride Unfolding of Lipase - Fluorescence Spectroscopy 
Lipase (0.1 mg/ml) was incubated in 6 M GdnHCl for two hours at room temperature.  
Fluorescence measurements were made of the protein in both the native and the GdnHCl 
unfolded state. 
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Figure 59: Guanidine Hydrochloride Unfolding if Lipase - Fluorescence Spectroscopy.   
In  the  fluorescence  spectrum  of  native  lipase,  the  wavelength  at  which  the  maximum 
fluorescence occurs is 338 nm.  This is in the range expected for a typical globular protein 
in which the tryptophan residues are buried within the structure.
40   
The aromatic amino acids in protein molecules give rise to the measured fluorescence.  As 
protein unfolding occurs, the once buried tryptophan residues begin to interact with the Katrina A. Davidson, 2008                                                                                               Chapter Four 
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external environment leading to a change in the fluorescent properties of the biomolecule.  
As the molecule unfolds, a red shift in the wavelength at which the maximum fluorescence 
intensity is seen, resulting in a maximum fluorescence at a longer wavelength.   
The  wavelength  at  which  the  maximum  fluorescence  intensity  occurs,  changes  upon 
incubation in GdnHCl to 350 nm.  This indicates that these aromatic residues are no longer 
buried  and  are  subsequently  free  to  interact  with  the  surrounding  solvent,  therefore 
suggesting that the protein is no longer in a folded state. 
4.1.1.2  Guanidine Hydrochloride Unfolding of Lipase - CD Spectroscopy 
Circular dichroism spectra of both the native and GdnHCl unfolded enzyme were obtained.   
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Figure 60: Guanidine Hydrochloride Unfolding of Lipase - Far UV CD Spectroscopy 
CD spectroscopy of GdnHCl unfolded lipase indicates that upon incubation of lipase in 6 
M GdnHCl for 2 hours, the protein is completely unfolded.  The spectral noise obtained 
below 200 nm is due to the presence of the GdnHCl.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.1.2 Preparation of Thermally-Unfolded Lipase 
For the preparation of thermally-unfolded lipase, it is first necessary to assess how the 
protein  responds  to heat  and at which  temperature unfolding takes place.   Differential 
Scanning Calorimetry can be used for this purpose. 
4.1.2.1  Differential Scanning Calorimetry of Lipase 
In order to assess the behaviour of lipase upon heating, Differential Scanning Calorimetry 
(DSC) was carried out on the protein.  This involves controlled heating to determine at 
which temperature the protein is unfolded and if there is any refolding of the protein upon 
cooling.  The DSC trace of lipase at 1 mg/ml is shown:  
 
 
 
 
 
 
 
 
 
Figure 61: DSC Thermogram of Lipase 
The DSC thermogram indicates that in order to unfold lipase thermally, the protein must be 
heated to a minimum of 64.3 °C (the measured Tm).  The rescan shows that upon cooling, 
there is no evidence that thermally-unfolded lipase regains any native structure.  This is a 
typical exothermic DSC signal which is typical of irreversible aggregation of unfolded 
protein.   
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4.1.2.2  Thermal Unfolding of Lipase - Fluorescence Spectroscopy 
Lipase (0.1 mg/ml) was thermally unfolded by heating to a temperature of 90 °C and then 
allowed to cool to room temperature.  Once cooled, visible aggregates were seen to form.  
The thermally-aggregated lipase was solubilised upon addition of 6 M GdnHCl and the 
aggregates  were  seen  to  dissolve  to  produce  heat  unfolded,  solubilised  lipase.    The 
fluorescence spectrum of both this aggregated and solubilised protein is presented. 
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Figure 62: Thermal Unfolding of Lipase - Fluorescence Spectroscopy  
Upon  heating,  the  wavelength  at  which  the  maximum  fluorescence  intensity  is  seen 
increases from 338 nm for the native protein to 348 nm.  This indicates that the protein is 
no longer in a native conformation.   
This wavelength is lower than that of the chemically-unfolded lipase.  Although the protein 
is no longer in a native state, the tryptophan residues which give rise to the fluorescence 
are confined within an aggregate and as such cannot interact with the surrounding solvent 
freely or in the same way as the native or chemically-unfolded protein.   
Upon solubilisation with GdnHCl, this maximum fluorescence is seen to shift to a higher 
wavelength (352 nm).  This indicates that the aggregates have been solubilised and the 
protein is no longer in an aggregated nor a native conformation. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.1.2.3  Thermal Unfolding of Lipase - CD Spectroscopy 
CD spectroscopy of the thermally-unfolded, GdnHCl-solubilised lipase was carried out in 
order to ascertain the effect of heating and subsequent solubilisation upon the enzyme 
structure 
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Figure 63: Thermal Unfolding of Lipase - CD Spectroscopy 
Circular  dichroism  spectroscopy  of  the  thermally-unfolded,  GdnHCl-solubilised  lipase 
indicates  that  upon  heating  and  subsequent  solubilisation,  the  enzyme  is  completely 
unfolded.   
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4.2   Immobilisation  of  Lipase  from  the  Native  and 
Unfolded State 
PCMC  of  both  native  and  unfolded  protein  were  prepared  in  order  to  determine  the 
efficacy of this method for both the immobilisation and potential folding of lipase. 
To  find  the  optimum  conditions  for  the  immobilisation  and  folding  steps,  various 
excipients, solvents and protein concentrations were employed.  Additives such as a redox 
couple (for example cystine and cysteine) and catalytic substrate (10 molar percent of p-
NPA) were also utilised in order to see if they had any effect upon the potential refolding 
of lipase.  Different methods were also employed for the formation of the PCMC.   
From previously published studies it is known that lipase from different sources can be 
immobilised upon the surface of PCMC with little or no loss of activity in both the aqueous 
and organic phases.
77  Techniques similar to these were adopted in this study and therefore 
little protein degradation or loss of activity is expected from the native state. 
Once precipitated, the samples were filtered, weighed and stored as dry powders in glass 
vials.  UV/vis spectroscopy and activity assays were carried out in order to determine the 
effect  of  both  chemical  and  thermal  unfolding,  solubilisation and  immobilisation  upon 
lipase. 
4.2.1 Immobilisation  of  Lipase  from  the  Native  and  Chemically-
Unfolded State 
4.2.1.1  Immobilisation  of  Lipase  from  the  Native  and  Guanidine  Hydrochloride 
Unfolded State - Results 
PCMC of both native and GdnHCl unfolded lipase were analysed via reconstitution of the 
immobilised protein sample in 50 mM Tris/HCl, pH 7.8 and subsequent determination of 
the %MPL (Measured Protein Loading) and the specific activity (0.1877 Amin
-1mg
-1 for 
untreated protein). 
Details of PCMC sample preparation can be found in Appendix 12. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Sample 
Identifier 
Sample 
Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC214-01  Lipase on K2SO4,   
1 % load in 2-PrOH  88.0  2.1  0.1614 (± 0.010)  86.0 (± 5.3) 
KC214-02  Lipase on K2SO4,   
5 % load in 2-PrOH  88.0  4.6  0.1472  78.4 
KC214-03 
Lipase on K2SO4,   
10 % load in         
2-PrOH 
86.5  11.2  0.1747  93.1 
KC214-04 
Lipase on K2SO4,    
15 % load in         
2-PrOH 
82.1  16.7  0.1779  94.8 
KC214-05 
Lipase on K2SO4,    
20 % load in         
2-PrOH 
84.5  21.2  0.1451  77.3 
KC214-06 
Lipase on K2SO4,    
50 % load in 2-
PrOH 
82.2  53.8  0.0944  75.2 
KC214-07 
Lipase in GdnHCl 
on K2SO4, 1 % load 
in 2-PrOH  
96.4  1.8  0.0439 (± 0.012)  23.4 (± 6.4) 
KC214-08 
Lipase in GdnHCl 
on K2SO4, 5 % load 
in 2-PrOH 
99.7  5.1  0.0358  19.1 
KC214-09 
Lipase in GdnHCl 
on K2SO4, 10 % 
load in 2-PrOH 
96.0  10.6  0.0376  36.3 
KC214-10 
Lipase in GdnHCl 
on K2SO4, 15 % 
load in 2-PrOH 
90.0  17.2  0.0681  34.2 
KC214-11 
Lipase in GdnHCl 
on K2SO4, 20 % 
load in 2-PrOH 
89.3  22.1  0.0653  34.8 
KC214-12 
Lipase in GdnHCl 
on K2SO4, 50 % 
load in 2-PrOH 
83.6  49.4  0.0143  7.6 
 
Table 13: Immobilisation of Lipase from the Native and Guanidine Hydrochloride Unfolded 
State - Results 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.2.1.1.1 Immobilisation of Lipase from the Native and Guanidine Hydrochloride 
Unfolded State - CD Spectroscopy 
CD  spectroscopy  was  carried  out  on  immobilised  native  (KC214_04)  and  GdnHCl 
unfolded  lipase  (KC214_09)  upon  reconstitution  in  order  to  gain  an  insight  into  the 
structure of the reconstituted protein sample. 
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Figure 64: Immobilisation of Lipase from the Native and Guanidine Hydrochloride Unfolded 
State - CD Spectroscopy 
4.2.1.2  Immobilisation  of  Lipase  from  the  Native  and  Guanidine  Hydrochloride- 
Unfolded State - Discussion 
The  measured  solids  recovery  of  the  prepared  PCMC  suggest  that  immobilised  lipase 
samples can be prepared using K2SO4 as an excipient with very little of the solid or protein 
being lost to the solvent.   
In order to ascertain the effect of the immobilisation of both the native and the GdnHCl 
unfolded  protein,  it  is  necessary  to  compare  the  observed  activity  measured  for  these 
samples. Katrina A. Davidson, 2008                                                                                               Chapter Four 
132 
8
6
.
0
7
8
.
4
9
3
.
1
9
4
.
8
7
7
.
3
7
5
.
2
2
3
.
4
1
9
.
1
3
6
.
3
3
4
.
2
3
4
.
8
7
.
6
0
20
40
60
80
100
120
1 5 10 15 20 50
Theoretical Protein Loading (%)
A
c
t
i
v
i
t
y
 
W
h
e
n
 
C
o
m
p
a
r
e
d
 
w
i
t
h
 
t
h
e
 
U
n
t
r
e
a
t
e
d
 
L
i
p
a
s
e
 
(
%
)
Native Immobilised Lipase 
GdnHCl Unfolded Immobilised Lipase
 
Figure 65: Immobilisation of Lipase from the Native and Guanidine Hydrochloride Unfolded 
State - Comparison of Regained Activity 
Immobilisation of the native protein on K2SO4 at theoretical protein loadings ranging from 
1 - 50 % can retain up to 94.8 % of activity when compared with the untreated protein.   
When lipase is unfolded in GdnHCl and further subjected to immobilisation, the protein 
regains up to 36.3 % of the activity of the untreated lipase.  This suggests that although 
experimentally  shown  to  be  unfolded  using  GdnHCl  (by  fluorescence  and  CD 
spectroscopy), lipase can regain a moderate level of activity upon removal of the salt from 
the protein environment.  
CD spectroscopy shows that upon reconstitution, the native immobilised sample is almost 
identical in structure to the untreated protein. Immobilisation of the GdnHCl incubated 
protein confers some regain of structure from the unfolded state. 
4.2.2 Immobilisation  of  Lipase  from  the  Native  and  Chemically-
Unfolded State Using a Syringe Pump 
In order to determine if increased enzymatic activity could be regained by the gradual 
mixing of the protein solution and excipient; a syringe pump was employed.  This allowed 
the excipient to be added to the protein containing solution at a slow rate (0.01 ml/min) to 
allow gradual dilution of the denaturant before the immobilisation step occurs. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.2.2.1  Immobilisation  of  Lipase  from  the  Native  and  Guanidine  Hydrochloride 
Unfolded State Using a Syringe Pump- Results 
PCMC of native and GdnHCl unfolded lipase manufactured using a syringe pump, were 
analysed via the reconstitution of the immobilised protein sample in 50 mM Tris/HCl, pH 
7.8  and  subsequent  determination  of  the  %MPL  (Measured  Protein  Loading)  and  the 
specific activity (0.1877A min
-1mg
-1 for untreated protein). 
Details of PCMC sample preparation can be found in Appendix 13. 
Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC255_01  Lipase, on K2SO4, 5 % 
load in 2-PrOH  84.7  6.04  0.127  67.9 
KC255_03 
Lipase in GdnHCl on 
K2SO4, 5 % load in     
2-PrOH 
83.3  **  **  ** 
 
Table 14: Immobilisation of Lipase from the Native and Guanidine Hydrochloride Unfolded 
State  Using  a  Syringe  Pump  -  Results  (**The  sample  was  insoluble  upon  attempted 
reconstitution) 
4.2.2.2  Immobilisation  of  Lipase  from  the  Native  and  Guanidine  Hydrochloride 
Unfolded State Using a Syringe Pump - Discussion 
Native lipase, when mixed gradually with excipient before precipitation using a syringe 
pump  shows  a  reduction  in  retained  activity  when  compared  with  an  identical  sample 
prepared in the conventional manner. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Figure 66: Immobilisation of Native Lipase at 5 % Loading - Effect of Using a Syringe Pump 
Identical PCMC formulations of native lipase immobilised on K2SO4 in propan-2-ol all 
retain activity within 2 % of each other.  However, when the excipient material and protein 
are  gradually  mixed  as  in  the  case  of  KC255_01,  the  retained  activity  decreases  to 
approximately 68 %.  This could be due to the time the aqueous solution of protein is kept 
at room temperature to carry out the slow mixing when compared with the immediate 
mixing and precipitation of the conventional PCMC preparation method. 
4.2.2.3  Dialysis Refolding of Lipase in the Guanidine Hydrochloride Unfolded State- 
Comparison with Immobilisation 
Dialysis  is  a  common  method  used  for  protein  folding  which  involves  the  gradual 
controlled removal of denaturing molecules from the environment of proteins.   
Dialysis, as a method for refolding was compared with the immobilisation method for 
GdnHCl unfolded lipase.  Lipase (6 mg/ml in 50 mM Tris/HCl, pH 7.8) which had been 
chemically-unfolded via the addition 6 M GdnHCl was subjected to dialysis against buffer 
containing  no  GdnHCl  salt.    The  protein  was  incubated  for  two  hours  before  being 
subjected to dialysis (two x three hours plus overnight).   
Upon dialysis, protein aggregation was seen to occur to some extent, although not all of the 
protein present had aggregated.  Upon removal of the protein from the dialysis cassette, the 
enzyme was subjected to fluorescence spectroscopy and the activity assay described for the 
protein.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Fluorescence spectra of the GdnHCl unfolded and dialysed protein were obtained.  The 
wavelength at which the maximum fluorescence intensity occurred for the native protein 
was the same as had been previously described (338 nm).  
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Figure 67: Dialysis Refolding of Lipase from the Guanidine Hydrochloride Unfolded State – 
Fluorescence Spectroscopy 
When the lipase had been subjected to GdnHCl unfolding, this wavelength increased (350 
nm) as expected.  Upon subjecting the unfolded protein to dialysis, the wavelength at 
which the maximum fluorescence intensity occurs decreased slightly to 346 nm.  This 
indicated that the protein was no longer in an unfolded, solubilised state. 
The enzymatic activity assay indicated that chemically-unfolded lipase at a concentration 
of 6 mg/ml could regain 11.37 % of the activity of the native, untreated protein.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Figure 68: Comparison of Dialysis and PCMC Preparation as Refolding Methods 
The data obtained indicated that lipase unfolded in GdnHCl regained activity to a greater 
extent via immobilisation using PCMC technology when compared with simple dialysis as 
a refolding method. 
Immobilisation by the formation of PCMC can therefore be described as a more efficient 
method for the refolding of GdnHCl unfolded lipase than simple dialysis refolding. 
4.2.3 Immobilisation  of  Lipase  from  the  Native  and  Thermally-
Unfolded State 
PCMC  were  prepared  of  both  native  and  thermally-unfolded  lipase,  solubilised  in  the 
presence of 6 M GdnHCl  
4.2.3.1  Immobilisation  of  Lipase  from  the  Native  and  Thermally-Unfolded, 
Solubilised State - Results 
PCMC of native and thermally-unfolded lipase were analysed via the reconstitution of the 
immobilised protein sample in 50 mM Tris/HCl, pH 7.8 and subsequent determination of 
the %MPL (Measured Protein Loading) and the specific activity (0.1877A min
-1mg
-1 for 
untreated protein). 
Details of PCMC sample preparation can be found in Appendix 14. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity         
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC216_01  Lipase on K2SO4,      
1 % load in 2-PrOH  97.4  1.3  0.1798 (± 0.014)  95.8 (± 7.5) 
KC216_02  Lipase on K2SO4,      
5 % load in 2-PrOH  94.5  5.1  0.1697  90.4 
KC216_03  Lipase on K2SO4,    
10 % load in 2-PrOH  93.6  11.7  0.1599  85.2 
KC216_04  Lipase on K2SO4,    
15 % load in 2-PrOH  95.6  15.3  0.1757  93.6 
KC216_05  Lipase on K2SO4,    
20 % load in 2-PrOH  90.5  21.3  0.1440  76.7 
KC216_06  Lipase on K2SO4,    
50 % load in 2-PrOH  80.6  53.2  0.1630 (± 0.012)  86.9 (± 6.4) 
KC216_07  Lipase on D,L-valine,  
1 % load in 2-PrOH  83.2  1.4  *  * 
KC216_08  Lipase on D,L-valine,  
5 % load in 2-PrOH  84.9  4.8  *  * 
KC216_09  Lipase on D,L-valine, 
10 % load in 2-PrOH  83.0  10.7  *  * 
KC216_10  Lipase on D,L-valine, 
15 % load in 2-PrOH  74.6  16.1  *  * 
KC216_11  Lipase on D,L-valine, 
20 % load in 2-PrOH  66.2  21.7  *  * 
KC216_12  Lipase on D,L-valine, 
50 % load in 2-PrOH  72.2  51.6  *  * 
 
Table  15:  Immobilisation  of  Lipase  from  the  Native  State  Using  K2SO4  and  D,L-Valine  as 
Excipients - Results (*The data could not be determined for this sample) 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
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Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC226_01 
Lipase, heat unfolded 
on K2SO4, 1 % load in 
2-PrOH 
92.4  **  **  ** 
KC226_02 
Lipase, heat unfolded 
on K2SO4, 5 % load in 
2-PrOH 
98.9  **  **  ** 
KC226_03 
Lipase, heat unfolded 
on K2SO4, 10 % load in 
2-PrOH 
98.8  **  **  ** 
KC226_04 
Lipase, heat unfolded 
on K2SO4, 15 % load in 
2-PrOH 
97.7  **  **  ** 
KC226_05 
Lipase, heat unfolded 
on K2SO4, 20 % load in 
2-PrOH 
87.5  **  **  ** 
KC226_06 
Lipase, heat unfolded 
on K2SO4, 50 % load in 
2-PrOH 
90.5  **  **  ** 
KC226_07 
Lipase, heat unfolded 
on D,L-valine, 1 % load 
in 2-PrOH 
80.8  **  **  ** 
KC226_08 
Lipase, heat unfolded 
on D,L-valine, 5 % load 
in 2-PrOH 
60.0  **  **  ** 
KC226_09 
Lipase, heat unfolded 
on D,L-valine, 10 % 
load in 2-PrOH 
75.4  **  **  ** 
KC226_10 
Lipase, heat unfolded 
on D,L-valine, 15 % 
load in 2-PrOH 
84.3  **  **  ** 
KC226_11 
Lipase, heat unfolded 
on D,L-valine, 20 % 
load in 2-PrOH 
87.3  **  **  ** 
KC226_12 
Lipase, heat unfolded 
on D,L-valine, 50 % 
load in 2-PrOH 
80.5  **  **  ** 
 
Table 16: Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State - Results   
(**The sample was insoluble upon attempted reconstitution) 
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4.2.3.2  Immobilisation  of  Lipase  from  the  Native  and  Thermally-Unfolded, 
Solubilised State - Discussion 
When  lipase  is  thermally-unfolded  with  subsequent  solubilisation  by  GdnHCl,  the 
aggregates which form are seen to dissolve.  When this protein mixture is further subjected 
to immobilisation via the formation of PCMC, the resultant material is insoluble under the 
aqueous conditions required for the activity assay to be carried out.  Filtration of these re-
constituted samples results in removal of these insoluble particles, but also removal of 
virtually  all  protein  from  the  buffer  solution  as  the  protein  is  held  in  these  insoluble 
species.  The MPL and specific activity of these samples was therefore undeterminable. 
The measured solids recovery of the PCMC prepared using D,L-valine as an excipient was 
lower than those which were prepared from K2SO4.  This could be due to the fact that 
although  the  precipitating  solvent  is  saturated  with  the  excipient  before  precipitation 
occurs, some of the amino acid has been lost to the solvent due to the increasing water 
content as the protein/excipient mixture is added. 
4.2.3.2.1 Lipase coated K2SO4  
Native lipase, when immobilised on K2SO4 using theoretical protein loadings of 1 - 50 %, 
retained up to 95.8 % of the activity of the untreated protein.  This indicates that lipase in 
the  native  state  can  be  immobilised  upon  this  excipient  using  the  PCMC  preparation 
method with very little detrimental effect on the activity of the protein.   
4.2.3.2.2 Lipase coated D,L-Valine 
Upon analysis of lipase coated D,L-valine samples, both native and heat unfolded, there 
seemed to be an anomaly with the activity assay.  Activity of up to 200 % was seen for 
each sample, and this was obviously unexpected.   
The assay was subsequently carried out in the presence of uncoated crystals (no lipase 
present).    This  demonstrated  that  the  excipient  had  a  kinetic  effect  upon  the  rate  of 
hydrolysis of p-NPA (the substrate used in the activity assay).  This therefore resulted in 
the activity of the immobilised enzyme being masked by the effect of the D,L-valine upon 
the reaction.   
Subsequent investigation proved that this effect was not due to any pH change occurring 
upon addition of the amino acid to the substrate solution, and it appeared therefore that the 
D,L-valine was also able to hydrolyse the ester.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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There is precedent for this reaction.  p-NPA is insoluble in water and therefore acetonitrile 
is used as a solvent for the substrate.  The ester, in the presence of an organic solvent, is 
susceptible to hydrolysis by the amino acids.
146, 147 D,L-valine therefore has the ability to 
hydrolyse the p-NPA ester under these conditions. 
PCMC of thermally-unfolded lipase immobilised upon D,L-valine showed activity upon 
reconstitution even although there were aggregates present.  This could be attributed to the 
fact that the D,L-valine was soluble in the buffer (even although the protein was not) and 
was therefore able to hydrolyse the ester substrate under these conditions. 
D,L-valine  is  therefore  not  a  suitable  excipient  for  the  immobilisation  and  potential 
refolding of lipase as the enzymatic activity of the samples one of the primary analysis 
techniques being carried out, could not be determined for any of these powders.   
4.2.3.3  Dialysis Refolding of Thermally-Unfolded, Solubilised Lipase - Comparison 
with Immobilisation 
Dialysis, as a method for refolding was compared with the immobilisation method for 
thermally-unfolded,  solubilised  lipase.    Lipase  (6  mg/ml  in  50  mM  Tris/HCl,  pH  7.8) 
which had been thermally unfolded via heating to 90 ºC and subsequently solubilised by 
incubation in 6 M GdnHCl, was subjected to dialysis against buffer containing no GdnHCl 
salt.  The protein was incubated for two hours before being subjected to dialysis (two x 
three hours plus overnight).   
Upon dialysis, protein aggregation was seen to occur immediately upon gradual removal of 
the denaturing salts from the protein environment.  Upon removal of the protein from the 
dialysis cassette, the enzyme was subjected to fluorescence spectroscopy and the activity 
assay described for the protein.   
Fluorescence spectra of the GdnHCl unfolded and dialysed protein was obtained.  The 
wavelength at which the maximum fluorescence intensity occurred for the native protein 
was the same as had been previously described (338 nm).   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Figure  69:  Dialysis  Refolding  of  Thermally-Unfolded,  Solubilised  Lipase  –  Fluorescence 
Spectroscopy 
When  the  lipase  had  been  subjected  to  thermal  unfolding  and  solubilisation,  this 
wavelength  increased  (351  nm)  as  expected.    Upon  being  subjected  to  dialysis,  the 
wavelength at which the maximum fluorescence intensity occurs decreased slightly to 350 
nm.   
CD  spectroscopy  was  carried  out  upon  the  thermally-unfolded  lipase  and  the  dialysed 
lipase.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Figure 70: Dialysis Refolding of Thermally-Unfolded, Solubilised Lipase - CD Spectroscopy 
The CD spectrum of the dialysed protein shows that there has been no regain in secondary 
structure towards the native state upon dialysis. 
The previously described activity assay was carried out on the filtered dialysed protein 
with the result that no activity was regained upon dialysis.  The PCMC prepared from the 
thermally-unfolded,  solubilised  lipase  also  showed  no  regain  of  activity  upon 
immobilisation  and  therefore,  neither  method  was  appropriate  for  the  refolding  of 
thermally-unfolded lipase at this concentration. 
4.2.4 Immobilisation  of  Lipase  from  the  Native  and  Thermally-
Unfolded State with the Introduction of a Redox Couple 
The  immobilisation  of  thermally-unfolded  lipase  had  previously  formed  insoluble 
aggregates upon reconstitution and no further analysis could therefore be carried out.  This 
could be attributed to the fact that the protein molecules immobilised upon the surface of 
the excipient were not folded in an active conformation or had interacted with each other to 
form insoluble species immediately prior to immobilisation. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Many  studies  have  been  carried  out  employing  redox  couples  to  potentially  form  the 
correct  disulfide  pairing  and  aid  the  folding  process.
148-150    Upon  incubation  of  the 
thermally-unfolded, solubilised lipase with a redox couple such as cystine/cysteine, the 
disulfides which have been broken can be allowed to reform and break again until the most 
energetically favourable correct combination is found.    
4.2.4.1  Immobilisation of Lipase from the Native State Utilising K2SO4 and KCl as 
Excipient Materials - Results 
PCMC of native lipase were analysed via reconstitution of the immobilised protein sample 
in 50 mM Tris/HCl, pH 7.8 and subsequent determination of the %MPL (Measured Protein 
Loading) and the specific activity (0.1877A min
-1mg
-1 for untreated protein).   
Details of PCMC sample preparation can be found in Appendix 15. 
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Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC240_01  Lipase on K2SO4, 5 
% load in 2-PrOH  91.0  5.3  0.1663 (± 0.013)  88.6 (± 6.9) 
KC240_02  Lipase on K2SO4, 10 
% load in 2-PrOH  88.0  10.9  0.1386  73.9 
KC240_03  Lipase on K2SO4, 15 
% load in 2-PrOH  89.3  15.7  0.1636  87.2 
KC240_04  Lipase on K2SO4, 20 
% load in 2-PrOH  86.7  21.3  0.1373  73.2 
KC240_05  Lipase on KCl, 5 % 
load in 2-PrOH  69.8  5.5  0.1590 (± 0.015)  84.5 (± 6.9) 
KC240_06  Lipase on KCl, 10 % 
load in 2-PrOH  82.0  9.2  0.1220  65.0 
KC240_07  Lipase on KCl, 15 % 
load in 2-PrOH  82.3  14.6  0.1655  88.2 
KC240_08  Lipase on KCl, 20 % 
load in 2-PrOH  82.7  20.8  0.1254  67.0 
 
Table  17:  Immobilisation  of  Lipase  from  the  Native  State  Utilising  K2SO4  and  KCl  as 
Excipient Materials - Results 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
4.2.4.2  Immobilisation of Lipase from the Native State Utilising K2SO4 and KCl as 
Excipient Materials - Discussion 
Analysis of the PCMC of native lipase indicated that the enzyme could be immobilised on 
the  surface  of  K2SO4  crystals  with  the  retention  of  up  to  89  %  of  the  activity  of  the 
untreated enzyme.   
Similarly, immobilisation of the native protein on the surface of KCl prepares immobilised 
enzyme with the retention of up to 88 % of the activity of untreated lipase. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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The measured solids yield of the KCl samples is significantly less than that of the K2SO4 
preparations.  This could be due to some of the KCl dissolving in the precipitating solvent 
rather than being involved in PCMC co-precipitation. 
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Figure 71: Comparison of K2SO4 and KCl as Excipients for Lipase Immobilisation 
From the data provided it is evident that K2SO4 is a marginally better excipient for lipase 
immobilisation at these protein loadings than KCl.  The PCMC prepared using KCl as an 
excipient in general have lower solid recovery and retain less activity than their K2SO4 
counterparts.   
4.2.4.3  Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State - 
Results  
PCMC of thermally-unfolded lipase (prepared from 6 mg/ml lipase) were analysed via 
reconstitution of the immobilised protein preparation in 50 mM Tris/HCl, pH 7.8 with a 
view  to  subsequent  determination  of  the  %MPL  (Measured  Protein  Loading)  and  the 
specific activity (0.1877A min
-1mg
-1 for untreated protein).  However the PCMC samples 
proved to be insoluble. 
Details of PCMC sample preparation can be found in Appendix 16. 
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Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC240_17 
Lipase, heat unfolded 
on K2SO4, 5 % load in 
2-PrOH 
96.3  **  **  ** 
KC240_18 
Lipase, heat unfolded 
on K2SO4, 10 % load in 
2-PrOH 
95.8  **  **  ** 
KC240_19 
Lipase, heat unfolded 
on K2SO4, 15 % load in 
2-PrOH 
99.5  **  **  ** 
KC240_20 
Lipase, heat unfolded 
on K2SO4, 20 % load in 
2-PrOH 
97.0  **  **  ** 
KC240_21 
Lipase, heat unfolded 
on KCl, 5 % load in        
2-PrOH 
86.5  **  **  ** 
KC240_22 
Lipase, heat unfolded 
on KCl, 10 % load in  
2-PrOH 
71.8  **  **  ** 
KC240_23 
Lipase, heat unfolded 
on KCl, 15 % load in  
2-PrOH 
86.2  **  **  ** 
KC240_24 
Lipase, heat unfolded 
on KCl, 20 % load in  
2-PrOH 
79.3  **  **  ** 
 
Table 18: Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State - Results 
(**The sample was insoluble upon attempted reconstitution) 
4.2.4.4  Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State - 
Discussion 
The PCMC prepared using lipase which had been thermally-unfolded were insoluble in the 
reconstitution  buffer  and  as  such,  further  physical  measurements  of  the  immobilised 
enzyme could not be carried out.  
4.2.4.5  Immobilisation  of  Lipase  from  the  Thermally-Unfolded,  Solubilised  State 
with the Introduction of a Redox Couple - Results 
In an attempt to aid refolding (and therefore the solubility of the prepared PCMC), a redox 
couple was added to the unfolded protein during the GdnHCl solubilisation step in an 
effort  to  allow  the  correct  reformation  of  disulfide  bonds  formed  from  the  9  cystine 
residues present in wheat germ lipase. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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PCMC of thermally-unfolded lipase with the addition of a redox couple (prepared from 6 
mg/ml lipase) were analysed via reconstitution of the immobilised protein preparation in 
50 mM Tris/HCl, pH 7.8 with a view to subsequent determination of the %MPL (Measured 
Protein  Loading)  and  the  specific  activity  (0.1877A  min
-1mg
-1  for  untreated  protein).  
However the PCMC samples proved to be insoluble. 
Details of PCMC sample preparation can be found in Appendix 17. 
Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC240_09 
Lipase, heat unfolded 
with redox pair on 
K2SO4, 5 % load in     
2-PrOH 
93.5  **  **  ** 
KC240_10 
Lipase, heat unfolded 
with redox pair on 
K2SO4, 10 % load in    
2-PrOH 
97.8  **  **  ** 
KC240_11 
Lipase, heat unfolded 
with redox pair on 
K2SO4, 15 % load in    
2-PrOH 
96.7  **  **  ** 
KC240_12 
Lipase, heat unfolded 
with redox pair on 
K2SO4, 20 % load in    
2-PrOH  
98.2  **  **  ** 
KC240_13 
Lipase, heat unfolded 
with redox pair on KCl,  
5 % load in 2-PrOH 
83.8  **  **  ** 
KC240_14 
Lipase, heat unfolded 
with redox pair on KCl, 
10 % load in 2-PrOH 
84.1  **  **  ** 
KC240_15 
Lipase, heat unfolded 
with redox pair on KCl, 
15 % load in 2-PrOH 
85.3  **  **  ** 
KC240_16 
Lipase, heat unfolded 
with redox pair on KCl, 
20 % load in 2-PrOH 
87.0  **  **  ** 
 
Table 19: Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State with the 
Introduction  of  a  Redox  Couple  -  Results  (**The  sample  was  insoluble  upon  attempted 
reconstitution) Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.2.4.6  Immobilisation  of  Lipase  from  the  Thermally-Unfolded,  Solubilised  State 
with the Introduction of a Redox Couple - Discussion 
The addition of cystine/cysteine as a redox couple appeared to have little or no effect upon 
the solubility of the PCMC samples prepared and as such the sample remained insoluble.   
Again,  the  protein  concentration  before  immobilisation  for  these  samples  was  high  (6 
mg/ml) and further investigation was required to see if a lower concentration of protein 
would provide more favourable results.   
Another consideration is the loading of the protein on the surface of the crystals.  If the 
protein molecules are beginning to fold via immobilisation, the close proximity of these 
biomolecules to one another may lead to interactions between them, and hence, to the 
formation of protein aggregates. 
4.2.4.7  Dialysis Refolding of Lipase from the Thermally-Unfolded, Solubilised State 
with the Addition of a Redox Couple - Comparison with Immobilisation 
The process of immobilisation of unfolded protein and the rapid removal of the denaturing 
salts from the environment of the protein did not yield soluble crystals.  It can be assumed 
therefore that the immobilisation method for potential lipase refolding is unsuccessful.   
Lipase (6 mg/ml) which had been thermally-unfolded and allowed to cool was solubilised 
in the presence of 6 M GdnHCl containing the redox couple of cystine and cysteine.  The 
protein was incubated for 2 hours before being subjected to dialysis (two x three hours plus 
overnight).   
The  protein  in  the  dialysis  cassette  was  seen  to  aggregate  almost  immediately  upon 
dialysis.    This  observation  can  be  attributed  to  the  solubilising  agent  GdnHCl  being 
removed from the environment of the protein and therefore resulting in the interaction of 
the protein molecules with each other, forming aggregates.   
4.2.5 Immobilisation  of  Lipase  from  the  Native  and  Thermally-
Unfolded  State  at  Low  Concentrations  and  Loadings  with 
the Introduction of a Redox Couple.  
PCMC  were  prepared  of  lipase  from  the  native  and  thermally-unfolded  state.  These 
samples were prepared both in the presence and absence of a redox couple at low loadings 
from protein at a concentration of 1 mg/ml in the appropriate buffer. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.2.5.1  Immobilisation of Lipase from the Native State at Low Concentrations and 
Loadings - Results 
PCMC  of  native  lipase  were  analysed  via  reconstitution  of  the  immobilised  protein 
preparation in 50 mM Tris/HCl, pH 7.8 with a view to subsequent determination of the 
%MPL  (Measured  Protein  Loading)  and  the  specific  activity  (0.1877A  min
-1mg
-1  for 
untreated protein). 
Details of PCMC sample preparation can be found in Appendix 18. 
Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC245_01  Lipase on K2SO4,    
0.01 % load in 2-PrOH  85.3  0.018  *  * 
KC245_02  Lipase on K2SO4, 0.1 % 
load in 2-PrOH  84.5  0.21  *  * 
KC245_03  Lipase on K2SO4, 0.5 % 
load in 2-PrOH  84.8  0.59  *  * 
KC245_04  Lipase on KCl, 0.01 % 
loading in 2-PrOH  78.1  0.024  *  * 
KC245_05  Lipase on KCl, 0.1 % 
load in 2-PrOH  80.1  0.19  *  * 
KC245_06  Lipase on KCl, 0.5 % 
load in 2-PrOH  77.7  0.61  *  * 
 
Table  20:  Immobilisation  of  Lipase  from  the  Native  State  at  Low  Concentrations  and 
Loadings - Results (*The data could not be determined for this sample) 
4.2.5.2  Immobilisation of Lipase from the Native State at Low Concentrations and 
Loadings - Discussion 
The assay used to determine the activity of lipase was not sensitive enough to be used with 
protein  at  such  low  concentrations;  therefore,  the  specific  activity  if  the  immobilised 
protein samples could not be determined. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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In order to gain some kind of insight into the effect that immobilisation confers on to the 
protein, the fluorescence spectrum of each of the PCMC samples was obtained.  There was 
no evidence of refolding having taken place from the fluorescence spectra. 
4.2.5.3  Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State at 
Low Concentration and Loading - Results 
PCMC of thermally-unfolded lipase were analysed via reconstitution of the immobilised 
protein in 50 mM Tris/HCl, pH 7.8 with a view to subsequent determination of the %MPL 
(Measured Protein Loading) and the specific activity (0.1877A min
-1mg
-1 for untreated 
protein). 
Details of the PCMC sample preparation can be found in Appendix 19. 
Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC245_07 
Lipase, heat unfolded 
on K2SO4, 0.01 % load 
in 2-PrOH 
86.4  **  **  ** 
KC245_08 
Lipase, heat unfolded 
on K2SO4, 0.1 % load 
in 2-PrOH 
84.8  **  **  ** 
KC245_09 
Lipase, heat unfolded 
on K2SO4, 0.5 % load 
in 2-PrOH 
87.8  **  **  ** 
KC245_10 
Lipase, heat unfolded 
on KCl, 0.01 % load in 
2-PrOH 
76.9  **  **  ** 
KC245_11 
Lipase, heat unfolded 
on KCl, 0.1 % load in 
2-PrOH 
76.6  **  **  ** 
KC245_12 
Lipase, heat unfolded 
on KCl, 0.5 % load in 
2-PrOH 
70.2  **  **  ** 
 
Table 21: Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State at Low 
Concentrations  and  Loadings  -  Results  (**The  sample  was  insoluble  upon  attempted 
reconstitution) Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.2.5.4  Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State at 
Low Concentration and Loading - Discussion 
Upon reconstitution, the thermally-unfolded immobilised samples were again shown to be 
insoluble in the aqueous phase, although appeared to have reconstituted to a greater extent.  
To the naked eye, there appeared to be fewer, smaller aggregates.   
4.2.5.5  Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State at 
Low Concentration and Loading with the Introduction of a Redox Couple - 
Results 
PCMC of thermally-unfolded lipase with the addition of a redox couple were analysed via 
reconstitution  of  the  immobilised  protein  in  50  mM  Tris/HCl,  pH  7.8  with  a  view  to 
subsequent  determination  of  the  %MPL  (Measured  Protein  Loading)  and  the  specific 
activity (0.1877A min
-1mg
-1 for untreated protein). 
Details of the PCMC sample preparation can be found in Appendix 20. 
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Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC245_13 
Lipase, heat unfolded 
with redox pair on 
K2SO4, 0.01 % load in 
2-PrOH 
83.5  **  **  ** 
KC245_14 
Lipase, heat unfolded 
with redox pair on 
K2SO4, 0.1 % load in 2-
PrOH 
82.7  **  **  ** 
KC245_15 
Lipase, heat unfolded 
with redox pair on 
K2SO4, 0.5 % load in 2-
PrOH 
85.5  **  **  ** 
KC245_16 
Lipase, heat unfolded 
with redox pair on KCl, 
0.01 % load in  2-PrOH 
83.0  **  **  ** 
KC245_17 
Lipase, heat unfolded 
with redox pair on KCl, 
0.1 % load in 2-PrOH 
79.9  **  **  ** 
KC245_18 
Lipase, heat unfolded 
with redox pair on KCl, 
0.5 % load in 2-PrOH 
83.1  **  **  ** 
 
Table 22: Immobilisation of Lipase from the Thermally-Unfolded, Solubilised State with the 
Addition  of  a  Redox  Couple  -  Results  (**The  sample  was  insoluble  upon  attempted 
reconstitution) 
4.2.5.6  Immobilisation  of  Thermally-Unfolded  Lipase  at  Low  Concentration  and 
Loading with the Introduction of a Redox Couple - Discussion 
Upon lowering of both the stock protein concentration and the theoretical protein loading, 
the  PCMC  appeared  to  have  marginally  greater  solubility  in  the  aqueous  phase.    The 
addition of the redox couple however showed no improvement in the solubility of the 
immobilised protein 
The PCMC appear to the eye to have reconstituted to a greater extent than previously 
prepared samples.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Figure 72: Fluorescence Spectra of Immobilised Lipase Samples 
The fluorescence spectra of the reconstituted PCMC, show that although the solubility of 
the  samples  has improved  somewhat,  the  protein  immobilised  upon  the  surface  of  the 
crystals is not in a folded state.  The addition of the redox couple has no significant effect 
upon the state of the immobilised protein. 
4.2.6 Immobilisation  of  Lipase  from  the  Native  and  Thermally-
Unfolded State with the Addition of a Catalytic Substrate 
In an effort to trigger the refolding of thermally-unfolded lipase, a catalytic concentration 
(10 molar %) of enzymatic substrate was added to the solubilised protein in the incubation 
step.  The incubation was carried out at both room temperature and at 37 ºC (the optimum 
temperature of the enzyme). 
4.2.6.1  Immobilisation of Lipase from the Native State in the Presence of Catalytic 
Substrate at Room Temperature and 37 ºC - Results 
PCMC samples of native lipase (both in the presence and absence of catalytic substrate) 
were analysed via the reconstitution of the immobilised protein preparation in 50 mM 
Tris/HCl, pH 7.8 with a view to subsequently determining the %MPL (Measured Protein 
Loading) and the specific activity.   Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Details of the PCMC sample preparation can be found in Appendix 21. 
Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC253_01  Lipase on K2SO4, 1 
% load in 2-PrOH  96.5  1.67  0.1787 (± 0.017)  95.2 (± 9.1) 
KC253_02  Lipase on K2SO4, 5 
% load in 2-PrOH  99.7  4.79  0.1699  90.5 
KC253_03 
Lipase on K2SO4, 1 
% load in 2-PrOH at 
37 ºC 
90.7  1.34  0.1779  94.8 
KC253_04 
Lipase on K2SO4, 5 
% load in 2-PrOH at 
37 ºC 
95.2  6.12  0.1729  92.1 
KC253_05 
Lipase + 10 molar % 
p-NPA on K2SO4, 1 
% load in 2-PrOH  
90.7  1.22  0.1775 (± 0.017)  94.6 (± 9.1) 
KC253_06 
Lipase + 10 molar % 
p-NPA on K2SO4, 5 
% load in 2-PrOH 
95.2  5.61  0.1691  90.1 
KC253_07 
Lipase + 10 molar % 
p-NPA on K2SO4, 1 
% load in 2-PrOH at 
37 ºC  
96.2  1.66  0.1717  91.5 
KC253_08 
Lipase + 10 molar % 
p-NPA on K2SO4, 5 
% load in 2-PrOH at 
37 ºC 
86.9  5.61  0.1693  90.2 
 
Table  23:    Immobilisation  of  Lipase  from  the  Native  State  in  the  Presence  of  Catalytic 
Substrate - Results 
Results for multiple measurements are indicated in the data by listing the mean value (± standard 
deviation).  Standard errors for single measurements are anticipated to be of the same order of 
magnitude. 
4.2.6.2  Immobilisation  of  Lipase  from  the  Native  State  with  the  Addition  of 
Catalytic Substrate - Discussion 
The addition of a catalytic concentration of the substrate p-NPA appears to have a slight 
detrimental effect upon the measured solid recovery.    The substrate is insoluble in water 
and therefore has to be dissolved in acetonitrile.  The effect upon the solid recovery could 
perhaps  be  attributed  to  the  excipient  material  being  dissolved  in  the  added  in  the 
coprecipitation. Katrina A. Davidson, 2008                                                                                               Chapter Four 
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Figure  73:  Immobilisation  of  Lipase  from  the  Native  State  in  the  Presence  of  Catalytic 
Substrate at Room Temperature and 37 ° C - Measured Solid Recovery (%) 
It can be noted that the measured solids recovery of the PCMC which were prepared at 37 
°C  show a higher yield than their room temperature counterparts. 
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Figure  74:  Immobilisation  of  Lipase  from  the  Native  State  in  the  Presence  of  Catalytic 
Substrate at Room Temperature and 37 ° C - Activity  
Manufacturing PCMC at 37 °C showed no significant effect upon the retained activity of 
the immobilised native lipase samples.  The presence of catalytic substrate also showed Katrina A. Davidson, 2008                                                                                               Chapter Four 
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little  effect  upon  the  activity  retained  during  immobilisation  when  compared  with  the 
untreated protein.    
4.2.6.3  Immobilisation  of  Lipase  from  the  Thermally-Unfolded  State  with  the 
Addition of Catalytic Substrate - Results 
PCMC samples of thermally unfolded lipase (both in the presence and absence of catalytic 
substrate) were analysed via the reconstitution of the immobilised protein preparation in 50 
mM Tris/HCl, pH 7.8 with a view to subsequently determining the %MPL (Measured 
Protein Loading) and the specific activity.   
Details of the PCMC sample preparation can be found in Appendix 22. 
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Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC253_09 
Lipase, heat unfolded, 
on K2SO4, 1 % load in 
2-PrOH  
95.0  **  **  ** 
KC253_10 
Lipase, heat unfolded, 
on K2SO4, 5 % load in 
2-PrOH 
99.3  **  **  ** 
KC253_11 
Lipase, heat unfolded, 
on K2SO4, 1 % load in 
2-PrOH at 37 ºC 
96.7  **  **  ** 
KC253_12 
Lipase, heat unfolded, 
on K2SO4, 5 % load in 
2-PrOH at 37 ºC 
99.7  **  **  ** 
KC253_13 
Lipase, heat unfolded + 
10 molar % p-NPA on 
K2SO4, 1 % load in 2-
PrOH  
97.5  **  **  ** 
KC253_14 
Lipase, heat unfolded + 
10 molar % p-NPA on 
K2SO4, 5 % load in 2-
PrOH 
97.8  **  **  ** 
KC253_15 
Lipase, heat unfolded + 
10 molar % p-NPA on 
K2SO4, 1 % load in 2-
PrOH at 37 ºC 
94.3  **  **  ** 
KC253_16 
Lipase, heat unfolded + 
10 molar % p-NPA on 
K2SO4, 5 % load in 2-
PrOH at 37 ºC 
98.7  **  **  ** 
 
Table  24:  Immobilisation  of  Thermally-Unfolded  Lipase  with  the  Addition  of  Catalytic 
Substrate - Results (**The sample was insoluble upon attempted reconstitution) 
4.2.6.4  Immobilisation  of  Lipase  from  the  Thermally-Unfolded  State  with  the 
Addition of Catalytic Substrate - Discussion 
The addition of p-NPA to the thermally-unfolded protein at the solubilisation stage appears 
to have no effect on the resultant PCMC when compared with samples prepared in the 
absence  of  substrate.    The  resultant crystals are found  to  remain  insoluble  in  aqueous 
buffer and as such the %MPL and the specific activity cannot be determined.   
The preparation of PCMC from lipase in the thermally-unfolded state at 37 °C results in no 
improvement  in  the  observed  solubility  over  the  room  temperature  counterparts.    The 
thermally-unfolded, immobilised samples prepared at room temperature and at 37 °C both Katrina A. Davidson, 2008                                                                                               Chapter Four 
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in  the  presence  and  absence  of  p-NPA  show  no  evidence  of  refolding  or  increased 
solubility. 
4.2.7 Immobilisation  of  Lipase  from  the  Native  and  Thermally-
Unfolded State Using a Syringe Pump 
In order to determine if the gradual dilution of the denaturing salt from the environment of 
the thermally-unfolded, solubilised protein would help to regain activity from the protein, 
PCMC samples were prepared using a syringe pump.  This equipment allows the gradual 
dilution  of  the  GdnHCl  from  the  environment  before  precipitation  begins  (therefore 
beginning the refolding process via dilution). 
4.2.7.1  Immobilisation  of  Lipase  from  the  Native  and  Thermally-Unfolded  State 
Using a Syringe Pump - Results 
PCMC were prepared of lipase (from both the native and thermally-unfolded, solubilised 
state)  using  a  syringe  pump  to  mix  the  excipient  and  protein  together  gradually  (0.01 
ml/min  excipient  into  protein)  followed  by  immediate  precipitation  of  mixture  into  2-
PrOH.   
These samples were analysed via the reconstitution of the immobilised protein in 50 mM 
Tris/HCl, pH 7.8 with a view to subsequently determining the %MPL (Measured Protein 
Loading) and the specific activity.   
Details of the PCMC sample preparation can be found in Appendix 23. 
Sample 
Identifier 
Sample Description 
Measured 
Solids 
Recovery 
(%) 
Measured 
Protein 
Loading 
(%) 
Specific 
Activity        
(A min
-1mg
-1) 
% Activity 
of Native 
Protein 
KC255_01  Lipase, on K2SO4, 5 % 
load in 2-PrOH  84.7  6.04  0.127  67.9 
KC255_02 
Lipase, heat unfolded, 
on K2SO4, 5 % load in   
2-PrOH 
78.9  **  **  ** 
 
Table 25: Immobilisation of Lipase from the Native and Unfolded State - PCMC Preparation 
using a Syringe Pump - Results (**The sample was insoluble upon attempted reconstitution) Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.2.7.2  Immobilisation  of  Lipase  from  the  Native  and  Thermally-Unfolded  State 
Using a Syringe Pump - Discussion 
PCMC of thermally-unfolded, solubilised lipase prepared using syringe pumps were found 
to be insoluble in the reconstitution buffer, similarly to other thermally-unfolded samples.  
The gradual dilution of the denaturing salt from the environment of the lipase followed by 
subsequent precipitation therefore appeared to have no beneficial effect upon either the 
solubility of the crystals or the refolding of the protein.  Katrina A. Davidson, 2008                                                                                               Chapter Four 
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4.3  Discussion and Conclusions                      
In the refolding of wheat germ lipase, there are three stages at which the refolding of the 
enzyme can occur: during the mixing of the unfolded protein and excipient material (and 
associated dilution of denaturing agents); during the process of PCMC formation; and in 
the reconstitution of the material under aqueous conditions.   
Activity measurements for lipase indicate that upon dilution (and subsequent removal) of 
the  denaturing  molecules  from  the  protein  environment,  the  enzyme  has  no  catalytic 
activity.    
Evidence obtained with lysozyme suggests that any possible folding of enzyme molecules 
occurs  upon  the  formation  of  PCMC  with  the  result  that  the  protein  is  in  a  native 
conformation upon reconstitution under aqueous conditions.   
Lipase from the chemically-unfolded state can be immobilised via the formation of PCMC 
with the regain of enzymatic activity.  The immobilisation of lipase from the GdnHCl 
unfolded state upon carriers such as K2SO4 yielded crystals coated with the protein with 
the regain of up to 36.3 % of the activity of the untreated enzyme.  Dialysis of GdnHCl 
unfolded lipase as a method for refolding regained 11.4 % of the activity of the native 
enzyme.    The  refolding  of  lipase  via  the  formation  of  PCMC  therefore  compared 
favourably with a general protein folding method such as dialysis. 
However,  the  immobilisation  of  lipase  from  the  thermally-unfolded,  solubilised  state 
proved to be a difficult challenge for this methodology.  Reducing enzyme concentration 
and protein loading appears to have a visible effect upon the level of aggregation, however, 
not to the extent required to complete further analysis.  The introduction of redox couples 
and catalytic concentrations of enzymatic substrate seemed to have little or no effect upon 
the  aggregation  of  the  enzyme  and  as  such  PCMC  prepared  using  lipase  from  these 
conditions gave rise to insoluble protein particles.   
Dialysis of lipase from the thermally-unfolded, solubilised state fared no better than PCMC 
formation.    Upon  removal  of  the  solubilising  agent  from  the  protein  environment,  the 
biomolecule was seen to form aggregates with no enzymatic activity.  This was true for the 
introduction  of  a  redox  couple  to  the  solubilised  protein  solution  and  also  catalytic 
concentrations of substrate.  
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5  Project Conclusions and Further Work 
At the commencement of this project, the aim was to develop a method for the one-step 
immobilisation  and  simultaneous  refolding  of  proteins  using  PCMC  formation.  Two 
enzymes were unfolded utilising various methods and subsequently immobilised via the 
formation of PCMC.  The purpose of this was to ascertain the effect of immobilisation 
upon  enzyme  structure  and  to  determine  if  it  is  possible  to  refold  proteins  using  this 
method.  It was also an aim to determine when, if any, refolding took place; during the 
mixing  of  protein  and  crystal  forming  component;  during  coprecipitation  or  upon 
reconstitution of the powder back into the aqueous phase.    
Lysozyme  is known to  be amenable to chemical  unfolding  and refolding  experiments.  
Upon chemical unfolding and subsequent immobilisation of this enzyme by the formation 
of  PCMC,  the  protein  has  been  seen  to  have  refolded  to  varying  extents  during  co-
precipitation.  Solid State CD spectroscopy indicates that the refolding of lysozyme occurs 
upon the formation of PCMC and that the protein is in a native-like state on the surface of 
the coprecipitant material.   
The refolding of thermally unfolded lysozyme proved to be a more difficult task for this 
immobilisation  method.    Upon  reconstitution,  the  resultant  immobilised  protein  coated 
crystals were insoluble and therefore further analysis was not possible. 
Utilising the enzyme lipase for refolding studies also proved to be difficult.  This enzyme 
is more reluctant to refold and this was evident in the work carried out here.  Chemically 
unfolded lipase  subjected to immobilisation lead to the regain of  up to  36.3 %  of the 
activity of the untreated enzyme.  However, thermally-unfolded, solubilised lipase which 
was immobilised from a range of conditions, proved to be insoluble in the aqueous phase.   
The  scope  for  further  work  in  this  area  is  vast.    There  are  a  number  of  chemical 
modifications which remain to be investigated with this process.  Parameters with scope 
for investigation include the choice of protein, solvent, crystal forming component, final 
water content of the solvent, rate of mixing of aqueous and organic phases and the addition 
of molecules known to promote protein folding such as arginine and detergents. 
The determination of the chemical constituents of the formulated protein after precipitation 
and  isolation  by  filtration  is  important.    There  are  a  number  of  different  chemical 
components used in the manufacture of these species including buffers, solubilising agents, Katrina A. Davidson, 2008                                                                                               Chapter Five 
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solvents etcetera, and the identification of exactly what is remaining of these in the final 
product is important for the full understanding of their behaviour.   
The greatest scope for further study of this methodology is the analytical methods which 
can be used to analyse the particles as a whole (protein + crystal forming component) or 
individually. Spectroscopic and imaging methods could provide a great deal of valuable 
information:   
•  The secondary structure of protein molecules can be investigated using methods 
such  as  FTIR  (Fourier  Transform  Infra-Red)  spectroscopy  which  would  detect 
small changes in the structure of the backbone of the protein molecule or hydrogen 
bonding  properties  as  a  result  of  immobilisation  (in  the  solid  state)  or  upon 
reconstitution. 
•  NMR  (Nuclear  Magnetic  Resonance)  spectroscopy  is  a  tool  for  the  analysis  of 
protein structure, detecting very small changes in protein conformation to great 
precision.    This  technique  could  be  employed  for  the  analysis  of  optimised 
formulations  to  determine  the  structural  characteristics  of  the  protein  upon 
immobilisation and its conformational state. 
•  The PCMC could be subjected to powder XRD (X-Ray Diffraction) to determine 
the physical state of the core material and how this is affected upon coprecipitation 
with protein.   
•  SEM (Scanning Electron Microscopy) could be routinely used to ascertain the size, 
shape and general morphology of the precipitated material. 
•  AFM (Atomic Force Microscopy) would give information regarding the surface 
morphology  of  the  precipitated  material  and  the  size  and  shape  of  the  protein 
clusters present upon the excipient. 
Scope for further work could also include measuring the stability of the formulations with 
respect to time under varying conditions of temperature and humidity stress.  This would 
indicate the shelf-life of such refolded protein products. 
The immobilisation of lysozyme from both the chemically and thermally-unfolded state is 
possible  via  the  formation  of  PCMC.    As  a  method  for  the  refolding  of  chemically-Katrina A. Davidson, 2008                                                                                               Chapter Five 
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unfolded lysozyme or lipase, PCMC formation fares better than a generally applied method 
such as dialysis.  However, further research is required to exhaust the possibility of using 
this immobilisation technique as a method for the refolding of protein molecules from the 
thermally-unfolded state.      
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6  Appendices 
6.1  Appendix 1 
6.1.1 Immobilisation of Lysozyme from the Native State - Sample 
Preparation 
Lysozyme (6 mg/ml in 50 mM Tris/HCl, pH 8.1) was prepared for immobilisation by 
mixing with an aqueous solution of excipient material (D,L-valine; 60 mg/ml).  The protein 
and excipient solution were mixed in the appropriate ratio to achieve the desired protein 
loading  before  being  added  drop-wise  to  a  stirring  organic  solvent  (1000  rpm).    The 
volume of solvent required was calculated so that the water content of the solvent after 
precipitation is between 4 and 5 % 
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC158_01 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  1.3 ml D,L-
valine solution 
66 ml    
2-PrOH  15.0 
KC158-02 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  0.8 ml D,L-
valine solution 
56 ml    
2-PrOH  20.0 
KC158-03 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  0.6 ml D,L-
valine solution 
52 ml    
2-PrOH  25.0 
 
Table 26: Immobilisation of Lysozyme from the Native State - Sample Preparation 
After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
167 
6.1.2 Immobilisation  of  Lysozyme  from  the  Guanidine 
Hydrochloride Unfolded State - Sample Preparation 
Lysozyme  (6  mg/ml  in  50  mM  Tris/HCl,  pH  8.1)  was  subject  to  unfolding  upon  the 
addition of 6 M GdnHCl.  The protein and excipient solution (D,L-valine; 60 mg/ml) were 
mixed in the appropriate ratio to achieve the desired protein loading and subsequently 
added drop-wise to stirring organic solvent (1000 rpm). The volume of solvent required 
was calculated so that the water content of the solvent after precipitation is between 4 and 
5 % 
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading       
(% TPL) 
KC162_01 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
1.3 ml D,L-
valine solution 
66 ml    
2-PrOH  12.5 
KC162_02 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
1.13 ml D,L-
valine solution 
63 ml    
2-PrOH  15.0 
KC162_03 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
0.93 ml D,L-
valine solution 
59 ml    
2-PrOH  17.5 
KC162_04 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
0.8 ml D,L-
valine solution 
56 ml    
2-PrOH  20.0 
KC162_05 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
0.7 ml D,L-
valine solution 
54 ml    
2-PrOH  22.5 
KC162_06 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
0.6 ml D,L-
valine solution 
52 ml    
2-PrOH  25.0 
 
Table 27: Immobilisation of Lysozyme from the Guanidine Hydrochloride Unfolded State - 
Sample Preparation 
After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.2  Appendix 2 
6.2.1 Immobilisation of Lysozyme from the Native State at Lower 
Protein Loadings - Sample Preparation 
In order to determine if lysozyme could be immobilised and refolded successfully at lower 
protein  loadings,  samples  were  prepared  of  native  and  GdnHCl  unfolded  lysozyme  (6 
mg/ml) at protein loadings ranging from 0.6 - 20 %.   
Lysozyme (6 mg/ml in 50 mM Tris/HCl, pH 8.1) was prepared for immobilisation by 
mixing with an aqueous solution of excipient material (D,L-valine; 60 mg/ml) before being 
added drop-wise to stirring organic solvent (1000 rpm).  The volume of solvent required 
was calculated so that the water content of the solvent after precipitation is between 4 and 
5 %. 
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC198_01 
0.3 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  5.0 ml D,L-
valine solution 
125 ml    
2-PrOH  0.6 
KC198_02 
6 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Native  1.9 ml D,L-
valine solution 
73 ml    
2-PrOH  5.0 
KC198_03 
6 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Native  0.9 ml D,L-
valine solution 
48 ml    
2-PrOH  10.0 
KC198_04 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  1.12 ml D,L-
valine solution 
78 ml    
2-PrOH  15.0 
KC198_05 
15 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  1.0 ml D,L-
valine solution 
87 ml    
2-PrOH  20.0 
 
Table 28: Immobilisation of Lysozyme from the Native state at Lower Protein Loadings - 
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After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. 
6.2.2 Immobilisation  of  Lysozyme  from  the  Guanidine 
Hydrochloride Unfolded State at Lower Protein Loadings - 
Sample Preparation 
Lysozyme  (6  mg/ml  in  50  mM  Tris/HCl,  pH  8.1)  was  subject  to  unfolding  upon  the 
addition of 6 M GdnHCl.  The protein and excipient solution (D,L-valine; 60 mg/ml) were 
mixed  and  subsequently  added  drop-wise  to  stirring  organic  solvent  (1000  rpm).  The 
volume of solvent required was calculated so that the water content of the solvent after 
precipitation is between 4 and 5 % 
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC187_05 
0.3 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
5.0 ml D,L-
valine solution 
125 ml    
2-PrOH  0.6 
KC187_06 
6 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Unfolded with 
6 M GdnHCl 
1.9 ml D,L-
valine solution 
73 ml    
2-PrOH  5.0 
KC187_07 
6 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Unfolded with 
6 M GdnHCl 
0.9 ml D,L-
valine solution 
48 ml    
2-PrOH  10.0 
KC187_08 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1  
Unfolded with 
6 M GdnHCl 
1.12 ml D,L-
valine solution 
78 ml    
2-PrOH  15.0 
KC187_09 
15 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
1.0 ml D,L-
valine solution 
87 ml    
2-PrOH  20.0 
 
Table 29: Immobilisation of Lysozyme from the Guanidine Hydrochloride Unfolded State - 
Sample Preparation 
After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.3  Appendix 3 
6.3.1 Immobilisation of Lysozyme from the Native and Guanidine 
Hydrochloride  Unfolded  State  Using  a  Syringe  Pump  - 
Sample Preparation 
In order to determine if more enzymatic activity could be regained by the gradual mixing 
of the protein solution and excipient; a syringe pump was employed.  This allowed the 
excipient to be added to the protein containing solution at a slow rate (0.01 ml/min) to 
allow gradual dilution of the denaturant before the immobilisation step occurs. 
Lysozyme (1 mg/ml in 50 mM Tris/HCl, pH 8.1) was chemically unfolded via incubation 
in 6 M GdnHCl for 2 hours.  PCMC were prepared of both this GdnHCl unfolded protein 
and native lysozyme.  The aqueous solution of excipient material (D,L-valine; 60 mg/ml) 
was then added to the unfolded protein at a rate of 0.01 ml min
-1 in an attempt to determine 
if the gradual dilution of the denaturing salt from the protein environment can trigger 
refolding.  When the gradual mixing is complete, the protein/excipient mixture was added 
drop-wise to stirring organic solvent (1000 rpm).  The volume of solvent required for 
precipitation was determined so as to keep the final water content of the solvent between 4 
and 5 %.  
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC258_16 
3.0 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  0.95 ml D,L-
valine solution 
99 ml    
2-PrOH  5.0 
KC258_19 
3.0 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with 
6 M GdnHCl 
0.95 ml D,L-
valine solution 
99 ml    
2-PrOH  5.0 
 
Table  30:  Immobilisation  of  Lysozyme  from  the  Native  and  Guanidine  Hydrochloride 
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After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.4  Appendix 4 
6.4.1 Immobilisation  of  Urea  Incubated  and  Urea  Unfolded, 
Reduced Lysozyme - Sample Preparation 
Lysozyme (12 mg/ml in 50 mM Tris/HCl, pH 8.1) was incubated in 8 M Urea to form urea 
incubated lysozyme.  To prepare urea unfolded, reduced protein, lysozyme (12 mg/ml in 
50 mM Tris/HCl, pH 8.1) was incubated in 8 M Urea with the addition of 32 mM DTT.  
The urea incubated and urea unfolded, reduced protein were prepared for immobilisation 
by mixing with the appropriate concentration of excipient material (D,L-valine; 60 mg/ml) 
before subsequent addition of the mixture drop-wise to stirring organic solvent (1000 rpm).   
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC111_01 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
1.0 ml D,L-
valine solution 
30 ml    
EtOH  16.5 
KC111_02 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
1.0 ml D,L-
valine solution 
30 ml    
2-PrOH  16.5 
KC111_03 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
1.0 ml D,L-
valine solution 
30 ml    
1-PrOH  16.5 
KC111_04 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1  
Incubated in       
8 M urea  
1.0 ml D,L-
valine solution 
30 ml    
EtOH  16.5 
KC111_05 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Incubated in       
8 M urea 
1.0 ml D,L-
valine solution 
30 ml    
2-PrOH  16.5 
KC111_06 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Incubated in       
8 M urea 
1.0 ml D,L-
valine solution 
30 ml    
1-PrOH  16.5 
 
Table 31: Immobilisation of Lysozyme from the Urea Incubated and Urea Unfolded, Reduced 
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After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
174 
6.5  Appendix 5 
6.5.1 Immobilisation  of  Lysozyme  from  the  Urea  Incubated  and 
Urea  Unfolded,  Reduced  State  Using  L-Glutamine  as  an 
Excipient - Sample Preparation 
PCMC  of  urea  incubated  and  urea  unfolded,  reduced  lysozyme  were  manufactured 
utilising  L-glutamine as  an excipient.    The  urea  incubated  and  urea  unfolded,  reduced 
protein were prepared for immobilisation by mixing with the appropriate concentration of 
excipient  material  (L-glutamine;  20  mg/ml)  before  subsequent  addition  of  the  mixture 
drop-wise to stirring organic solvent (1000 rpm).   
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC111_07 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
1.0 ml L-
glutamine 
solution 
30 ml    
EtOH  37.5 
KC111_08 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
1.0 ml L-
glutamine 
solution 
30 ml    
2-PrOH  37.5 
KC111_09 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
1.0 ml L-
glutamine 
solution 
30 ml    
1-PrOH  37.5 
KC111_10 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1  
Incubated in       
8 M urea  
1.0 ml L-
glutamine 
solution 
30 ml    
EtOH  37.5 
KC111_11 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Incubated in       
8 M urea 
1.0 ml L-
glutamine 
solution 
30 ml    
2-PrOH  37.5 
KC111_12 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Incubated in       
8 M urea 
1.0 ml L-
glutamine 
solution 
30 ml    
1-PrOH  37.5 
 
Table 32: Immobilisation of Lysozyme from the Urea Incubated and Urea Unfolded, Reduced 
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After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. 
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6.6  Appendix 6 
6.6.1 Immobilisation  of  Lysozyme  from  the  Native  and  Urea 
Unfolded,  Reduced  state  at  Lower  Protein  Loadings  - 
Sample Preparation 
Lysozyme (12 mg/ml in 50 mM Tris/HCl, pH 8.1) was incubated in 8 M Urea to form urea 
incubated lysozyme.  To prepare urea unfolded, reduced protein, lysozyme (12 mg/ml in 
50 mM Tris/HCl, pH 8.1) was incubated in 8 M Urea with the addition of 32 mM DTT. 
The urea incubated and urea unfolded, reduced protein were prepared for immobilisation 
by mixing with the appropriate concentration of excipient material (D,L-valine; 60 mg/ml) 
before subsequent addition of the mixture drop-wise to stirring organic solvent (1000 rpm). 
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC119_01 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
2.0 ml D,L-
valine solution 
30 ml    
EtOH  9.0 
KC119_02 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
2.0 ml D,L-
valine solution 
30 ml    
1-PrOH  9.0 
KC119_03 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
2.0 ml D,L-
valine solution 
30 ml    
2-PrOH  9.0 
KC119_07 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1  
Incubated in       
8 M urea  
2.0 ml D,L-
valine solution 
30 ml    
EtOH  9.0 
KC119_08 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Incubated in       
8 M urea 
2.0 ml D,L-
valine solution 
30 ml    
1-PrOH  9.0 
KC119_09 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Incubated in       
8 M urea 
2.0 ml D,L-
valine solution 
30 ml    
2-PrOH  9.0 
 
Table 33: Immobilisation of Lysozyme from the Native and Urea Unfolded, Reduced state at 
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After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
6.7  Appendix 7 
6.7.1 Immobilisation  of  Lysozyme  from  the  Urea  Unfolded, 
Reduced  State  at  Lower  Concentrations  -  Sample 
Preparation 
The  previously  described  PCMC  were  manufactured  from  various  protein  stocks  at  a 
concentration of 12 mg/ml lysozyme in 50 mM Tris/HCl, pH 8.1 containing 8 M Urea and 
32 mM DTT.  To determine if reducing the concentration of the protein stock from which 
samples were prepared could have any positive effect upon the solubility (and observed 
activity) of the PCMC, immobilised protein samples were prepared.   
Lysozyme (6 mg/ml in 50 mM Tris/HCl, pH 8.1) was incubated in 8 M Urea to form urea 
incubated lysozyme.  To prepare urea unfolded, reduced protein, lysozyme (6 mg/ml in 50 
mM Tris/HCl, pH 8.1) was incubated in 8 M Urea with the addition of 32 mM DTT.   
The urea incubated and urea unfolded, reduced protein were prepared for immobilisation 
by mixing with the appropriate concentration of excipient material (D,L-valine; 60 mg/ml) 
before subsequent addition of the mixture drop-wise to stirring organic solvent (1000 rpm). 
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Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC77_01 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
2.0 ml D,L-
valine solution 
30 ml    
EtOH  9.0 
KC77_02 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
2.0 ml D,L-
valine solution 
30 ml    
2-PrOH  9.0 
KC77_03 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  2.0 ml D,L-
valine solution 
30 ml    
EtOH  9.0 
KC77_04 
12 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1  
Native  2.0 ml D,L-
valine solution 
30 ml    
2-PrOH  9.0 
 
Table  34:  Immobilisation  of  Lysozyme  from  the  Urea  Unfolded,  Reduced  State  at  Lower 
Concentrations - Sample Preparation 
After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.8  Appendix 8 
6.8.1 Immobilisation  of  Lysozyme  from  the  Native  and  Urea 
Unfolded,  Reduced  State  Using  a Syringe  Pump  -  Sample 
Preparation 
In order to determine if more enzymatic activity could be regained by the gradual mixing 
of the protein solution and excipient; a syringe pump was employed.  This allowed the 
excipient to be added to the protein containing solution at a slow rate (0.01 ml/ml) to allow 
gradual dilution of the denaturant before the immobilisation step occurs. 
Urea unfolded, reduced lysozyme was prepared via incubation of 1 mg/ml protein in 50 
mM Tris/HCl, pH 8.1 containing 8 M urea and 32 mM DTT.  PCMC were prepared of 
both this urea unfolded, reduced protein and native lysozyme. 
The aqueous solution of excipient material (D,L-valine; 60 mg/ml) was then added to the 
unfolded protein at a rate of 0.01 ml min
-1 in an attempt to determine if the gradual dilution 
of  the  denaturing  salt  from  the  protein  environment  can  trigger  refolding.    When  the 
gradual  mixing  was  complete,  the  protein/excipient  mixture  was  added  drop-wise  to 
stirring organic solvent (1000 rpm).  The volume of solvent required for precipitation was 
determined so as to keep the final water content of the solvent between 4 and 5 %.  
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC258_16 
3.0 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native  0.95 ml D,L-
valine solution 
99 ml    
2-PrOH  5.0 
KC258_20 
3.0 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Unfolded with    
8 M urea + 32 
mM DTT 
0.95 ml D,L-
valine solution 
99 ml    
2-PrOH  5.0 
 
Table 35: Immobilisation of Lysozyme from the Native and Urea Unfolded, Reduced State 
Using a Syringe Pump - Sample Preparation Katrina A. Davidson, 2008                                                                                                 Appendices 
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After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.9  Appendix 9 
6.9.1 Immobilisation of Lysozyme from the Native and Thermally 
Unfolded,  Guanidine  Hydrochloride  Solubilised  State  - 
Sample Preparation  
Lysozyme (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 
°C and then allowed to cool to room temperature.  The resultant protein aggregates were 
then solubilised by the addition of 6 M GdnHCl.  This solution of thermally unfolded, 
solubilised protein was then used to prepare PCMC by mixing with a solution of excipient 
material  (D,L-valine;  60  mg/ml)  before  precipitation  in  stirring  organic  solvent  (1000 
rpm).  The volume of solvent required was calculated so that the water content of the 
solvent after precipitation is between 4 and 5 %. 
Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC258_01 
0.6 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native 
0.99 ml 
D,L-valine 
solution 
40 ml    
2-PrOH  1.0 
KC258_02 
3 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Native 
0.95 ml 
D,L-valine 
solution 
99 ml    
2-PrOH  5.0 
KC258_03 
0.6 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Thermally unfolded, 
solubilised with        
6 M GdnHCl 
0.99 ml 
D,L-valine 
solution 
40 ml    
EtOH  1.0 
KC258_04 
3 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Thermally unfolded, 
solubilised with        
6 M GdnHCl 
0.95 ml 
D,L-valine 
solution 
99 ml    
2-PrOH  5.0 
 
Table 36: Immobilisation of Lysozyme from the Native and Thermally Unfolded, Guanidine 
Hydrochloride Solubilised State - Sample Preparation 
After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.10 Appendix 10 
6.10.1  Immobilisation  of  Lysozyme  from  the  Native  and 
Thermally  Unfolded,  Urea  Solubilised  State  -  Sample 
Preparation  
Lysozyme (1 mg/ml in 50 mM Tris/HCl, pH 8.1) was thermally unfolded by heating to 100 
°C and then allowed to cool to room temperature.  The resultant protein aggregates were 
then  solubilised  by  the  addition  of  8  M  Urea.    This  solution  of  thermally  unfolded, 
solubilised protein was then used to prepare PCMC by mixing with a solution of excipient 
material  (D,L-valine;  60  mg/ml)  before  precipitation  in  stirring  organic  solvent  (1000 
rpm).  The volume of solvent required was calculated so that the water content of the 
solvent after precipitation is between 4 and 5 %. 
Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC258_01 
0.6 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native 
0.99 ml 
D,L-valine 
solution 
40 ml    
2-PrOH  1.0 
KC258_02 
3 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Native 
0.95 ml 
D,L-valine 
solution 
99 ml    
2-PrOH  5.0 
KC258_05 
0.6 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Thermally unfolded, 
solubilised with        
8 M Urea 
0.99 ml 
D,L-valine 
solution 
40 ml    
EtOH  1.0 
KC258_06 
3 mg lysozyme in 
50 mM Tris/HCl, 
pH 8.1 
Thermally unfolded, 
solubilised with        
8 M Urea 
0.95 ml 
D,L-valine 
solution 
99 ml    
2-PrOH  5.0 
 
Table  37:  Immobilisation  of  Lysozyme  from  the  Native  and  Thermally  Unfolded,  Urea 
Solubilised State - Sample Preparation 
After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.11 Appendix 11 
6.11.1  Immobilisation  of  Lysozyme  from  the  Native  and 
Thermally Unfolded State Using a Syringe Pump – Sample 
Preparation 
In order to determine if more enzymatic activity could be regained by the gradual mixing 
of the protein solution and excipient; a syringe pump was employed.  This allowed the 
excipient to be added to the protein containing solution at a slow rate (0.01 ml/ml) to allow 
gradual dilution of the denaturant before the immobilisation step occurs. 
Lysozyme (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 
°C and then allowed to cool to room temperature.  The resultant protein aggregates were 
then solubilised by the addition of either 6 M GdnHCl or 8 M Urea.  An aqueous solution 
of excipient material (D,L-valine; 60 mg/ml) was then added to the unfolded protein at a 
rate of 0.01 ml min
-1 in an attempt to determine if the gradual dilution of the denaturing 
salt from the protein environment can trigger refolding.  When the gradual mixing was 
complete, the protein/excipient mixture was added drop-wise to stirring organic solvent 
(1000 rpm).  The volume of solvent required for precipitation was determined so as to keep 
the final water content of the solvent between 4 and 5 %.  
Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC258_16 
3.0 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Native 
0.95 ml 
D,L-valine 
solution 
99 ml    
2-PrOH  5.0 
KC258_17 
3.0 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Thermally unfolded, 
solubilised with        
6 M GdnHCl 
0.95 ml 
D,L-valine 
solution 
99 ml    
2-PrOH  5.0 
KC258_18 
3.0 mg lysozyme 
in 50 mM 
Tris/HCl, pH 8.1 
Thermally unfolded, 
solubilised with        
8 M Urea 
0.95 ml 
D,L-valine 
solution 
99 ml    
2-PrOH  5.0 
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After precipitation, the PCMC samples were filtered and allowed to dry overnight in a 
pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped from the filter 
membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.12 Appendix 12 
PCMC of lipase from both the native and chemically unfolded state were prepared in order 
to ascertain the efficacy of this immobilisation method for the refolding of chemically 
unfolded lipase 
6.12.1.1 Immobilisation of Lipase from the Native State - Sample Preparation 
Lipase is prepared for immobilisation by dissolving in 200 µl of 50 mM Tris/HCl, pH 7.8 
and  subsequently  mixed  with  an  aqueous  solution  of  excipient  material  (K2SO4;  100 
mg/ml).  The protein and excipient solution were mixed in the appropriate ratio to achieve 
the desired protein loading before being added drop-wise to stirring organic solvent (1000 
rpm).  The volume of solvent required for precipitation was determined so as to keep the 
final water content of the solvent between 4 and 5 %.   
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC214-01 
0.6 mg lipase in 50 
mM Tris/HCl,     
pH 7.8 
Native  0.6 ml K2SO4 
solution 
20 ml    
2-PrOH  1.0 
KC214-02 
3.0 mg lipase in 50 
mM Tris/HCl,     
pH 7.8 
Native  0.6 ml K2SO4 
solution 
20 ml    
2-PrOH  5.0 
KC214-03 
6.0 mg lipase in 50 
mM Tris/HCl,     
pH 7.8 
Native  0.54 ml K2SO4 
solution 
18.5 ml 
2-PrOH  10.0 
KC214-04 
9.0 mg lipase in 50 
mM Tris/HCl,     
pH 7.8 
Native  0.48 ml K2SO4 
solution 
17 ml    
2-PrOH  15.0 
KC214-05 
12.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Native  0.48 ml K2SO4 
solution 
17 ml    
2-PrOH  20.0 
KC214-06 
18.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Native  0.18 ml K2SO4 
solution 
10 ml    
2-PrOH  50.0 
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After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. 
6.12.2  Immobilisation  of  Lipase  from  the  Guanidine 
Hydrochloride Unfolded State - Sample Preparation 
Lipase (6 mg/ml in 50 mM Tris/HCl, pH 7.8) was subjected to unfolding upon the addition 
of 6 M GdnHCl and incubated under these conditions for two hours.  The unfolded protein 
was  subsequently  mixed  with  an  aqueous  solution  of  excipient  material  (K2SO4;  100 
mg/ml) at an appropriate ratio so that the desired protein loading could be achieved.  The 
protein/excipient mixture was then added drop-wise to stirring organic solvent (1000 rpm).  
The volume of solvent required for precipitation was determined so as to keep the final 
water content of the solvent between 4 and 5 %.  
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC214-07 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.6 ml K2SO4 
solution 
15 ml    
2-PrOH  1.0 
KC214-08 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.6 ml K2SO4 
solution 
22 ml    
2-PrOH  5.0 
KC214-09 
6.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.54 ml K2SO4 
solution 
31.5 ml    
2-PrOH  10.0 
KC214-10 
9.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.48 ml K2SO4 
solution 
50 ml    
2-PrOH  15.0 
KC214-11 
12.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.48 ml K2SO4 
solution 
62 ml    
2-PrOH  20.0 
KC214-12 
18.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.18 ml K2SO4 
solution 
80 ml    
2-PrOH  50.0 
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After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.13 Appendix 13 
6.13.1  Immobilisation  of  Lipase  from  the  Native  and 
Guanidine  Hydrochloride  Unfolded  State  Using  a  Syringe 
Pump - Sample Preparation 
In order to determine if more enzymatic activity could be regained by the gradual mixing 
of the protein and excipient solutions, a syringe pump was employed.  This allowed the 
excipient to be added to the protein solution at a slow rate (0.01 ml/min) to allow gradual 
dilution of the denaturing salt before the immobilisation step occurs. 
Lipase (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was subjected to unfolding upon addition of 
6 M GdnHCl and incubated under these conditions for 2 hours.  The aqueous solution of 
excipient material (K2SO4; 100 mg/ml) was then added to the unfolded protein at a rate of 
0.01 ml min
-1.  When the gradual mixing is complete, the protein/excipient mixture was 
added drop-wise to stirring organic solvent (1000 rpm).  The volume of solvent required 
for  precipitation  was  determined  so  as  to  keep  the  final  water  content  of  the  solvent 
between 4 and 5 %.  
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC255_01 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Native  0.57 ml K2SO4 
solution 
89 ml    
2-PrOH  5.0 
KC255_03 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.57 ml K2SO4 
solution 
89 ml    
2-PrOH  5.0 
 
Table 41: Immobilisation of Lipase from the Native and Chemically Unfolded State Using a 
Syringe Pump - Sample Preparation 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
190 
6.14 Appendix 14 
PCMC of lipase from both the native and thermally unfolded state were prepared in order 
to  ascertain  the  efficacy  of  this  immobilisation  method  for  the  refolding  of  thermally 
unfolded lipase. 
6.14.1  Immobilisation  of  Lipase  from  the  Native  State  with 
Various Excipients - Sample Preparation 
Lipase was prepared for immobilisation by dissolving in 200 µl of 50 mM Tris/HCl, pH 
7.8 and subsequently mixed with an aqueous solution of excipient material (K2SO4; 100 
mg/ml or D,L-valine; 60 mg/ml).  The protein and excipient solution were mixed in the 
appropriate ratio to achieve the desired protein loading before being added drop-wise to 
stirring organic solvent (1000 rpm).  The volume of solvent required for precipitation was 
determined so as to keep the final water content of the solvent between 4 and 5 %.  
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Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading      
(% TPL) 
KC216_01  0.6 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.6 ml K2SO4 
solution 
20 ml    
2-PrOH  1.0 
KC216_02  3.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.6 ml K2SO4 
solution 
20 ml    
2-PrOH  5.0 
KC216_03  6.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.54 ml K2SO4 
solution 
18.5 ml 
2-PrOH  10.0 
KC216_04  9.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.48 ml K2SO4 
solution 
17 ml    
2-PrOH  15.0 
KC216_05  12.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.48 ml K2SO4 
solution 
17 ml    
2-PrOH  20.0 
KC216_06  18.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.18 ml K2SO4 
solution 
10 ml    
2-PrOH  50.0 
KC216_07  0.6 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  1.0 ml D,L-
valine solution 
30 ml    
2-PrOH  1.0 
KC216_08  3.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  1.0 ml D,L-
valine solution 
30 ml    
2-PrOH  5.0 
KC216_09  6.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.9 ml D,L-
valine solution 
27.5 ml 
2-PrOH  10.0 
KC216_10  9.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.8 ml D,L-
valine solution 
25 ml    
2-PrOH  15.0 
KC216_11  12.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.8 ml D,L-
valine solution 
25 ml    
2-PrOH  20.0 
KC216_12  18.0 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.3 ml D,L-
valine solution 
12.5 ml 
2-PrOH  50.0 
 
Table 42: Immobilisation of Lipase from the Native State with Various Excipients - Sample 
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After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. 
6.14.2  Immobilisation of Lipase from the Thermally Unfolded, 
Solubilised State - Sample Preparation 
Lipase (6 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 °C 
and then allowed to cool to room temperature.  The resultant protein aggregates were then 
solubilised  by  the  addition  of  6  M  GdnHCl.    This  solution  of  thermally  unfolded, 
solubilised protein was then used to prepare PCMC by mixing with a solution of excipient 
material  (K2SO4;  100  mg/ml  or  D,L-valine;  60  mg/ml)  before  precipitation  in  stirring 
organic  solvent  (1000  rpm).      The  volume  of  solvent  required  for  precipitation  was 
determined so as to keep the final water content of the solvent between 4 and 5 %.    
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Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC226_01 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.6 ml 
K2SO4 
solution 
20 ml    
2-PrOH  1.0 
KC226_02 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl  
0.6 ml 
K2SO4 
solution 
20 ml    
2-PrOH  5.0 
KC226_03 
6.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.54 ml 
K2SO4 
solution 
18.5 ml 
2-PrOH  10.0 
KC226_04 
9.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.48 ml 
K2SO4 
solution 
17 ml    
2-PrOH  15.0 
KC226_05 
12.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl  
0.48 ml 
K2SO4 
solution 
17 ml    
2-PrOH  20.0 
KC226_06 
18.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.18 ml 
K2SO4 
solution 
10 ml     
2-PrOH  50.0 
KC226_07 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
1.0 ml D,L-
valine 
solution 
30 ml    
2-PrOH  1.0 
KC226_08 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl  
1.0 ml D,L-
valine 
solution 
30 ml    
2-PrOH  5.0 
KC226_09 
6.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.9 ml D,L-
valine 
solution 
27.5 ml 
2-PrOH  10.0 
KC226_10 
9.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl  
0.8 ml D,L-
valine 
solution 
25 ml    
2-PrOH  15.0 
KC226_11 
12.0 mg lipase in  
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.8 ml D,L-
valine 
solution 
25 ml    
2-PrOH  20.0 
KC226_12 
18.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.3 ml D,L-
valine 
solution 
12.5 ml 
2-PrOH  50.0 
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After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.15 Appendix 15 
In order to determine if the addition of a redox couple could assist in the potential refolding 
of thermally unfolded lipase, the solubilised lipase was incubated with the redox couple of 
cystine/cysteine (0.3 mM: 3 mM).   
6.15.1  Immobilisation  of  Lipase  from  the  Native  State  - 
Sample Preparation 
Lipase was prepared for immobilisation by dissolving in 200 µl of 50 mM Tris/HCl, pH 
7.8 and subsequently mixed with an aqueous solution of excipient material (K2SO4; 100 
mg/ml  and  KCl;  300  mg/ml).    The  protein  and  excipient  solution  were  mixed  in  the 
appropriate ratio to achieve the desired protein loading before being added drop-wise to 
stirring organic solvent (1000 rpm).  The volume of solvent required for precipitation was 
determined so as to keep the final water content of the solvent between 4 and 5 %.   
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Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC240_01 
3.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.57 ml K2SO4 
solution 
20 ml     
2-PrOH  5.0 
KC240_02 
6.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.54 ml K2SO4 
solution 
19 ml    
2-PrOH  10.0 
KC240_03 
9.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.51 ml K2SO4 
solution 
18 ml    
2-PrOH  15.0 
KC240_04 
12.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.48 ml K2SO4 
solution 
17 ml    
2-PrOH  20.0 
KC240_05 
3.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.19 ml KCl 
solution 
10 ml    
2-PrOH  5.0 
KC240_06 
6.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.18 ml KCl 
solution 
10 ml    
2-PrOH  10.0 
KC240_07 
9.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.17 ml KCl 
solution 
9 ml      
2-PrOH  15.0 
KC240_08 
12.0 mg lipase + 
200 µl 50 mM 
Tris/HCl, pH 7.8 
Native  0.16 ml KCl 
solution 
9 ml      
2-PrOH  20.0 
 
Table 44: Immobilisation of Lipase from the Native State - Sample Preparation 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.16 Appendix 16 
6.16.1  Immobilisation of Lipase from the Thermally Unfolded, 
Solubilised State - Sample Preparation 
Lipase (6 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 °C 
and then allowed to cool to room temperature.  The resultant protein aggregates were then 
solubilised  by  the  addition  of  6  M  GdnHCl.    This  solution  of  thermally  unfolded, 
solubilised protein was then used to prepare PCMC by mixing with a solution of excipient 
material  (K2SO4;  100  mg/ml  or  D,L-valine;  60  mg/ml)  before  precipitation  in  stirring 
organic  solvent  (1000  rpm).      The  volume  of  solvent  required  for  precipitation  was 
determined so as to keep the final water content of the solvent between 4 and 5 %.    
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Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC240_17 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.57 ml 
K2SO4 
solution 
27 ml     
2-PrOH  5.0 
KC240_18 
6.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl  
0.54 ml 
K2SO4 
solution 
38 ml    
2-PrOH  10.0 
KC240_19 
9.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.51 ml 
K2SO4 
solution 
50 ml    
2-PrOH  15.0 
KC240_20 
12.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.48 ml 
K2SO4 
solution 
62 ml    
2-PrOH  20.0 
KC240_21 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.19 ml 
KCl 
solution 
17 ml    
2-PrOH  5.0 
KC240_22 
6.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl  
0.18 ml 
KCl 
solution 
 30 ml    
2-PrOH  10.0 
KC240_23 
9.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.17 ml 
KCl 
solution 
42 ml      
2-PrOH  15.0 
KC240_24 
12.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.16 ml 
KCl 
solution 
54 ml      
2-PrOH  20.0 
 
Table 45: Immobilisation of Lipase from the Thermally Unfolded, Solubilised State - Sample 
Preparation 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.17 Appendix 17 
6.17.1  Immobilisation of Lipase from the Thermally Unfolded 
State  with  the  Introduction  of  a  Redox  Couple  -  Sample 
Preparation 
Lipase (6 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 °C 
and then allowed to cool to room temperature.  The resultant protein aggregates were then 
solubilised by the addition of 6 M GdnHCl and the redox couple of 0.3 mM cystine and 3 
mM cysteine for disulfide rearrangement.  This mixture was incubated at room temperature 
for  two  hours  to  equilibrate  prior  to  being  utilised  in  the  formation  of  PCMC.    This 
solution of thermally unfolded, solubilised protein was then used to prepare PCMC by 
mixing with a solution of excipient material (K2SO4; 100 mg/ml or D,L-valine; 60 mg/ml) 
before  precipitation  in  stirring  organic  solvent  (1000  rpm).      The  volume  of  solvent 
required  for precipitation was determined so as to keep the final water content  of the 
solvent between 4 and 5 %.    
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Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC240_09 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.57 ml 
K2SO4 
solution 
27 ml     
2-PrOH  5.0 
KC240_10 
6.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.54 ml 
K2SO4 
solution 
38 ml    
2-PrOH  10.0 
KC240_11 
9.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.51 ml 
K2SO4 
solution 
50 ml    
2-PrOH  15.0 
KC240_12 
12.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.48 ml 
K2SO4 
solution 
62 ml    
2-PrOH  20.0 
KC240_13 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.19 ml 
KCl 
solution 
17 ml    
2-PrOH  5.0 
KC240_14 
6.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.18 ml 
KCl 
solution 
 30 ml    
2-PrOH  10.0 
KC240_15 
9.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.17 ml 
KCl 
solution 
42 ml      
2-PrOH  15.0 
KC240_16 
12.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.16 ml 
KCl 
solution 
54 ml      
2-PrOH  20.0 
 
Table 46: Immobilisation of Lipase from the Thermally Unfolded State with the Introduction 
of a Redox Couple - Sample Preparation 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
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6.18 Appendix 18 
PCMC were prepared of lipase at low protein concentration and loadings to see the effect 
upon the immobilised native and thermally unfolded enzyme. 
6.18.1  Immobilisation of Lipase from the Native State at Low 
Concentration and Loadings - Sample Preparation 
Lipase (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was prepared for immobilisation by mixing 
of the protein with an aqueous solution of excipient material (K2SO4; 100 mg/ml and KCl; 
300 mg/ml).  The protein and excipient solution were mixed in the appropriate ratio to 
achieve  the  desired  protein  loading  before  being  added  drop-wise  to  stirring  organic 
solvent (1000 rpm).  The volume of solvent required for precipitation was determined so as 
to keep the final water content of the solvent between 4 and 5 %.   
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC245_01  0.01 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  1.0 ml K2SO4 
Solution 
25 ml    
2-PrOH  0.01 
KC245_02  0.1 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.999 ml 
K2SO4 Solution 
27.5 ml    
2-PrOH  0.1 
KC245_03  0.5 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.995 ml 
K2SO4 Solution 
37.5 ml    
2-PrOH  0.5 
KC245_04  0.01 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.334 ml KCl 
Solution 
8.5 ml   
2-PrOH  0.01 
KC245_05  0.1 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.333 ml KCl 
Solution  
10.8 ml 
2-PrOH  0.1 
KC245_06  0.5 mg lipase in 50 
mM Tris/HCl, pH 7.8  Native  0.332 ml KCl 
Solution 
20.8 ml 
2-PrOH  0.5 
 
Table 47: Immobilisation of Lipase from the Native State at Low Concentration and Loadings 
- Sample Preparation Katrina A. Davidson, 2008                                                                                                 Appendices 
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After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
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6.19 Appendix 19 
6.19.1  Immobilisation of Lipase from the Thermally Unfolded, 
Solubilised  State  at  Low  Concentration  and  Loadings  - 
Sample Preparation 
Lipase (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 °C 
and then allowed to cool to room temperature.  The resultant protein aggregates were then 
solubilised upon addition of 6 M GdnHCl.  This solution of thermally unfolded, solubilised 
protein was then used to prepare PCMC by mixing with a solution of excipient material 
(K2SO4; 100 mg/ml and KCl; 300 mg/ml) before precipitation in stirring organic solvent 
(1000 rpm).  The volume of solvent required for precipitation was determined so as to keep 
the final water content of the solvent between 4 and 5 %.   
Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC245_07 
0.01 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with        
6 M GdnHCl 
1.0 ml 
K2SO4 
Solution 
25 ml    
2-PrOH  0.01 
KC245_08 
0.1 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with        
6 M GdnHCl  
0.999 ml 
K2SO4 
Solution 
27.5 ml    
2-PrOH  0.1 
KC245_09 
0.5 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with        
6 M GdnHCl  
0.995 ml 
K2SO4 
Solution 
37.5 ml    
2-PrOH  0.5 
KC245_10 
0.01 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with        
6 M GdnHCl  
0.334 ml 
KCl 
Solution 
8.5 ml   
2-PrOH  0.01 
KC245_11 
0.1 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with        
6 M GdnHCl  
0.333 ml 
KCl 
Solution  
10.8 ml 
2-PrOH  0.1 
KC245_12 
0.5 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with        
6 M GdnHCl   
0.332 ml 
KCl 
Solution 
20.8 ml 
2-PrOH  0.5 
 
Table 48: Immobilisation of Lipase from the Thermally Unfolded, Solubilised State at Low 
Concentration and Loadings - Sample Preparation Katrina A. Davidson, 2008                                                                                                 Appendices 
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After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
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6.20 Appendix 20 
6.20.1  Immobilisation of Lipase from the Thermally Unfolded, 
Solubilised  State  with  the  Addition  of  a  Redox  Couple  - 
Sample Preparation 
For the preparation of PCMC of lipase with the addition of a redox couple, the protein was 
thermally  unfolded  (1  mg/ml  in  50  mM  Tris/HCl,  pH  7.8)  by  heating  to  100  °C  and 
subsequently  allowed  to  cool  to  room  temperature.    The  solubilised  protein  was 
subsequently mixed with an aqueous solution of excipient (K2SO4; 100 mg/ml and KCl; 
300 mg/ml) prior to precipitation in stirring organic solvent (1000 rpm). The volume of 
solvent required for precipitation was determined so as to keep the final water content of 
the solvent between 4 and 5 %.  
 
 
 
 
 
 
 
 
 
 Katrina A. Davidson, 2008                                                                                                 Appendices 
206 
Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC245_13 
0.01 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
1.0 ml 
K2SO4 
Solution 
25 ml    
2-PrOH  0.01 
KC245_14 
0.1 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.999 ml 
K2SO4 
Solution 
27.5 ml    
2-PrOH  0.1 
KC245_15 
0.5 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.995 ml 
K2SO4 
Solution 
37.5 ml    
2-PrOH  0.5 
KC245_16 
0.01 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.334 ml 
KCl 
Solution 
8.5 ml   
2-PrOH  0.01 
KC245_17 
0.1 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.333 ml 
KCl 
Solution  
10.8 ml 
2-PrOH  0.1 
KC245_18 
0.5 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl with redox 
couple 
0.332 ml 
KCl 
Solution 
20.8 ml 
2-PrOH  0.5 
 
Table 49: Immobilisation of Lipase from the Thermally Unfolded, Solubilised State at Low 
Concentration and Loading - Sample Preparation 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.21 Appendix 21 
To determine if the addition of a catalytic concentration of enzymatic substrate would 
trigger refolding of thermally unfolded lipase and increase solubility of the immobilised 
samples, PCMC were prepared 
6.21.1  Immobilisation of Lipase from the Native State with the 
Addition of Catalytic Substrate at Room Temperature and 37 
ºC - Sample Preparation 
Lipase (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was prepared for immobilisation by mixing 
with 10 molar % pNPA before adding an aqueous solution of excipient material (K2SO4; 
100 mg/ml) before subsequent precipitation in stirring organic solvent (1000 rpm). The 
volume of solvent required for precipitation was determined so as to keep the final water 
content of the solvent between 4 and 5 %.  
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Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC253_01 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Native 
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1.0 
KC253_02 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Native 
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5.0 
KC253_03 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8  
Native at 37 °C 
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1.0 
KC253_04 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8  
Native at 37 °C 
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5.0 
KC253_05 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8  
Native in presence of 
pNPA 
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1.0 
KC253_06 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8  
Native in presence of 
pNPA  
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5.0 
KC253_07 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 + pNPA  
Native in presence of 
pNPA at 37 °C 
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1 
KC253_08 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 + pNPA 
@ 37 °C 
Native in presence of 
pNPA at 37 °C 
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5 
 
Table 50: Immobilisation of Lipase from the Native State with the Addition of pNPA at Room 
Temperature and 37 °C 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.22 Appendix 22 
6.22.1  Immobilisation of Lipase from the Thermally Unfolded, 
Solubilised State with the Addition of Catalytic Substrate at 
Room Temperature and 37 ºC 
Lipase (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 °C 
before solubilisation upon addition of 6 M GdnHCl.  A small concentration of enzymatic 
substrate (10 molar %) was added at this incubation step before the excipient material was 
added  (K2SO4;  100  mg/ml).    The  protein/excipient  mixture  was  then  subjected  to 
precipitation in stirring organic solvent (1000 rpm). The volume of solvent required for 
precipitation was determined so as to keep the final water content of the solvent between 4 
and 5 %.  
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Sample 
Identifier 
Protein Solution  Protein Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC253_09 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl  
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1.0 
KC253_10 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl 
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5.0 
KC253_11 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8  
Thermally unfolded, 
solubilised with 6 M 
GdnHCl at 37 °C 
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1.0 
KC253_12 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl at 37 °C 
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5.0 
KC253_13 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 + pNPA 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl in presence 
of pNPA 
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1.0 
KC253_14 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 + pNPA 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl in presence 
of pNPA 
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5.0 
KC253_15 
0.6 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 + pNPA 
@ 37 °C 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl in presence 
of pNPA at 37 °C 
0.6 ml 
K2SO4 
Solution 
30 ml    
2-PrOH  1.0 
KC253_16 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 + pNPA 
@ 37 °C 
Thermally unfolded, 
solubilised with 6 M 
GdnHCl in presence 
of pNPA at 37 °C 
0.57 ml 
K2SO4 
Solution 
89 ml    
2-PrOH  5.0 
 
Table 51: Immobilisation of Lipase from the Thermally Unfolded, Solubilised State with the 
Addition of pNPA at at Room Temperature and 37 °C 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 Appendices 
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6.23 Appendix 23 
6.23.1  Immobilisation  of  Lipase  from  the  Native  and 
Thermally Unfolded State Using a Syringe Pump – Sample 
Preparation 
Lipase (1 mg/ml in 50 mM Tris/HCl, pH 7.8) was thermally unfolded by heating to 100 °C 
and solubilised upon addition of 6 M GdnHCl and incubated under these conditions for 2 
hours.  The aqueous solution of excipient material (K2SO4; 100 mg/ml) was then added to 
the unfolded protein at a rate of 0.01 ml min
-1.  When the gradual mixing is complete, the 
protein/excipient mixture was added drop-wise to stirring organic solvent (1000 rpm).  The 
volume of solvent required for precipitation was determined so as to keep the final water 
content of the solvent between 4 and 5 %.  
Sample 
Identifier 
Protein Solution 
Protein 
Condition 
Excipient 
Solution 
Solvent 
Theoretical 
Protein 
Loading        
(% TPL) 
KC255_01 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Native  0.57 ml K2SO4 
solution  89  5.0 
KC255_03 
3.0 mg lipase in 
50 mM Tris/HCl, 
pH 7.8 
Unfolded with 
6 M GdnHCl 
0.57 ml K2SO4 
solution  89  5.0 
. 
Table  52:  Immobilisation  of  Lipase  from  the  Native  and  Thermally  Unfolded,  Solubilised 
State Using a Syringe Pump - Sample Preparation 
After  precipitation,  the  PCMC  samples  were  filtered  and  allowed  to  dry  completely 
overnight in a pierced-parafilm covered petri-dish.  The PCMC were subsequently scraped 
from the filter membranes and stored in glass vials on the bench top. Katrina A. Davidson, 2008                                                                                                 References 
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